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If you can keep your head when all about you
Are losing theirs and blaming it on you,
If you can trust yourself when all men doubt you,
But make allowance for their doubting too;
If you can wait and not be tired by waiting,
Or being lied about, don't deal in lies,
Or being hated, don't give way to hating,
And yet don't look too good, nor talk too wise:
If you can dream - and not make dreams your master,
If you can think - and not make thoughts your aim;
If you can meet with Triumph and Disaster
And treat those two impostors just the same;
If you can bear to hear the truth you've spoken
Twisted by knaves to make a trap for fools,
Or watch the things you gave your life to, broken,
And stoop and build 'em up with worn-out tools:
If you can make one heap of all your winnings
And risk it all on one turn ofpitch-and-toss,
And lose, and start again at your beginnings
And never breath a word about your loss;
If you can force your heart and nerve and sinew
To serve your turn long after they are gone,
And so hold on when there is nothing in you
Except the Will which says to them: "Hold on!"
If you can talk with crowds and keep your virtue,
Or walk with kings - nor lose the common touch,
If neither foes nor loving friends can hurt you,
If all men count with you, but none too much;
If you can fill the unforgiving minute
With sixty seconds' worth of distance run,
Yours is the Earth and everything that's in it,




I declare that I have written this thesis based on my own work and that any
contributions made by others have been clearly indicated. The work contained in





The haemangioblast is believed to be the common precursor of haematopoietic cells,
the endothelial cells that form the vessels as well as the mural cells associated with
the vessel endothelium. Despite its suggested existence, such a cell has eluded
discovery and isolation in vivo. Its existence has been inferred however, by in vitro
differentiation and analysis of embryonic stem (ES) cells. The possibility of
generating haemangioblastic progenitors from ES cells may have therapeutic
applications.
The flk-1 gene is believed to be a key marker of the haemangioblast. Flk-1 is a
receptor tyrosine kinase known to be expressed on a subset of mesodermal cells
designated to form the vasculature. Its role is believed to be to ensure the migration
of haemangioblastic precursors to the appropriate sites for further proliferation and
differentiation to the various vascular lineages.
A promoter trap strategy was used to target a single allele of the flk-1 gene with one
of two reporter constructs. One placed the EGFP reporter underflk-1 transcriptional
control, while the other transcribed the selectable HPRT enzyme, which could be
used to isolateflk-1 expressing cells in the HM1 hprt deficient ES cell line.
Homologous recombination was successfully achieved with both targeting vectors.
After initially promising results indicating that all targeted lines were appropriately
expressing the reporter, silencing of the GFP reporter was observed in both of the
successfully isolated targeted lines. The cause of silencing could not be deduced
although as both targeted lines were silenced, the design of the targeting vector may
have been responsible. Four HPRT targeted selectable lines were successfully
isolated. All lines showed appropriate transgene expression at high enough levels for
effective HAT selection to isolate pure populations offlk-1 expressing cells.
Two methods of deriving haemangioblastic progenitors from ES cells were tested for
their efficacy in the isolation of a pure haemangioblast population based on the
iii
expression offlk-1. Methylcellulose cultures were found to be highly variable and
problematic to carry out successfully whereas monolayer differentiation on collagen
IV was more consistent. This system was then used to optimise the differentiation
and selection regime applied to the flk-1/HPRT targeted cells in an attempt to isolate
a pure haemangioblast progenitor population.
F/&-7/HPRT targeted cells were marked with a constitutive GFP transgene,
differentiated and selected for/7&-7/HPRT expression on collagen IV. The selected
cells were injected into the blastocyst stage embryo to see whether a developmental^
more advanced cell population would survive and contribute to the expected cell
lineages.
Contribution of the GFP marked cells was observed in mesodermal and highly
vascularised organs such as the heart, liver and kidney but was absent from the
ectodermally derived brain. Expression was strongly localised around regions of
vascularisation but further transplantation experiments are required to assess whether
the injected cells were directly contributing to the vasculature, or whether they had a
broader potentiality as a result of dedifferentiation, reprogramming or contamination
by more primitive cells.
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Cell-based therapies are beginning to be considered as real possibilities in the
treatment of a variety of disorders resulting from irreversible cell loss or
degeneration, and where cell function has been lost or abrogated. Their success and
range of applications has been limited by an inability to source the appropriate cell
types, which will graft and proliferate, in a large enough quantity to be functionally
active, whilst maintaining cell identity and cell cycle integrity. The discovery of
embryonic stem (ES) cells and their pluripotency was a key step towards addressing
the limitations of somatic cell therapies. Although much remains to be done to
address problems of functionality, tumorigenicity and proliferative control in
differentiated ES cells, prior to transplantation or in situ transplanted ES cells post¬
transplantation, some indirect studies already hint at the powerful impact of ES cell
technology on disease and cellular degeneration (Kim et al., 2002; Nishimura et al.,
2003). With the isolation (Thomson et al., 1998) and successful differentiation of
human ES cells to a variety of cell lineages (reviewed by Pera, 2001), ES cell
transplantation as a therapeutic option has made a crucial move towards becoming a
reality and research is increasingly being directed to overcome the obstacles to its
success.
A model scenario for the therapeutic use of ES cells is to derive a lineage-specific
progenitor population in vitro, which is then transplanted to the required site to graft
and proliferate. The population should be free of undifferentiated ES cells that could
be tumorigenic in an inappropriately controlled environment. It should also be able
to respond to environmental cues to control its activity with respect to proliferation
and direction of differentiation.
This project has been designed to investigate the possibility of using an in vitro-
derived progenitor population therapeutically. The progenitor population chosen for
investigation is the haemangioblast: the hypothesised precursor to all cells that
comprise the vertebrate vasculature. By deriving a pure haemangioblastic population
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from ES cells in vitro, and transplanting the cells back into embryos and tracking the
progress of the cells, several questions will be addressed. It has yet to be tested
whether in vitro differentiation protocols adequately mimic in vivo events. The
stringent controls and complex signalling molecules' interactions, present in the
developing embryo as well as the adult organism, may be beyond our scope for
understanding and almost certainly beyond our abilities to replicate in culture.
However it may not be necessary to replicate these exact scenarios to obtain a
population of cells recognisable by the intrinsic signalling machinery of the organism
in which they are transplanted. The only possible requirement is that once engrafted,
a functioning cell population carrying enough of the differentiated characteristics,
such as cell surface receptors and activated transcription factors, is maintained long
enough to be captured by the appropriate pathways and directed to carry out its
designated function.
A haemangioblastic or endothelial progenitor population could have therapeutic
potential in several disorders. Endothelial dysfunction is commonly associated with
atherosclerosis and the onset of coronary syndromes. Loss of endothelial function
results in a loss of vasomotor control, reduction in nitric oxide production and
elevated levels of inflammation and the development of a procoagulant surface
(Kathir and Adams, 2003). Type 2 diabetes can also lead to endothelial dysfunction
as can hypertension, both of which ultimately result in organ damage. Alzheimer's
disease has also been postulated to be a microvascular disorder with
neurodegenerative consequences instead of the reverse, which was previously
thought to be the case (de la Torre and Stefano, 2000). Endothelial progenitors
could aid the repair of the endothelial layer gaps that appear in advancing stages of
Alzheimer's disease.
3
1.2. Aims of this Project
To utilise transgenic strategies to enable the selection of a defined haemangioblastic
or endothelial progenitor population.
To test the in vivo viability and functionality of a purified haemangioblastic or
endothelial progenitor population derived from the differentiation of ES cells.
1.2.1. Objectives
• Genetic modification of a murine ES (mES) cell line at the flk-1 locus using
gene targeting, to enable the identification and isolation of a pure population
of haemangioblastic progenitors.
• Optimisation of in vitro differentiation protocols for the derivation of
haemangioblastic precursors from mES cells.
• Isolation of a pure population of haemangioblastic precursors in vitro.
• Gauging the repopulation capacity of the isolated haemangioblastic
progenitors and thus the ability to isolate a transplantable progenitor
population in vitro by transplantation into murine embryos.
• Blastocyst injection offlk-1 heterozygous knockout ES cell lines to generate
chimaeric mice, and following germline transmission, the generation of
heterozygous knockout mice to track haemangioblast expression. (The
ultimate intention was to discover whether an ES cell-derived
haemangioblastic population is sufficient to rescue a lethal gene knockout
that prevents the development of intrinsic haemangioblasts).
1.3. Background
1.3.1. Embryonic Carcinoma Cells
Teratomas are tumours that consist of a disorganised mass of differentiated cells and
tissues derived from any or all of the three germ layers (Solter and Damjanov, 1979;
Martin, 1980; Mintz and Fleischman, 1981). They are referred to as germ cell
tumours due to their being commonly found in the gonads (Etooper, 1991).
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The differentiated cells comprising the tumour arise from a pluripotent and malignant
cell population of embryonic carcinoma (EC) cells. The differentiated cells are
benign and it is the activity of residual EC cells that are the cause of malignant
teratomas, also known as teratocarcinomas. Teratocarcinomas can be generated
experimentally by the transplantation of genital ridges consisting of primordial germ
cells (PGCs) of male embryos from certain mouse strains or the grafting of early
embryos from most strains (Hooper, 1991). The strain specificity of teratogenesis in
PGCs can be attributed to genetic variation between strains. However, the ability of
teratomas to form from epiblast cells from most mouse strains can only be attributed
to the inherent properties of the epiblast that liken them to EC cells and not to
oncogenic mutations. This hinted at a close functional relationship between EC cells
and a population of cells that had a similar potentiality and parallel role within a
developing embryo (Stevens, 1958; Pierce and Beal, 1964). This implied that EC
cells were essentially the same as the cells within the epiblast, only differing due to
extrinsic influences and stimuli they received from their microenvironment. This
was supported by observations that EC cells contributed to many tissues in the
development of embryos without disrupting the normal course of differentiation and
tissue formation when transplanted into an embryo.
The growing understanding of the properties of EC cells and especially the fact that
tumorigenicity was not a property of all EC cell lines emphasised the importance of
the microenvironment in their isolation and maintenance. This provided the stimulus
to isolate equivalent cells from the early embryo, which, when cultured in vitro, form
ES cells.
1.3.2. Embryonic Stem Cells
1.3.2.1. Isolation of ES Cells
ES cells were first derived in 1981 using two different isolation methods (Evans and
Kaufman, 1981; Martin, 1981). Evans and Kaufman cultured blastocysts after
implantational delay by ovarioectomy, selecting and subculturing the inner cell mass
(ICM) cells on feeder cells until an ES cell line was established. Martin isolated
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ICM cells using immunosurgery which involved the lysis of the exposed
trophectoderm with a readily binding antibody that could trigger the complement
cascade when its constituents were added to the cells (Solter and Knowles, 1975;
Martin, 1981), leaving only the ICM remaining. These ICM cells were used to
establish ES lines after culture on feeder layers but also included the addition of
conditioned medium from the PSA-1 EC cell line (Martin, 1981).
These two strategies have since been modified and perfected. It is now known that
neither implantation delay nor the addition of conditioned medium is crucial for the
success of ES cell isolation methods (as long as leukaemia inhibitory factor (LIF) is
included in the isolation medium). Genetic background appears to be a key issue in
the successful isolation of ES cells from murine embryos, with success being limited
mostly to 129 and C57BL/6 strains. Embryonic stage seems less of an important
factor with ES cells being isolated from morulae (Eistetter, 1989) as well as from
early postimplantation embryos (Wells et al., 1991). More recently, ES cell lines
from CBA strain mice - a strain known to be refractory to ES cell isolation, have
been isolated using transgenic strategies (McWhir et al., 1996; Gallagher et al.,
2003). As well as strain specificity, there also appears to be a selective pressure in
favour of male lines. This may be due to an absence of X-chromosome inactivation
(Robertson et al., 1983) or lack of imprinting of the X-chromosome in female ES cell
lines.
ES cells have not been subjected to as abnormal a microenvironment as EC cells are
subject to in tumorigenesis and they are therefore believed to mimic the natural
course of embryonic development more accurately than EC cells (Beddington and
Robertson, 1989). However, the exact developmental stage that corresponds to ES
and EC cells is more ambiguous. The expression profile of some lines of EC cells
show greater similarities to the epiblast than other cell types in the embryo (Dewey et
al., 1978; Martin et al., 1978b; Lovell-Badge and Evans, 1980).
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1.3.2.2. Obstacles to ES Cell Isolation in Other Species
Until the recent isolation of human ES (hES) cells, ES cell isolation has been limited
to certain inbred strains of mice and several F1 strains. Although ES cells has been
reported from a range of species such as rat (Iannaccone et al., 1994), chick (Pain et
al., 1996), pig (Shim et al., 1997), horse (Saito et al., 2002), rabbit (Graves and
Moreadith, 1993) and fish (Sun et al., 1995), none have been proved in the
generation of germline chimaeras, germline transmission being the widely accepted
test of true pluripotency. HES cells cannot be tested in such a way for obvious
ethical objections.
1.3.3. Properties of mES Cells
1.3.3.1. Maintenance of ES cell pluripotency
1.3.3.1.1. Leukaemia Inhibitory Factor
ES cell isolation was carried out by culturing the ICM and the resulting ES cell lines
on feeder cells - typically murine foetal fibroblasts. It was discovered that the
soluble factors secreted by the feeder layer were enough to maintain ES cell
pluripotency and conditioned medium from the buffalo rat liver (BRL) cell line was
sufficient for ES cell survival and self-renewal (Smith and Hooper, 1987). The
cytokine responsible for this activity in the conditioned medium was identified as
LIF (Smith et al., 1988).
The LIF knockout mouse is viable and lives to adulthood although females are sterile
(Stewart et al., 1992). This indicates that survival of the epiblast cells is not solely
dependent on the activity of LIF and that there must be pleiotropy between LIF and
other members of the cytokine family to which it belongs. LIF binds to a
heterodimer between the LIF receptor and the glycoprotein 130 (gpl30)
transmembrane receptor to maintain ES cells in the pluripotent state, reminiscent of
the cells of the epiblast. Stimulation of gpl30 results in the activation of signal
transducer and activator of transcription 3 (Niwa et al., 1998) and the MEK/ERK
signalling pathway (Burdon et al., 1999). In the absence of LIF, gpl30 homodimers
can be activated by binding interleukin 6 (IL6). In vitro, IL6 cannot be used in place
of LIF for the maintenance of ES cells unless the IL6 receptor (which ES cells do not
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express) is provided in its soluble form (Nichols et al., 1994; Yoshida et al., 1994).
This functional redundancy may explain the non-lethal phenotype of the LIF
knockout. The knockout of the LIF receptor is lethal, resulting in severe
developmental abnormalities. These defects do not emerge until after implantation
(Ware et al., 1995). The gpl30 knockout mouse also develops normally beyond the
epiblast stage of development until midgestation (Yoshida et al., 1996), again
signifying the non-essential role of gpl30-mediated signalling for the survival of the
pluripotent cells in the epiblast. However murine embryos lacking gpl30 do not
survive past the epiblast stage if they go through diapause (a process of implantation
delay seen in mice that become pregnant when they are lactating, or after severe
environmental stresses) suggesting a role for gpl30-mediated signalling in the
maintenance of the epiblast through diapause (Nichols et al., 2001).
1.3.3.1.2. Oct4
The octamer binding protein 4 (oct4) is a member of the POU (Pit, Oct, Unc) family
of transcription factors, which have various roles in development. Oct4 is
ubiquitously expressed in the blastomeres of the early embryo before becoming
restricted to the ICM and the epiblast (Pesce et al., 1998). It is a key transcription
factor in the maintenance of ES cell pluripotency and is essential for the formation of
the ICM. Similar to LIF, oct4 has a role in the activation of STAT3 and the
maintenance of pluripotency. Unlike LIF however, the knockout is lethal and results
in the failed development of pluripotential ICM (Nichols et al., 1998).
1.3.3.1.3. Nanog
Human ES cells fail to respond to gpl30 stimulation as is seen in mES cells. This
hints at the possibility of there being alternative mechanisms that could maintain
pluripotency. Recently a transcription factor called nanog has been identified in the
ICM and in ES cells that has a role in maintaining pluripotency but which acts
independently of gpl30 and STAT3 signalling (Chambers et al., 2003; Mitsui et al.,
2003). Interestingly, the nanog knockout phenotype was comparable with the
phenotype observed when oct4 was overexpressed: embryonic cells and ES cells
differentiated to parietal endoderm; it may therefore act to suppress differentiation to
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the endodermal lineage. Nanog was also found not to function properly in the
absence of oct4 hinting at a cooperative balance of the two transcription factors in
the maintenance of pluripotency. Figure 1.1 shows a schematic of the key genes
involved in the regulation of ES cell self-renewal and the decision to differentiate.
Primitive Endodeim
Germ Layers
Figure 1.1 Interactions and influences of transcription factors in the maintenance and loss of
pluripotency. Oct4 and nanog are both essential for the maintenance of ES cell self-renewal.
Oct4 blocks trophoblast differentiation and promotes differentiation to the endodermal
lineage and the germ layers. Nanog blocks the differentiating influence of Oct4 and in so
doing, also positively regulates Oct4, which is downregulated by the process of
differentiation. STAT3, activated by the influence of LIF, carries out a similar role to Nanog.
Figure adapted from Chambers et at. (2003).
1.3.4. Embryonic Germ Cells
A third source of pluripotent cells can be isolated from the primordial germ cells of
the genital ridge. When cultured in the presence of LIF, stem cell factor (SCF) and
basic fibroblast factor (Kazemi et al., 2002), they proliferate and behave as ES cells
do and are known as embryonic germ (EG) cells (Matsui et al., 1992; Resnick et al.,
1992). They have similar properties and expression patterns to ES cells and the only
key difference between the two types of cells is the imprinting status of EG cells
derived from latter stage PGCs (after approximately 10 days post coitum (dpc)) when
their genomic imprinting status has been lost. As a consequence, EG cells from
older embryos are unable to contribute to the germline of chimaeras (Labosky et al.,
1994).
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1.4. Murine ES Cell Differentiation
The pluripotency of ES cells has been greatly exploited for germline modification
and the generation of transgenic mice. In vitro differentiation has enabled the
modelling of in vivo events during development that would otherwise be
inaccessible, thus allowing complex pathways and associated signalling mechanisms
to be dissected. Despite the removal of the microenvironment that would provide
much of the direction for a differentiating cell, some headway has been made in the
mimicry of various factors that may constitute what a differentiating cell would
encounter in its in vivo microenvironment.
Beyond the possible oversimplification of the microenvironment, and despite their
ability to contribute to germline chimaeras, it has been observed in several studies
that the imprinting status of ES cells can be relaxed (Poirier et al., 1991; Allen et al.,
1994; Szabo and Mann, 1994). The targeting of several key proto-oncogenes
highlighted disparities between in vivo and in vitro phenotypes as a consequence of
gene loss. C-fos (Field et al., 1992; Hilberg and Wagner, 1992) and c-myc (Davis et
al., 1993) showed no apparent alteration of ES cell behaviour or differentiation yet
the in vivo implications of their loss was severe and led to noticeable abnormalities.
Such possibilities must be considered in the in vitro modelling of developmental
events. ES cells may not manifest the complete range of developmental functions
and requirements because of the absence of the same physical delineation of
differentiated cell populations or barriers to cell signalling and differentiation. This
could lead to redundancy in several signalling mechanisms allowing for the
compensation of function that could not occur in vivo.
When cultured in suspension, in the absence of LIF, both EC and ES cells generate
embryoid bodies (EBs), as well as differentiated cells from the three germ layers
(Martin et al., 1977; Doetschman et al., 1985). In EBs (called this because of a
phenotypic resemblance to the egg cylinder stage embryo (Hooper, 1991)), cells
were seen to undergo compaction, similar to the morula stage of the embryo. The
surface develops to comprise endodermal cells and the ball of cells eventually
develops a cavity. The internal cells were seen to form a variety of differentiated
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tissues. (Martin et al., 1977; Doetschman et al., 1985; Karbanova and Mokry, 2002).
Cavitation of the EBs has been found to be a crucial step in their further
differentiation. Cystic EBs form spontaneously (Evans and Kaufman, 1981; Martin,
1981). Similar cavitation is seen in the embryonic YS and is a result of apoptotic
mechanisms (Doetschman et al., 1985; Wang et al., 1992; Goumans et al., 1999).
The mechanisms that form the cavity in a developing embryo and those that form the
cavity in an EB are distinct however (Boyd et al., 1984). In many differentiation
systems, transcriptional activation and the subsequent expression of receptor
molecules and cell surface markers to conduct signalling cascades for differentiation
are identical to those seen in the tissue of question in the developing embryo.
For the purposes of this project, in vitro models of haematopoiesis and
vasculogenesis in particular will be discussed in Section 1.9.
1.5. The isolation of Human ES Cells
Following the isolation of primate ES cells in 1995 (Thomson et al., 1995), human
ES cells were successfully isolated from blastocyst stage embryos for the first time in
1998 (Thomson et al., 1998). Although initially they required growth on murine
embryonic fibroblasts, a conditioning regime that eliminated the need for an actual
feeder layer was eventually created (Xu et al., 2001). These hES cells (including
clonally derived cell lines) were found to be karyotypically normal, had high
telomerase activity and were proven to be able to differentiate to the three germ layer
both in vivo after injection into SCID mice (Thomson et al., 1998) and in vitro
following the generation of EBs(Itskovitz-Eldor et al., 2000) (Amit et al., 2000;
Eiges et al., 2001).
1.5.1.1. Differentiation Capability of HES Cells
The pattern of differentiation for hES cells is similar to what is seen for mES cells
(as discussed in greater detail in section 1.4). Initially spherical structures, consisting
of densely packed cells form. These eventually cavitate and form cystic EBs. Cells
from all three germ layers have been detected including haematopoietic cells
(Kaufman et al., 2001), insulin secreting p cells (Assady et al., 2001),
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neuroectodermal cells (Reubinoff et al., 2000; Schuldiner et al., 2001) and
cardiomyocytes (Itskovitz-Eldor et al., 2000).
Endothelial cells have also been successfully isolated from hES cells (Levenberg et
al., 2002). 13-15 day-old EBs were found to contain vascular cells isolated on the
basis of expression of platelet-endothelial cell adhesion molecule 1 (PECAM-1) and
vascular endothelial cadherin (VE-Cadherin). Cells expressing these two markers
formed vessel-like structures. When injected into SCID mice, PECAM-1+ cells
formed microvessels, some of which were found to exhibit functionality and had
murine blood in their lumen. Interestingly, flk-1 was expressed in undifferentiated
cells. This was thought to represent either a differentiated subpopulation within the
growing cells or was another variable between hES cells and mES cells that are
reported not to express flk-1 in the undifferentiated state.
1.5.1.2. Variation between hES and mES cells
There are several key differences between murine and human ES cells. The most
obvious is the morphological variation that is apparent as well as hES cells'
requirement for a more substantial matrix to attach to, either as a feeder layer or
Matrigel. Whereas mES cells grow three-dimensionally as well as spreading over
the culture surface, hES cells have been observed to grow flatter in culture. HES
cells also appear to have a different surface marker expression pattern. Whereas
mES cells show expression of stage-specific embryonic antigen-1 (SSEA-1) and lack
of expression of SSEA-3 and SSEA-4, the opposite is seen in hES cells. Another
interesting disparity between mES and hES cells is the inability of hES cells to
respond to LIF (Thomson et al., 1998; Pera et al., 2000). This is also seen in human
EC cells (Pera et al., 1989; Roach et al., 1993) and primate ES cells (Thomson and
Marshall, 1998). In the murine embryo, LIF signalling is known to play a role in the
survival of the epiblast through diapause (Nichols et al., 2001); human embryos are
probably unresponsive to LIF due to the absence of a mechanism for implantation
delay. With the discovery that nanog signalling maintains pluripotency in the
absence of STAT3 activation, evidence is suggesting that in hES cells, an alternative
12
mechanism for the maintenance of pluripotency is dominant over that initiated by
STAT3 activation.
1.6. Adult Stem Cells as Alternative Sources of
Therapeutic Cells
Stem cells persist in the adult, residing in niches that control their activity and
proliferation. These adult stem cells (ASCs) enable lifelong cellular renewal in
anatomical systems that require continual regeneration such as the haematopoietic,
nervous and gastrointestinal systems and in the skin, hair follicle and the circulation
(Raff, 2003).
The existence of ASCs was known of several decades before the discovery of ES
cells, mainly through the study of the haematopoietic stem cell (Kumaravelu et al.,
2002). Their study has increased understanding of development and differentiation
of various cell types and has led to transplantation therapies such as bone marrow
transplantation for the treatment of blood disorders and leukaemias. The importance
of the existence and function of a stem cell niche is highlighted by the lack of
success when bone marrow transplantation is used for conditions such as myeloid
metaplasia and myeloproliferative disorders where the stem cell niche is permanently
damaged by fibrosis of the bone marrow. In such cases, when bone marrow
transplantation is used, engraftment is often unsuccessful (Singhal et al., 1995;
Gurevitch et al., 1999; Daley, 2002).
1.6.1. Traditional Beliefs Regarding ASC Potentiality
Until recently, it was believed that ES cells were the only truly pluripotent cell type;
ASCs were thought to be multi-potent, with the ability to differentiate to form a set
of distinct yet related cell types, but unable to differentiate to form cell types from a
different tissue type or germ layer.
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1.6.2. Possible Pluripotency of ASC
Several studies challenged these beliefs and hinted at the possible pluripotency of
ASCs from a variety of niches. Not only do ASCs appear to be able to differentiate
to lineages that are entirely unrelated to the location of their residing niche, but there
have also been examples of stem cells differentiating into lineages that belong to
another germ layer. First, it was shown that cells from muscle and the brain were
able to contribute to haematopoiesis (Bjomson et al., 1999; Jackson et al., 1999).
Haematopoietic stem cells, the best-characterised ASCs, have also been directed
down many different lineages including hepatocytes and neurons (Lagasse et al.,
2000; Thiese et al., 2000; Krause et al., 2001). Muscle and blood cells have been
derived from the stem cells of either system (Jackson et al., 1999; Gussoni et al.,
1999) however, much controversy still remains regarding ASC plasticity. The
possible mechanisms under play in ASC maintenance and plasticity include
transdifferentiation, de-differentiation, fusion and the existence of multiple stem cell
types or a universal pluripotent ASC (Wagers and Weissman, 2004).
One study by Catherine Verfaillie's group has identified a population of
mesenchymal stem cells entitled multipotent adult progenitor cells (MAPCs) (Jiang
et al., 2002). These cells have shown remarkable potentiality and have been
differentiated to numerous lineages from all three germ layers (Reyes and Verfaillie,
2001; Reyes et al., 2002; Schwartz et al., 2002; Zhao et al., 2002; Zhao et al., 2002).
Upon injection, they are able to colonise the mouse blastocyst and form a chimaera,
however they have yet to be shown to colonise the germline. MAPCs are a product
of extended culture in vitro, under the stressful conditions of low density and low
serum supplementation. It is a matter of some debate whether these cells actually
reside in the bone marrow or whether culture of mesenchymal stem cells under these
conditions results in the abrogation of the expected cell-cell interactions, signalling
and growth factor release to maintain the normal potentiality of a mesenchymal stem
cell. This loss of control in the absence of a niche could result in the cells being left
to either die or differentiate and senesce, with a minority dedifferentiating to a more
primitive and pluripotent state.
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The Verfaille studies have been supported with the discovery of marrow-isolated
adult multilineage (MIAMI) cells (D'Ippolito et al., 2004). These cells are distinct
from MAPCs with respect to their expression profile but have a similarly broad
potentiality for differentiation. Although care was taken in order to recreate an in
vivo microenvironment thought to support stem cells, these cells were also subject to
culture at low density for a prolonged period of time and must be considered with
caution as a true pluripotent stem cell population. Encouragingly, MIAMI cells did
show oct-4 and rex-1 expression, both of which are typically expressed by ES cells.
Also, MIAMI cells have been easily isolated from many individuals of varying age
and do not appear to senesce or lose their differentiation potential following
extensive time in culture (D'lppolito et al., 2004).
Knowledge of the effects of niches on the development of primitive progenitor
populations, and the signalling pathways that control cellular migration, expansion
and differentiation is accumulating fast. Learning more about the lineage boundaries
in place and the resolution of several conflicting findings will hopefully not be long
in the coming and will elucidate the true pluripotency of ASCs.
Recent investigations into the nuclear reprogramming capabilities of ES cells when
cultured with somatic cells have given rise to an alternative explanation for ASC
plasticity. Somatic neural cells and bone marrow cells were cultured with murine ES
cells. Where the somatic cells were found to appear ES cell-like, it was found that
the ES cells and the somatic cells had fused spontaneously, generating hybrid
tetraploid cells that had the ability to proliferate rapidly and were able to contribute
to the three germ layers (Pells et al., 2002; Terada et al., 2002; Ying et al., 2002).
Observations of spontaneous fusion in vivo have since been documented in the liver
(Vassilopoulos and Russell, 2003; Wang et al., 2003). Alvarez-Dolado et al. (2003)
showed that bone marrow cells could contribute to non-haematopoietic lineages e.g.
cardiomyocytes, hepatocytes and Purkinje neurons, but that in all instances, this
contribution could be attributable to cell fusion. Only further understanding of the
behaviour of ASCs and their tracking in vivo will enable their true mode of action
and potentiality to be deciphered.
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1.7. Ethical Implications of the Use of ES Cells
ES cells have key advantages for use as a therapeutic tool over ASCs. Their
potential and molecular profile is better characterised and their differentiation to a
multitude of lineages has to date been more easily achieved. They also proliferate
more quickly than ASCs and can be maintained as healthy cell populations in vitro
more easily. After their isolation from human embryos (Thomson et al., 1998;
Reubinoff et al., 2000), their potential use for generating cell-based therapies has
been avidly investigated. ASCs have not been overlooked entirely for therapeutic
applications however because they hold two key advantages over ES cells as a
therapeutic tool. The ethical implications of isolating and utilising hES cells are
already a key issue. Not only does their isolation require the destruction of a
developing human embryo, but also, to obtain fully histocompatible cells would
require therapeutic cloning of an embryo using a recipient-derived cell. Recipient-
derived ASCs would be histocompatible, and the use of ASCs would overcome any
moral issues arising from the destruction of a living embryo or carrying out the
cloning process.
1.8. Gene Targeting
Germline modification was initially achieved by inserting exogenous DNA into the
genome via retroviral transfection or direct pronuclear microinjection into a fertilised
egg (Jaenisch, 1988). These methods of transgenesis lent themselves to the study of
gene function and regulation. However, they were limited in their utility due to the
crudeness of the techniques being used. DNA could only be inserted and the sites of
integration were, on the whole, random.
The ability of endogenous chromosomal DNA and exogenous DNA to recombine at
homologous sites has enabled the "targeting" and modification of any genetic locus.
This strategy has been used for over a decade to introduce subtle changes to the
mouse genome.
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ES cell technology, specifically the ability to genetically modify ES cells using
homologous recombination, has bridged genetic manipulation of the genome with the
study of development in the mouse model. The development of gene-targeting has
enabled scientists to make predetermined changes to most genetic loci and study the
effects of the resulting genetic disruption in heterozygotes, and homozygotes where
homozygosity is not lethal., Typically, a reporter gene is inserted into the locus of
interest in an ES cell line, disrupting the expression of the endogenous gene whilst
also sequestering the gene of interest's transcriptional control. Blastocyst injection
of the modified ES cells can give rise to chimaeric mice with possible ES cell-
derived germ cells. Backcrossing the chimaeras can generate heterozygotes, which
in turn can be bred to homozygosity if the loss of gene function is not lethal. By
tracking the reporter gene expression in the heterozygous and homozygous mutants,
the expression pattern and gene function can be studies.
The first endogenous gene to be modified by gene targeting was the P-globin gene in
foetal fibroblasts (Smithies et al., 1985). The rate of homologous recombination to
non-homologous recombination was 1:1000. The first instance of gene targeting in
ES cells was carried out by Thomas et al. (Thomas et al., 1986) where a similar
targeting frequency was observed to that seen in foetal fibroblasts. This inherent
ability provided a convenient method of modifying any genetic locus and introducing
the resultant changes to the germline of the resulting chimaeric mice because
karyotypically normal ES cells have the ability to colonise the germline (Bradley et
al, 1984).
1.9. In Vitro Models of Haematopoiesis
1.9.1. Spontaneous Haematopoietic and Vascular
Differentiation
Although direct studies of embryogenesis have contributed to a greater
understanding of early developmental processes such as haematopoiesis, technical
difficulties have hampered discoveries. Such problems include accessing the
embryo, which has a very low total cell number when the haematopoietic system
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arises, distinguishing cell types e.g. identifying the haemangioblast from multipotent
mesoderm and deciphering the potentiality of a progenitor population. In vitro
differentiation of ES cells has enabled scientists to model the in vivo processes that
take place for the development and differentiation of the haematopoietic system. The
use of ES cells targeted at genetic loci believed to have critical roles in
developmental processes have also aided the unravelling of the molecular
mechanisms that guide differentiation and development.
When placed in conditions that promote the aggregation and formation of EBs from
ES cells, the aggregates are able to differentiate spontaneously to many lineages
(Evans and Kaufman, 1981; Martin, 1981; Doetschman et al., 1985). EBs have been
established in culture as a way of mimicking the spatial organization of
differentiating cells in the embryo (Nishikawa et al., 1998a). It was through these
structures that haematopoiesis was first observed in vitro (Doetschman et al., 1985;
Wiles and Keller, 1991).
Doetschman et al. (Doetschman et al., 1985) investigated the in vitro differentiation
of EBs extensively. They noted that by day 8-10, approximately 50% of EBs were
cystic. 30% of these exhibited cardiogenesis and when cultured in Iscove's modified
Dulbecco Medium (IMDM) with cord blood serum 30% formed blood islands
(Doetschman et al., 1985). Cystic EBs have also been observed to form vascular
channels from these blood islands, some of which were found to contain
haematopoietic cells (Wang et al., 1992). ES cell-derived haematopoietic cells
showed the full complement of globin genes expressed in the correct temporal order
as in the developing embryo (Lindenbaum and Grosveld, 1990). Plating in
methylcellulose simulated the same colony forming cells as are derived from bone
marrow (Schmitt et al., 1991) and the synthesis of embryonic and adult globins
(Wiles and Keller, 1991). The addition of erythropoietin increased the incidence of
erythroid cells in methylcellulose cultures of ES cells (Wiles and Keller, 1991).
Close examination showed that the pockets of blood cells seen in the EBs were
surrounded by an endothelial layer on either side (Doetschman et al., 1985). This
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observation of simple spontaneously differentiating EBs shows the close relationship
of the vascular and haematopoietic lineages even in the absence of organising signals
in an otherwise disorganised mass of differentiating cells. This ability has enabled
the in vitro study of the molecular events that determine cellular differentiation in ES
cells and can be extrapolated to probable events in the developing embryo. Until the
development of the methylcellulose assay for haematopoietic colonies, only
erythroid cells could be identified from differentiated EBs and their appearance was
highly variable (Doetschman et al., 1985). Definitive haematopoietic precursors can
also be observed in EBs soon after primitive erythroid cells appear (Keller et al.,
1993).
1.9.2. Isolation of the Haemangioblast in Vitro
The haemangioblast is believed to emerge directly after mesoderm specification in
vivo (in vivo development of the vasculature is discussed in greater detail in section
1.10). At this time, there are few cells in the developing embryo, which is, in turn,
difficult to access for isolation of the haemangioblast. Studies of haemangioblast
specification and characterisation have therefore turned to in vitro models from ES
cell differentiation.
The BLast-Colony-Forming Cell (BL-CFC) is detected in ES cell culture and its
existence goes some way to corroborating the possible existence of the
haemangioblast. BL-CFCs respond to VEGF (see Section 1.10.4.1 for details of
VEGF's action in haemangioblast specification), form blast colonies (undefined
colonies in methylcellulose culture) that express FLK-1, a key marker of the putative
haemangioblast (Section 1.10.4.2) and eventually differentiate down both
haematopoietic and endothelial lineages after being grown in a methylcellulose
matrix (Kennedy et al., 1997; Choi et al., 1998). In this culture system, both
primitive and definitive haematopoietic elements are seen. The clonal nature of these
colonies was confirmed with a mixing experiment whereby two differentially
labelled ES cell lines were mixed prior to the setting up of the BL-CFC assay. It was
found that the blast colonies were from either one or the other ES cell line (Kennedy
et al., 1997; Choi et al., 1998).
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BL-CFCs are evident in 2.5-3.5-day-old EBs (Kennedy et al., 1997; Choi et al.,
1998). They are a transient population that appear before other haematopoietic and
endothelial populations (Kennedy et al., 1997; Choi et al., 1998). In methylcellulose
culture they form blast colonies that express FLK-1, SCL/TAL-1, CD34 and GATA-
1, all of which are markers expressed by haematopoietic progenitors. The FLK-
1/VEGF interaction is believed to be important for the proliferation and
differentiation of these precursors. Residual haematopoiesis in flk-1'1' embryos show
that the interaction is not required for mesoderm commitment as is true in the
embryo (Kennedy et al., 1997). It has been observed that when FLK-1+ cells are
supplied with VEGF, both endothelial and haematopoietic cells form, however, when
VEGF is not supplied, FLK-1+ cells differentiate down the haematopoietic lineage
only (Eichmann et al., 1997). This may appear to contradict findings that in the
absence of VEGF, FLK-1+ cells differentiate to form mural cells (Yamashita et al.,
2000). Elowever, as neither study addresses the possibility of other lineages being
differentiated other than the ones of interest, it may be the case that both
haematopoietic and smooth muscle cells form from FLK-1+ cells in the absence of
VEGF.
BL-CFC did not express brachyury therefore they were at a more advanced stage
than mesoderm (Kennedy et al., 1997). They could be differentiated further to form
haematopoietic colonies, expressed haematopoietic markers and both primitive and
definitive globin genes. Blast colonies formed from BL-CFCs, expressed FLK-1 and
responded to VEGF. They had the capacity to differentiate to endothelial and
haematopoietic lineages. Once picked and plated in Matrigel, 30-40% of blast
colonies derived from 3.25-day-old EBs could differentiate to both endothelial and
haematopoietic lineages (Kennedy et al., 1997). The remainder produced only
haematopoietic progeny. The fact that blast colonies derived from so-called BL-
CFCs appear to have the bipotentiality to differentiate down both endothelial and
haematopoietic lineages supports the argument in favour of the existence of the
haemangioblast (Choi et al., 1998).
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2.5-day-old EBs were found to have the highest (75%) level of bipotentiality and as
the age of the EBs increased, the level of bipotentiality dropped. 3.5-day-old EBs
had a <25% bipotentiality. This indicated that the BL-CFC was a transient cell
population and a likely in vitro model of the presumptive haemangioblast.
Doetchmann et al. (Doetschman et al., 1985) suggested that blood islands could only
be induced via three-dimensional EBs, a concept that has been carried through by
convention to the present day in the in vitro culture systems that have been
developed. Nishikawa et al. (1998a) have done studies using two-dimensional cell
differentiation that suggest a possible alternative to EB differentiation. Their culture
system is based on using a collagen IV surface for cell growth and the reculturing of
cells sorted at intermediate stages for common haematopoietic and endothelial cell
surface markers. It is interesting that such differing culture systems could be utilised
in similar studies in development. However it does present questions as to their
reliability, based on the fact that the microenvironment that the cells are cultured in
varies so much.
Nishikawa et al. (Nishikawa et al., 1998b) generated lymphohaematopoietic cells
from endothelial cells sorted from embryos on the basis if their expression of VE-
Cadherin from 9.5 dpc embryos or YS. The endothelial cells were identified by their
co-expression of FLK-1, CD31, and CD34 with VE-Cadherin. They also showed
that endothelial cells that had already formed vessel structures had haematopoietic
capabilities in vitro. It is however, unknown whether this capability is present in
vivo and what mechanisms control haematopoietic cell differentiation if endothelia
do have haemogenic capabilities.
Both the Keller and Nishikawa differentiation protocols are discussed further in
Chapter 4.
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1.10.The Vertebrate Haematopoietic System and its
Development
1.10.1. Mechanisms Involved in the Formation of the
Vasculature
The haematopoietic system and the organs involved directly in its generation and
maintenance are the first to develop in ontogeny. Although intensely studied for
over a century and despite there being a wealth of information on its development,
there remains a great deal of ambiguity and uncertainty about the origin, progression
and maintenance of the haematopoietic system.
The cell proposed for use in this project is believed to be the progenitor to all
lineages involved in vasculogenesis. To understand its origin and subsequent role in
development, the origins of haematopoietic development must first be reviewed.
Vasculogenesis gives rise to a homogenous lattice of blood vessels termed the
primary capillary plexus from the differentiation, expansion and coalescence of
vascular endothelial cells. The process of angiogenesis remodels this network and
includes the sprouting of new and differentially sized blood vessels from the pre¬
existing ones established in vasculogenesis. Angiogenesis also involves the
recruitment of associated tissues to the vasculature including supporting smooth
muscle and pericytes (Folkman and DAmore, 1996). Angiogenesis can occur where
needed in the embryo and the adult: in cases of genuine tissue ischaemia and in
pathological cases of neovascularisation such as tumorigenesis.
Neovascularisation does not rely solely on angiogenesis as evidence is emerging that
indicates that vasculogenesis may also occur in wound healing, tumour
vascularisation and tissue ischaemia. It has been shown that even after vascular
formation, circulating endothelial progenitors can incorporate into vessel
endothelium indicating the dynamism of the vasculature (Asahara et al., 1999).
Pathological angiogenesis e.g. tumour vascularisation, in wounding, chronic
inflammation and atherosclerosis is believed to proceed using the same mechanisms
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employed in embryonic angiogenesis. Tumours are believed to release angiogenic
growth factors to engage the angiogenic machinery and recruit the cells required to










Figure 1.2 Diagram showing the many components that form blood vessels. Adapted from
http://www. mmi. mcgill.ca/mmimediasampler2002/beforeandafter/after. htm
1.10.2. Initial Concepts on the Origins of the
Haematopoietic System in the Murine System
Studies on the origins and developmental path of the mammalian haematopoietic
system have been carried out for over a century. This has led to the accumulation of
a wealth of information on vasculogenesis and haematopoiesis. Vera Danchakoff
(Danchakoff, 1916) and Florence Sabin (Sabin, 1920) made insightful observations
of chick haematopoiesis that laid the foundations for existing models of
haematopoietic development. However, despite this, the current models for
haematopoietic development are still very fluid and constantly developing.
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The mesoderm forms at 6 dpc from signalling events between the primitive
endoderm and ectoderm (Dzierzak et al., 1998). Mesoderm migrates through the
primitive streak contributing to the visceral yolk sac (YS) and other structures (Haar
and Ackerman, 1971; Silver and Palis, 1997). The onset of haematopoiesis occurs at




Figure 1.3 Schematic representation of the course of haematopoietic colonisation through
murine ontogeny (stages shown on left). Haematopoiesis is first observed in the
extraembryonic YS at 7-7.5 doc. The para-aortic splanchnopleura/ aortic-gonad
mesonephros (PAS/AGM) region is next colonised although whether the haematopoietic
progenitors arise independently or migrate from the YS is still controversial. The foetal liver
is next colonised followed by the spleen and the bone marrow at birth.
Haematopoiesis begins in the embryonic YS with the formation of blood islands
(Danchakoff, 1916; Moore and Owen, 1967). Blood islands appear from aggregates
of mesoderm in the YS (Moore and Metcalf, 1970; Yamaguchi et al., 1993; Shalaby
et al., 1997). The peripheral flat cells of these blood islands differentiate to form
angioblasts i.e. endothelial precursors, while the inner round cells form primitive
erythrocytes (Shalaby et al., 1997; Dzierzak et al., 1998; Robb and Elefanty, 1998)
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(Figure 1.4). Primitive but committed haematopoietic progenitors were detected in
the YS between 7 and 8.5 dpc. These cells were nucleated and expressed foetal
globin isoforms (Moore and Metcalf, 1970; Johnson and Barker, 1985; Wong et al.,
1986). These observations of extraembryonic haematopoiesis have set a paradigm of
embryonic haematopoiesis arising in the YS followed by the colonisation of the
embryo by YS-derived haematopoietic progenitors. As development advanced, a
multipotent stem cell population derived from differentiation in the YS was believed
to migrate to the foetal liver via the established circulatory system, then to the foetal
spleen and finally the adult bone marrow (Figure 1.3). Initially, YS-derived
haematopoietic cells were believed to repopulate the entire haematopoietic system,
and parallels were drawn between the avian and the mammalian system (Moore and
Metcalf, 1970). YS stem cells were also thought to be capable of repopulating the
thymus and the lymphoid system adding support to this theory of multipotency, as at
8 dpc, the YS was found to contain erythroid and some lymphoid progenitors. The
embryo proper did not contain such cells and at 7.5 dpc, the embryo was believed to
be unable to develop any cells of the myeloid lineage in the absence of the YS







Figure 1.4 Regions annotated mark the sites of haematopoiesis in the murine embryo at: (a)
8.5 dpc, (b) 10.5 dpc (Dzierzak et a!., 1998).
This understanding of mammalian haematopoiesis was challenged by the theory that
haematopoiesis arises at several sites in the developing mammalian embryo
including the YS.
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Avian studies were central to the development of the theory that haematopoietic cells
initially developed in the YS (Dieterlen-Lievre, 1975); Dieterlen-Lievre and
colleagues extended their investigations by generating chick-quail YS chimaeras
where quail embryos were grafted onto chick YS to look at the origins of the most
primitive haematopoietic progenitors. Initial studies revealed that intraembryonic
haematopoiesis succeeded YS haematopoiesis (Dieterlen-Lievre et al., 1976) and had
the potentiality to colonise the YS (Martin et al., 1978a) as well as other
intraembryonic sites of haematopoietic development (Dieterlen-Lievre, 1975).
1.10.3. Developing Controversies on the Origins of the
Haematopoietic System
Grafting experiments challenged the initial concepts of YS haematopoiesis being the
origin of all subsequent haematopoiesis as they provided evidence suggesting that
definitive haematopoiesis originated independently in the intraembryonic aorta
gonad mesonephros (AGM) region and not the YS (Dieterlen-Lievre, 1975;
Beaupain et al., 1979; Lassila et al., 1982). The amphibian system had been
observed to have two distinct sites of haematopoietic activity as well (Turpen et al.,
1981). Support for this theory also came from observations that lymphoid and
myeloid precursors existed in the para-aortic splanchnopleura (PAS) (which develops
to form the AGM as early as 7.5 dpc in mice, a time when circulation has not been
established (Shalaby et al., 1997). The PAS/AGM comprises the endoderm of the
developing gut, the endothelium of blood vessels (dorsal aorta and
omphalomesenteric artery), the gential ridges, the pro/mesonephros and the
splanchnic mesoderm enveloping them.
Erythrocytes are first visible at 7.5 dpc in the YS. 8-8.5 dpc YS can be made to
generate B and T lymphocytes showing an inherent potentiality for definitive
haematopoiesis if given the right cues (Palacios and Imhof, 1993). By 9 dpc, YS
haematopoietic cells have repopulating potential (Dzierzak et al., 1998) with long-
term repopulating haematopoietic stem cells (LTR-HSCs) seen at 11 dpc (Moore and
Metcalf, 1970; Medvinsky et al., 1996; Shalaby et al., 1997; Dzierzak et al., 1998).
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However, at this stage, the circulatory system has been established, therefore LTR-
HSCs could have seeded the YS from the embryo (Shalaby et al., 1997). The focus
of investigation turned to the PAS/AGM. Parallel haematopoietic activity was
observed in the PAS/AGM region by 8 dpc, a time when the circulatory system has
yet to link YS haematopoiesis to the embryo proper (Cumano et al., 1993; Huang
and Auerbach, 1993; Godin et al., 1993).
The colony-forming units-spleen (CFU-S) assay involves tail vein injections of the
haematopoietic progenitors being assessed for their capability to form multilineage
haematopoietic progenitors in vivo by their ability to colonise the spleen of lethally
irradiated mice and form colonies (Till and McCulloch, 1961). Embryonic tissue is
isolated, grown in culture, dispersed to a single-cell suspension and injected into
lethally irradiated mice where potent haematopoietic progenitors are found to
colonise the spleens of these mice with a frequency that is in direct relationship to
their estimated haematopoietic potential. This assay indicates that despite the
simultaneous appearance of YS and AGM haematopoietic cells, those originating in
the AGM are more potent (Medvinsky et al., 1996; Dzierzak et al., 1998). At 8.5
dpc in the mouse, multipotent haematopoietic cells were found that were able to form
(Godin et al., 1995). CFU-S were detectable in both the YS and embryo at late day 9
when the circulation has been established (Medvinsky et al., 1993). 10 dpc AGM
CFU-S are similar in potentiality and composition to 11 dpc liver CFU-S therefore
there may be a migratory or co-developmental relationship between the two
structures. AGM-derived CFU-S were also morphologically more similar to foetal
liver CFU-S than YS-derived CFU-S (Medvinsky et al., 1996). In vitro assays show
that YS cells do not have multipotent potential before circulation has been
established, only erythroid and myeloid potentials (Dzierzak et al., 1998). The
model that evolved after these convincing investigations was that haematopoiesis
occurred in two distinct waves: a "primitive" one in the YS where the haematopoietic
cells that formed had little proliferative or repopulating potential, and a second wave
of "definitive" haematopoiesis within the AGM (Dzierzak et al., 1998; Palis et al.,
1999). This second wave was believed to give rise to HSC with long-term
repopulating capabilities and it was believed that it was only after circulation was
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established post-8.5 dpc that the YS acquired these haematopoietic cells and
consequently the same LTR ability (Medvinsky et al., 1996; Dzierzak et al., 1998).
Despite the popularity of this model, the significance and LTR ability of the first YS
precursors has remained an area of investigation. It has been argued that YS cells
prior to 11 dpc failed to show LTR ability in lethally irradiated mice because they
require a haematopoietic microenvironment to home to (Lu et al., 1996; Medvinsky
and Dzierzak, 1996; Delassus et al., 1995). Haematopoietic cells found in the AGM
are able to reconstitute an irradiated adult mouse following intravenous injection of
the purified progenitors (Muller et al., 1994; Medvinsky and Dzierzak, 1996). Age
matched YS cells do not exhibit this ability, however they are able to completely
reconstitute busulphan1 conditioned newborn mice (Yoder et al., 1997b; Yoder et al.,
1997a). These disparate findings can be reconciled if it is accepted that the newborn
mice may provide a microenvironment which is permissive for proliferation and the
development of the full spectrum of cell fates that the YS precursors can home to. In
neonatal mice, haematopoietic activity is present in the liver, spleen and bone
marrow (Wolf et al., 1995). It has been hypothesised that YS cells may graft in
neonatal mice that have active haematopoiesis but not in adult mice where liver
haematopoiesis no longer takes place (Yoder et al., 1997a; Yoder et al., 1997b). It
may hint that YS haematopoietic precursors have the full LTR potentiality seen in
the progenitors of the AGM but that until circulation is established, the YS
microenvironment limits their differentiation until they migrate to the AGM where
they differentiate further, proliferate and are directed to colonise the haematopoietic
organs of the embryo, namely the foetal liver, spleen, thymus and eventually the
bone marrow. The CFU-S generating progenitors are immature and highly
proliferative. These progenitors represent the haematopoietic cells from 10 dpc
onwards as haematopoietic cells from earlier stages of haematopoietic development
do not produce CFU-S. The assay assesses cells with LTR ability and not LTR
potential. This assay therefore cannot accurately assess the potentiality of the YS
haematopoietic precursors that arise in the YS or AGM before 10 dpc because they
1 Busulfan is an alkylating agent that interferes with DNA replication and is used in
myelosuppression.
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have not been primed for colonisation of other organs, such as the spleen in the CFU-
S assay.
When cultured on AGM-derived stromal cells however, YS derived from 8.5 day old
embryos were found to be able to reconstitute adult lethally irradiated mice
(Matsuoka et al., 2001) indicating that the AGM microenvironment may have an
inductive effect on haematopoietic progenitors allowing for their acquisition of LTR
activity. A proposal that YS-derived progenitors have properties that impede their
survival in the adult mouse has been put forward after more recent findings by Cai et
al. (Cai et al., 2000) who showed that YS from runxl heterozygous mice were able
to reconstitute the haematopoietic system of adult irradiated mice. The YS cells used
were from the 10-dpc embryos when the circulation would have been established so
the findings are not conclusive.
Further investigations in Xenopus by Turpen et al. (Turpen et al., 1997) showed that
by excising the two regions responsible for embryonic (ventral blood island) and
adult haematopoiesis (dorsal lateral plate) and substituting one for the other, that both
regions had the nascent ability to produce adult and embryonic blood and that it was
the microenvironmental signals that determined the type of haematopoiesis that took
place.
1.10.4. Key Elements in Vasculogenesis
To understand the sequence of events and molecular interplay involved in the
specification and differentiation of mesoderm, the spatial and temporal expression of
key receptors, ligands and transcription factors have been gradually dissected.
1.10.4.1. Vascular Endothelial Growth Factor
The VEGFs are essential for haematopoietic development during ontogeny,
postnatally and in the adult in instances of severe wounding or ischaemia.
VEGF/VEGF-A/Vascular Permeability Factor is a heparin-binding glycoprotein that
is secreted as a homodimer (Houck et al., 1991; Elouck et al., 1992; Park et al., 1993)
VEGF can increase vascular permeability, cause vasodilatation following activation
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of nitric oxide synthase, stimulate migration and inhibit apoptosis. It is a key
mitogen in the activation and differentiation of the vascular lineages. Although
endothelial cells respond to it, they rarely secrete it. It has also been found to be a
regulator of tumour angiogenesis (Millauer et al., 1994).
There are several splice variants for VEGF 121, 165, 189 and 206. The last is only
commonly found in the foetal liver . More recently 145 and 183 amino acid variants
have also been detected (Kozlowska et al., 1998; Liu et al., 1999). 165, 189 and 206
have heparin-binding domains that anchor them to the extracellular matrix and bind
with heparin sulphate to aid presentation of VEGF to its receptors.
VEGF-A expression is responsive to hypoxia, glucose concentration, pH as well as
the activity of certain oncogenes. Any element that induces the activation of
mitogen-activated protein kinase (MAPK) activates VEGF simultaneously (Milanini-
Mongiat et al., 2002) e.g. phosphorylation of hypoxia-inducible transcription factor
la (HIF-la) by MAPKs enhances VEGF transcription (Hofer et al., 2001). Figure
1.5 shows the various downstream effectors of VEGF signalling. As can be seen, the

























Figure 1.5 Signalling activity following KDR (VEGFR2/FLK-1) by VEGF. Activation of
KDR/FLK-1 results in receptor dimerisation and autophosphorylation at numerous tyrosine
residues of the cytoplasmic domain of the receptor. Various downstream signalling
mechanisms can be activated resulting in a variety of responses including migration, cell
survival, regulation of vascular permeability and the activation and regulation of
angiogenesis and vasculogenesis. Figure taken from Zachary, 2003.
VEGF B, C, D and placental growth factor (P1GF) (Schreiber et al., 2000) are also
part of the VEGF ligand family and related to the platelet-derived growth factor
(PDGF) A and B molecules. Figure 1.6 shows the binding of these ligands to their
respective receptors. These ligands are less well characterised than VEGF though it
is known that there is little functional overlap between them despite the
nomenclature: VEGF-B (Grimmond et al., 1996), VEGF-C (Joukov et al., 1996; Lee
et al., 1996), VEGF-D (Orlandini et al., 1996; Yamada et al., 1997; Achen et al.,
1998). Generally, they are all expressed by mesenchymal and epithelial cells and
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Figure 1.6 The VEGF receptor family and their ligands. There are three key receptors, each
of which can bind a range of VEGF molecules. VEGF receptors comprise an
immunoglobulin-like extracellular domain and a cytoplasmic domain comprising a kinase
domain. Neuropilin-1 (NP-1) is a non-tyrosine kinase receptor for the VEGF family of ligands
and consists of an extracellular domain with mephrin, AS, p tyrosine phosphatase (MAM).
Figure taken from Zachary, 2003.
All VEGFs bind to one of the VEGF receptors and activate their intracellular
tyrosine kinase domain (Figure 1.6). Three receptors commonly respond to VEGF
stimulation: Rl/FLT-1, R2/FLK-1, and R3/FLT-4. Neuropilin-1 and 2 are also
activated by VEGF binding. R3 is specific to lymphatic endothelium.
VEGF receptors have 7 extracellular immunoglobulin-like domains, a single
transmembrane domain and an intracellular tyrosine kinase domain, which is
responsible for signal transmission on VEGF binding (Eichmann et al., 1997).
VEGF (VEGF-A) is expressed in numerous pathological disorders including
retinopathies, psoriasis, tumours, vascular lesions and rheumatoid arthritis (Carmeliet
and Jain, 2000; Ferrara and Alitalo, 1999). The importance of VEGF in
tumorigenesis has been demonstrated with the use of dominant negative VEGF
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receptors (Millauer et al., 1996) and blocking antibodies against VEGF and VEGF-
R2 (Witte et al., 1998) all of which have successfully blocked angiogenesis and
tumour growth. The VEGF signalling pathway is therefore a popular target for anti-
tumour therapies (Laird et al., 2002; Fernando and Hurwitz, 2003; Zhang et al.,
2003).
Knocking out the function of a single VEGF allele is sufficient for lethality between
10-12 dpc (Ferrara et al., 1996; Carmeliet et al., 1996). It has been speculated that
the lethality is a result of insufficient FLK-1 activation (Eichmann et al., 1998). This
highlights the importance of gene dosage in its role in development. Embryos
sustain abnormalities to the heart, and dorsal aortae, and have a reduced number of
red blood cells in the YS resulting in tissue necrosis, presumably from the absence of
a functional vasculature. This indicates that VEGF function is dose-dependent and a
threshold for sufficient activity exists (Carmeliet et al., 1996; Ferrara et al., 1996).
VEGFR2 (FLK-1 in mice and KDR in humans) is the central receptor for VEGF to
trigger vasculogenesis and vascular permeability (Gille et al., 2001). VEGF is
expressed by the visceral endoderm of extra-embryonic endoderm when blood
islands first emerge and in intra-embryonic endoderm as well. Initially some
expression is also detected in the mesoderm. Cells expressing the FLK-1 receptor
respond to VEGF in a paracrine manner. FLK-1 is also upregulated by VEGF
(Kremer et al., 1997). FLK-1 is the dominantly required receptor for VEGF during
vasculogenesis, however FLT-1 appears to be more necessary for angiogenesis and
the vascular remodelling that takes place as part of the process.
Formation of mature vessels relies on subtle interplay between the VEGFs, the
angiopoietins that have a stabilising effect on vessel formation, and PDGFs. The
expression of VEGFs leads directly to endothelial proliferation and tubulogenesis.
The surrounding tissues of the formed, but immature blood vessels next express the
angiopoietins that lead to the induction of PDGFs that induce the migration of
pericytes and smooth muscle cells to support the vessels.
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The action of VEGF alone is unable to direct the correct formation and organisation
of blood vessels. A transgenic approach to targeted VEGF expression in the lens of
the mouse eye resulted in the proliferation of endothelial progenitors at the site of
expression but did not result in organised blood vessel formation (Ash and Overbeek,
2000).
Recently, VEGF has been found to have a role in neuroprotection. Insufficient levels
of VEGF have been implicated in the occurrence of the neurodegenerative disorder
amyotrophic lateral sclerosis, although the exact mechanisms underlying its role have
yet to be discovered (reviewed in Storkebaum et al., 2004).
1.10.4.2. FLK-1 Receptor Tyrosine Kinase
The haemangioblast's existence has been postulated by scientists (despite it never
having been isolated) because of the markers that are shared by both the endothelial
and haematopoietic lineages. These markers include CD34, SCL/TAL1, TIE-1 and
TIE-2 and c-KIT. However one particular receptor tyrosine kinase stands out as the
strongest candidate as a marker of the haemangioblast: foetal liver kinase-1
(Yamaguchi et al., 1993). FLK-l's importance is consistently emphasized in
development, however its precise role remains somewhat ambiguous.
Receptor tyrosine kinases are a group of transmembrane receptors that have growth
factors as their ligands (Millauer et al., 1993). They are regulators of growth and
differentiation. Upon binding, these receptors undergo phosphorylation, as do other
cellular components, thus inducing a complex cellular response (Ullrich and
Schlessinger, 1990). FLK-l's extracellular region contains seven immunoglobulin-
like domains similar to other members of the RTK superfamily of membrane
receptors such as c-k.it, and c-fms. Although considerably larger, it exhibits a high
level of homology withflt-1 (de Vries et al., 1992) initially isolated by Shibuya et al.
(1990) and with mirrored domain distributions. The intracellular domain of flk-1
showed a greater level of similarity with other RTKs with sites for tyrosine kinase
autophosphorylation.
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In mouse, chick, zebrafish and Xenopus, flk-1 is one of the earliest genes expressed
during haematopoiesis and vascularisation (Cleaver and Krieg, 1998; Dumont et al.,
1995; Eichmann et al., 1993; Flamme et al., 1995; Fouquet et al., 1997; Thompson et
al., 1998; Yamaguchi et al., 1993). FLK-1 has a very high affinity for VEGF and
their interaction plays a crucial role in development, being essential for
vasculogenesis and angiogenesis (Millauer et al., 1993; Quinn et al., 1993). VEGF's
interactions with FLK-1 are essential to invoke VEGF's full potential of possible
responses (Ferrara et al., 1996).
FLK-1 expression occurs initially at 7 dpc in the YS as blood islands form. Its
expression precedes that of VEGF's other main receptor involved in vasculogenesis,
flt-1 (de Vries et al., 1992; Peters et al., 1993). The timing of flk-1 expression
corresponds to the time when haemangioblasts are expected to arise. Soon after, flk-
1 expression is lost from cells in the haematopoietic lineage but is maintained in
endothelial cells throughout ontogeny although expression decreases as foetal age
increases. This corresponds to the decline in haematopoiesis and vasculogenesis as
well (Kabrun et al., 1997). Small colonies of adult HSCs maintain flk-1 expression.
Expression is also elevated at times of neovascularisation in the adult as well (Plate
et al., 1993). However, FLK-1 is not expressed on committed haematopoietic cells.
The flk-1'1' mutation is lethal to the embryo with a complete absence of organized
blood vessels and necrosis (believed to be due to circulatory failure) by 8.5 dpc. flk-
1+' targeted ES cells that were subsequently used in aggregation chimeras showed
that FLK-1+ cells derived from flk-l+'~ heterozygous knockout ES cells were able to
contribute to the endocardium, dorsal aorta, intersomitic vessels and the YS
vasculature (Shalaby et al., 1995). When the same study was carried out using flk-1'
double knockout ES cells, no ES cell contribution to these lineages was seen. The
wild-type embryo cells contributed to the haematopoietic cell fates while the flk-1'1'
ES cells were directed to other fates (Shalaby et al., 1997). This exhibited a cell
autonomous requirement for flk-l expression in the vasculature. In knockout
embryos, haematopoietic and endothelial precursors were thought to form normally
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as was seen at the site of mesoderm differentiation, but they were believed to rely on
the FLK-1-mediated signal for further differentiation or migration to an appropriate
site of differentiation. It may be that VEGF signalling from the endoderm of the YS
attracts FLK-1+ cells to the YS and so in the absence of the signalling event, the
mesoderm responds to other signals for alternative cell fates. The fact that flk-1'1'
cells failed to form haematopoietic and endothelial cells supports the case that FLK-1
is essential to both processes and marks the putative haemangioblast (Shalaby et al.,
1997).
Analysis of flk-1'1' chimaeric embryos has revealed that ablation of the
haematopoietic pathway may relate to a failure in a critical migratory step of FLK-1
deficient cells from the posterior primitive streak to the YS as well as possible
intraembryonic sites of definitive haematopoiesis. This failure, established at 8.5
dpc, supports the theory that FLK-1's role in the embryo is to mark cells for
migration to sites of endothelial and haematopoietic differentiation in response to
other growth factors present there and not for differentiation itself (Schuh et al.,
1999). The fact that haematopoietic and endothelial precursors arise even in the
absence of FLK-1 supports the view that FLK-1 is a marker that aids maintenance of
these lineages and that earlier signals are responsible for the mesodermal
differentiation, giving rise to the cells. Flk-1'1' ES cells retain the ability to form
haematopoietic and endothelial cells in EBs (Schuh et al., 1999; Hidaka et al., 1999).
This supports the hypothesis that flk-1 is involved in migration to sites of
proliferation and differentiation because you have removed the constraints of spatial
niches or the same stringent regulation of cell migration and morphogen gradients
that exist in vivo.
BL-CFCs that differentiate in flk-1'1' EBs form normally but are unresponsive to
VEGF. Blast colony numbers are reduced, as are their sizes, however, there is no
haematopoietic or endothelial development (Kabrun et al., 1997; Schuh et al., 1999).
If this is similar to what occurs in vivo, then haemangioblasts are clearly not involved
directly in differentiation.
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When flk-1'1', +/~ and +/+ EBs were compared, their haematopoietic and endothelial
differentiation potentials were similar. At 7.5 dpc flk-1'1' embryos have what is
considered to be a normal number of haematopoietic progenitors and yet the 8.5 dpc
embryo is highly deficient in such cells (Schuh et al., 1999). This shows that FLK-1
signalling is crucial in the specification of cell fate with respect to haematopoiesis
and vasculogenesis. However, it is not the differentiation-inducing factor itself; it is
likely to be involved in ensuring the correct migration and expansion of all
haematopoietic progenitors corroborating in vivo observations (Shalaby et al., 1995;
Shalaby et al., 1997).
1.10.4.3. FLT-1 Receptor Tyrosine Kinase
FLT-1, VEGF's alternative receptor, primarily binds to a different isoform of VEGF
to the one that FLK-1 recognises. Flt-1" embryos show an increase in endothelial
cells with a corresponding vascular disorganization (Fong et al., 1995; Fong et al.,
1999). The loss of organization appears to occur as a result of endothelial over-
proliferation rather than as a separate and direct consequence of the knockout. If the
kinase domain of FLT-1 is deleted, leaving the ligand binding domain as normal,
homozygous null mice appear normal and develop no vascular abnormalities
(Hiratsuka et al., 1998). FLT-1 appears to act as a "VEGF sink" to regulate the
amount of VEGF available for vascular development. In the absence of FLT-1
signalling, regulation ceases and endothelial proliferation results (Fong et al., 1999).
FLT-1 may even be responsible for the regulation of the differentiation of mesoderm
to haemangioblastic cell fates.
Ifflt-1 ablation results in haemangioblast proliferation due to regulatory failure, flt-1
knockout animals would be ideal as a means of harvesting haemangioblast cells for
transplantation, given their natural rarity at the very early stage of development when
they are present. This relies on their isolation at an early enough stage to avoid the
vascular disorganisation that would eventually ensue. High levels of VEGF in the
system may successfully "swamp" the flt-1 sink to simulate a situation similar to its
absence although it cannot be ruled out that vascular disorganisation and other knock
on implications offlt-1 overexpression could prevent the utility of such a strategy. It
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must be considered however, that due to several different isoforms of VEGF
existing, each being recognised by a different selection of receptors, unpredictable
outcomes may result from interference.
1.10.4.4. SCUtal ITranscription Factor
SCL/TAL-1 was discovered at the breakpoint of a chromosomal translocation in
cases of T-cell acute lymphoblastic leukaemia (T-ALL) placing the then unknown
scl/tal-1 gene beside the T cell receptor (Begley et al., 1989; Finger et al., 1989;
Chen et al., 1990). SCL/TAL-1 is a basic helix-loop-helix protein expressed in
blood, endothelial cells and the brain. It is a transcription factor that controls the
proliferation of multipotent haematopoietic cells as well as a positive regulator of
erythroid differentiation; (Robb et al., 1995; Shivdasani et al., 1995; Robb et al.,
1996; Gering et al., 1998).
SCL/TAL-1 has a role in primitive and definitive haematopoiesis (Porcher et al.,
1996) and is also expressed in the YS endothelium. It is expressed during a short
developmental window from 7.5 dpc in the blood islands (Elefanty et al., 1997;
Robertson et al., 2000; Endoh et al., 2002). Flk-1 expression has been shown to
precede scl/tal-1 in the developing embryo and is more widely expressed; however,
the markers are believed to be associated (Minko et al., 2003). SCL/TAL-1
expression mimics the expression patterns of FLK-1, except that scl/tal-1 transcripts
are not detected in the precardiac angioblasts that form the endocardium (Stainier et
al., 1993; Liao et al., 1997). When appropriate expression is knocked out, both
primitive and definitive haematopoiesis are blocked. In knockout studies lethality
occurs early in gestation (8.5dpc) due to the failure of haematopoietic precursors to
form in the YS (Shivdasani et al., 1995; Robb et al., 1995) (Figure 1.7). Both FLK-
1 and SCL/TAL-1 expressing cells develop when the other gene has been knocked
out. Scl/tal-1'1' ES cells can form endothelial cells (Faloon et al., 2000; Robertson et
al., 2000) showing that the most likely markers of the haemangioblast are
independently regulated and may play different roles in the establishment of the
haematopoietic and vascular systems. These endothelial cells that form cannot form
the primitive vascular plexus or undergo remodelling (Visvader et al., 1998; Elefanty
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et al., 1999) showing a requirement for SCL/TAL-1 in endothelial specification or
the requirement for haematopoietic precursors at the earliest stages of vascular
development.
Ectopic expression of scl/tal-1 results in overproduction of FLK-1+, SCL/TAL-1+
cells that are possibly haemangioblastic (Gering et al., 1998). This results in a
greater proportion of FLK-1+ cells being directed down the haematopoietic and
haemogenic endothelial lineages (Endoh et al., 2002). This imbalance in the
distribution of differentiating FLK-1+ cells results in fewer FLK-1+ cells being
directed to the smooth muscle lineage (Ema et al., 2003). This may be because
SCL/TAL-1 and MyoD - a master regulator for the muscle lineage, compete for
common partners (e.g. E bHLH proteins) (Goldfarb and Lewandowska, 1995).
SCL/TAL1
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SCL/TAL1
Figure 1.7 Schematic of the expression pattern of SCUTAL1 findings of gene targeting
experiments at the scl/tal-1 locus. Coloured boxes mark stages of haematopoietic and
vascular development when SCUTAL1 is expressed. The-%^shows aberrant expression.
The stages and effects of SCUTAL1 knockout are shown with red lines. (Figure adapted
from Barton et al., 1999).
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In SCL/TAL-l7" mice, vasculogenesis proceeds normally (Robb et al., 1995;
Shivdasani et al., 1995; Visvader et al., 1998) and it is the absence of the
haematopoietic lineage that is the direct cause of death. Scl/tal-l'1' ES cells can only
differentiate down the endothelial lineage (Gering et al., 1998; Faloon et al., 2000;
Robertson et al., 2000), with scl/tal-1'1' EBs expressing FLK-1 and other endothelial
cell markers at higher levels than in scl/tal-l+,+ cells. In culture, a fraction of all
FLK-1+ cells differentiate into BL-CFCs (the in Wtro-derived putative
haemangioblast; discussed in 1.9.2). All BL-CFCs are high expressers of SCL/TAL-
1 as well as FLK-1 (Chung et al., 2002). Chung et al. also showed that flk-l
expression precedes scl/tal-1 expression and that FLK-1+, SCL/TAL-1+ cells form
before FLK-1+, SCL/TAL-L and FLK-1", SCL/TAL-1+ cells. SCL/TAL-17" cells are
unable to form BL-CFCs or haematopoietic cells (Faloon et al., 2000; Robertson et
al., 2000), it is therefore possible that haemangioblasts are FLK-1+, SCL/TAL-1"1"
cells (see Figure 1.9 for a schematic of the likely expression profile of the
haemangioblast).
The naturally occurring zebrafish cloche mutants have lowered SCL/TAL-1 levels as
well as haematopoietic and endothelial defects. This indicates that a mutation in the
as yet unidentified cloche gene has a profound impact on both these lineages,
providing additional support for the possibility of their development being linked
through a common ancestor (Stainier et al., 1995). Genetic analysis has shown that
the scl/tal-1 locus is not linked to the cloche mutation (Liao et al., 1998), however,
the cloche mutation abrogates scl/tal-1 expression. Ectopic expression of the scl/tal-
1 cDNA partially rescued the vascular and haematopoietic defects attributed to the
cloche mutation indicating that scl/tal-1 acts downstream of the cloche gene and also
has a crucial role in both lineages (Liao et al., 1998). Ectopic expression also results
in the generation of FLK-1+, SCL/TAL-1"1" cells at the expense of other mesodermal
lineages (Gering et al., 1998).
1.10.4.5. VE-Cadherin
Vascular Endothelial Cadherin (VE-Cadherin)/CD144 is a calcium-dependent
adhesion molecule. It is exclusively and constitutively expressed on vascular
endothelium (Breier et al., 1996). It is localised to the intercellular junctions where it
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is crucial for vascular assembly (Vittet et al., 1997). It is also known to mediate
contact inhibition of endothelial cell growth and inhibit apoptosis.
As well as in mature vessels, VE-Cadherin is expressed by vascular precursors from
7.5 dpc onwards (Lampugnani et al., 1992; Breier et al., 1996). Early in ontogeny,
VE cadherin is expressed on multipotent progenitors. However by 9.5 dpc all
marked cells are destined to differentiate to form endothelial cells. VE-cadherin+
cells also express flk-1 at 9.5 dpc (Nishikawa et al., 1998a). Nishikawa et al have
used a two-dimensional culture system and cell sorting strategy to investigate the
role of VE-cadherin in haematopoiesis. It persists into the adult vasculature and
could be involved in maintaining vessel integrity. This cell marker is believed to be
involved in establishing the adherence junctions of endothelial cells (Breier et al.,
1996). However, VE-cadherin+ cells also have some lymphohaematopoietic
potential (Nishikawa et al., 1998b).
1.10.4.6. PECAM-1
Platelet-endothelial cell adhesion molecule 1 (PECAM-1)/CD31 was originally
identified as a marker of endothelium. It is a glycoprotein from the immunoglobulin
superfamily of cell adhesion molecules. It was initially found to be expressed on
many cells of the vascular system besides endothelial cells including platelets,
monocytes, neutrophils and some T cells (Ilan and Madri, 2003). Over time, it has
been found to have key roles in numerous signalling pathways displaying a broad
range of functions. It has been implicated in a diverse range of processes such as
leucocyte and endothelial cell migration, maintainance of the integrity of adherens
junctions, and modulation of vascular permeability (Jackson, 2003). PECAM-1
mediated cell-cell interactions are essential in angiogenesis (DeLisser et al., 1997;
Sheibani et al., 1997; Cao et al., 2002). PECAM-1 is also thought to affect the
structure of the cytoskeleton, regulate catenin localisation and in turn transcription of
many key players in various signalling pathways, it can itself bind several STATs
and is known to directly control apoptosis and epithelium to mesenchyme transition
(EMT) in the development of the cardiac cushion (Ilan and Madri, 2003).
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PECAM-1 processing results in two proteins with distinct functionality. The soluble
protein, comprising the receptor domain, blocks transendothelial cell migration of
neutrophils, monocytes and natural killer cells in vitro and is known to inhibit acute
inflammation in vivo (Liao et al., 1997; Liao et al., 2000). The cytoplasmic domain
bears the protein's strong signalling capabilities. PECAM-1 contains
intracytoplasmic immunoreceptor tyrosine inhibitory motifs (Newman et al., 2001)
that mediate inhibitory responses following phosphorylation via recruitment and
activation of protein-tyrosine phosphatases (PTPs), typically SE1P-2 (Jackson et al.,
1997; Hua et al., 1998; Henshall et al., 2001; Newman et al., 2001), as well as
immunoreceptor tyrosine-based activation motifs (ITAMs) (Pumphrey et al., 1999).
Tyrosine phosphorylation can be mediated by many mechanisms. For PECAM-1,
integrin a2bP3-mediated platelet aggregation, shear stress on endothelial cells,
binding with the T-cell receptor antigen or integrins on extracellular matrices and
stimulation with VEGF amongst others, are all known to cause this phosphorylation
effect (Jackson, 2003). PECAM-1 knockout mice are viable but have detectable
defects in leukocyte transmembrane membrane migration (Muller et al., 1993;
Vaporciyan et al., 1993; Wakelin et al., 1996; Duncan et al., 1999).
PECAM-1 is very highly expressed in the vasculature especially the vascular
endothelium and is believed to play a crucial role in vessel formation. In both rat and
murine models of angiogenesis, blocking PECAM-1 expression with antibody
binding prevented vessel formation in collagen I based three-dimensional cell
cultures (DeLisser et al., 1997). Endothelial PECAM-1 binds p-catenin (Ilan et al.,
1999). P-catenin phosphorylation plays a crucial role in the linkage of VE-Cadherin
to the actin cytoskeleton (Ukropec et al., 2002). Additionally, interactions between
PECAM-1+ cells and the extracellular matrix are know to coordinate endothelial cell
proliferation and apoptosis in blood vessel formation (and subsequent regression in
angiogenic remodelling) (Scatena and Giachelli, 2002).
PECAM-1 expression is also upregulated during the morula to blastocyst transition.
7 of the 8 known alternatively spliced PECAM-1 isoforms are expressed in the
blastocyst although expression is restricted to cell borders. Expression is still seen in
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the epiblast of the peri-implantation embryo but is undetectable by the egg cylinder
stage embryo (Robson et al., 2001). The cytoplasmic domain of PECAM-1 is known
to have both inhibitory and activating functions in cell signalling (Ilan et al., 1999;
Newton-Nash and Newman, 1999). PECAM-1 could therefore have a role in
maintaining pluripotency. PECAM-1 is known to bind SHP-2. SHP-2 binding to
gpl30 enhances ES cell self-renewal (Burdon et al., 1999) therefore PECAM-1 could
modulate SHP-2 availability to gpl30.
VEGF is known to induce the phosphorylation of adherens junctions including p-
catenin (Ilan et al., 1999; Abedi and Zachary, 1997; Esser et al., 1998).
Phosphorylation of P-catenin results in an increase in its association with PECAM-1.
This complex is believed to have a variety of roles including the modulation of
endothelial cell integrity and permeability (Graesser et al., 2002). Tyrosine
phosphorylation of p-catenin, along with other adherens junction components is
known to result in a loss of cellular adhesion in the vascular endothelium (Daniel and
Reynolds, 1997; Provost and Rimm, 1999). This could influence the migration of
vascular endothelial precursors in early development and in angiogenesis.
PECAM-1 is lost during epithelial to-mesenchymal transformation (EMT) in
endocardial cells of the heart resulting in the formation endocardial cushion. As
these PECAM-1 expressing cells lose their expression, they begin to acquire aSMA
expression. This process is thought to be stringently regulated by VEGF, with slight
variation in VEGF levels affecting the normal course of cardiac cushion EMT and in
turn, cardiac development (Enciso et al., 2003; Miquerol et al., 2000)
1.10.4.7. Other Potential Haemangioblastic Markers
1.10.4.7.1. Runxl
The coordinated emergence of endothelial and haematopoietic precursors in YS
blood islands is not seen intraembryonically where the dorsal aorta forms before the
emergence of HSC. This implies a different haemangioblast or route of progenitor
differentiation. The AGM has been observed to display overlapping expression of
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endothelial and haematopoietic markers on cells that form from the ventral walls of
the dorsal aorta (Marshall and Thrasher, 2001).
Runxl (cbfa2, AML-1, PEBP2) is a heterodimeric transcription factor, which
contains a rwnf-homology domain (Speck et al., 1999; Tracey and Speck, 2000). It is
expressed in the YS mesenchyme at 7.5 dpc. It is expressed in erythrocytes and the
endothelium at 8 dpc but its expression drops after this time and is expressed in the
AGM at 8.5 dpc in ventral aortic endothelial cells (North et al., 1999). The
mesenchyme and endothelium in the larger blood vessels express runxl thereafter as
well as haematopoietic clusters arising in the arteries. Runxl has been shown to be
required in the development of HSC in AGM but not in other regions e.g. vasculature
in the YS where haematopoiesis first emerges (Wang et al., 1996; Okuda et al.,
1996; Cai et al., 2000; Mukouyama et al., 2000). At 10 dpc, runxl is expressed in
haematopoietic cell clusters and endothelial cells of the vitelline and umbilical
arteries and the ventral wall or the dorsal aorta (North et al., 1999).
Runxl knockout mice have normal YS haematopoiesis but no foetal liver
haematopoiesis (Okuda et al., 1996; Wang et al., 1996; North et al., 1999;). North et
al. (1999) showed that all HSCs were RUNX1+ cells, expressing endothelial
markers, which supports the concept of the haemogenic endothelium theory. Runxl
therefore has a role in the establishment of definitive haematopoiesis and if YS
progenitors do migrate to intraembryonic sites for maturation and further
development, runxl expression may be implicated in setting up a homing signal to
the AGM or foetal liver sites of development. Haploinsufficient runxl mutants have
the unusual phenotype of elevated numbers of HSC at 10 dpc in the YS and AGM.
These hint that runxl is involved in cell expansion and differentiation.
1.10.4.7.2. Podocalyxin-Like Protein 1
Podocalyxin-like protein 1 (PCLP1) is another candidate marker of the
haemangioblast. Structurally, it is similar to CD34 and is expressed on endothelial
and haematopoietic cells (Hara et al., 1999). These authors showed that PCLP1+,
CD45" cells could form both lineages when cultured on stromal cells and also
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contributed to cells from both lineages in neonatal myeloablated mice. This cell
population appears endothelial, expressing FLK-1, CD34, CD31 with the ability to
take up acetylated low-density lipoproteins (acLDL), however, in keeping with the
hypothesis regarding the haemogenie potential of endothelium (Nishikawa et al.,
1998a; Nishikawa et al., 1998b; Ogawa et al., 1999), these endothelial-like cells also
have an observed capacity to differentiate to form haematopoietic cells in
conditioned neonatal mice. This population was heterogenous however and PCLP1+
cells will need to be analysed clonally for their potentiality and accompanied
expression profde to ascertain if PCLP1 is actually marking haemangioblastic cells.
1.10.5. The Haemangioblast Hypothesis
This constant change in haematopoietic development in the embryo emphasises the
dynamism of the system from its inception. Though the gradual shifts in
haematopoiesis are beginning to be understood, the complicated signalling that takes
place in order to trigger constant change with control and direction of progenitor
cells has eluded complete understanding thus far. The close developmental
association between haematopoietic and endothelial cells has led to a well-
established hypothesis suggesting that the lineages originate from a common
precursor.
Existence of a common precursor to haematopoietic and endothelial cells was first
postulated by Sabin (1920) from precise observations of haematopoietic development
of chick blastoderms (Figure 1.5). This common precursor was given the name of
haemangioblast by Murray (1932) following observations of YS haematopoiesis and
blood islands generation, again in the avian model. Though unproven, the existence
of the haemangioblast has been embraced and the theory unchallenged for nearly a
century.
Dieterlen-Lievre and colleagues have observed that in some chick-quail chimaeras,
groups of intramesodermal haematopoietic cells were of one or the other species
(Martin et al., 1980) suggesting that each group arose through multiplication of one
original cell. More recently Hirschi and Goodell (2001) have suggested the
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maintenance of the haemangioblastic population through to adulthood in the "side
population" cell (Goodell et al., 1996) that has been observed to contribute to both










Figure 1.8 Schematic diagram depicting the two hypotheses suggested for the differentiation
of the vascular lineages. In (a) the haemangioblast is the precursor to all three vascular
lineages whereas in (b) the endothelial lining of the blood vessels have the capability to
differentiation to haematopoietic progenitor cells which bud off the vascular wall.
1.10.6. The Haemogenic Endothelium
In 1916, Jordan was able to localise this haemogenic activity to the ventral surface of
major blood vessels and hypothesised that vessel branching typically took place from
the ventral surface, indicating that a more primitive stem cell population was
maintained along the ventral wall of blood vessels. Histological analysis of
vascular endothelium also showed that cells were budding from the endothelial wall
(Smith and Glomski, 1982; Tavian et al., 1996). More recent research in several
model species has clarified that it is haematopoietic cells that bud off the endothelial
walls of the ventral wall of the dorsal aorta (Figure 1.8). This indirectly supports the
theory for the existence of the haemogenic endothelium (Pardanaud et al., 1996;
Jaffredo et al., 1998; North et al., 1999; Tavian et al., 1996; Tavian, 1999). Critical
to the viability of the haemogenic endothelium hypothesis will be clarification of
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whether the haematopoietic cells are budding off endothelium, or if circulating
haematopoietic cells are adhering to endothelial surface ofblood vessels.
It is a possibility that in definitive haematopoiesis, haematopoietic cells arise from
the cells in the endothelium of the AGM: "haemogenic endothelial cells", but that in
primitive haematopoiesis, they are derived from the putative haemangioblast.
Beyond the in vitro evidence and the histological data in vivo that suggest its possible
existence, haemangioblasts or haemogenic endothelia have never been isolated or
identified in vivo.
1.10.6.1. Experimental Evidence in Support of the
Existence of the Haemangioblast
To check whether haematopoietic cells were actually budding off endothelial cells
Jaffredo et al., (1998) injected fluorescent acetylated low-density lipoproteins
(acLDL) into embryonic chick hearts before aortic haematopoietic clusters could be
observed so that the endothelium was tagged. They found that the clusters of
haematopoietic cells that appeared thereafter were also fluorescent and thus likely to
have divided from the endothelial cells.
Ogawa et al. (2001) have an interesting hypothesis to explain the possibility of there
being different developmental pathways for the generation of haematopoietic
progenitors. They suggest that 2 distinct pathways for differentiation exist and that
definitive haematopoiesis only utilises one but YS haematopoiesis uses both. Their
model accommodates the possible existence of the haemangioblast and the
haemogenic endothelium. The primitive haematopoietic system, arising in the YS of
a developing embryo is generated from the haemangioblast or a distinct population
of mesodermal cells. The definitive lineage - be it derived from the YS or arising in
the AGM, is derived from endothelial cells with a haemogenic capacity. They
suggest that not only do haematopoietic cells arise from further differentiating
endothelial precursors, but that endothelial cells provide the environment for the




Figure 1.9 Proposed course of differentiation of the haemangioblast to the lineages that
comprise the haematopoietic system based on current discoveries. The expression patterns
for FLK-1 and SCUTAL-1 are stated for each cell stage. Definitive markers of the vascular
lineages are included, as are potential haemangioblast markers.
1.10.7. The Haemangioblast and Mural Cells
Endothelial cells line the vessel lumen and mural cells (Sone et al., 2003) associate
with the outer endothelium (D'Amore, 2000). The interaction of the two cell types is
key in vascular development and function. This relationship has recently been
exemplified in culture. FLK-1+ cells derived from differentiated ES cells have been
found to express a marker for mural cells in culture: aSMA. When in the presence
of VEGF,flk-l+ cells tested positive for platelet endothelial cell adhesion molecule 1
(PECAM-1), an endothelial cell marker; these cells were surrounded by aSMA+
cells. Flk-1+ cells obtained from embryos behaved in the same way. aSMA positive
cells were seen to attach to PECAM-1+ endothelial tubes. A lumen then formed with
the cells within the lumen testing positive for blood cell markers (CD45 and Terl 19).
It was believed that in the absence of VEGF signalling, FLK-1+ cells would form
mural cells via PDGF-BB signalling as a default. PDGF-BB is required for vascular
smooth muscle and pericyte proliferation and migration (Hellstrom et al., 1999).
Mice deficient in PDGF-BB die in the latter stages of ontogeny from haemorrhaging
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and capillary rupture due to the lack of vessel-associated cells (Lindahl et al., 1997).
This indicates an alternative pathway for mural cell differentiation and a different
role for PDGF-BB. This is backed up by data from PDGF-BB"" mice that still had
aSMA expression on their mural cells. This was established in vitro whereby FLK-
1+ cells were exposed to either VEGF or PDGF-BB. When exposed to both
simultaneously, development of both endothelial and mural cells was enhanced. This
shows that cell fate is determined to a large extent by the exposure to growth factors
at timed intervals (Yamashita et al., 2000). When VEGF was applied to cells, flk-1
was maintained. If there was no VEGF, mural cells developed, and flk-1 expression
was lost gradually. In a positive feedback loop, it seems as though VEGF is required
for the maintenance of flk-1 expression and hence differentiation down the
endothelial lineage. Without VEGF, flk-1 expression is lost and the mural cell fate
becomes the default (Yamashita et al., 2000). These discoveries may suggest that
endothelial cells have the ability to transdifferentiate to mural cells in response to
PDGF-BB or an as yet unknown signal. It is also possible that a separate population
of mural cells share a common precursor with endothelial cells. This may well be a
sign that the haemangioblast is multipotent. Figure 1.9 shows a schematic of
haemangioblast differentiation and the likely expression profile of haemangioblastic
cells and their derivatives.
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1.11.Summary
• Cell-based therapies are increasingly being investigated as the knowledge of
the behaviour of and differentiation procedures for ES cells increases. The
possibility of carrying out cellular replacement has been strengthened
following the successful isolation of ES cells from humans.
• This project was designed to address the possibility of differentiating an
early, multipotent progenitor population from mES cells, purifying this
population and assessing whether such a population can engraft in vivo and
perform the range of functions expected from its endogenous counterpart.
• The progenitor being differentiated was the haemangioblast: the putative
progenitor of all the vascular lineages. This progenitor has never been
isolated or identified in development, but both in vivo and in vitro data have
supported the case for its existence.
• The FLK-1 receptor tyrosine kinase is the earliest known marker to segregate
cells designated to form vascular tissues from multipotent mesoderm. The
flk-1 gene was chosen for development of the targeting strategy (Chapter 3),
that enables the identification and isolation of a pure FLK-l+cell population,
following directed differentiation for haemangioblastic cell fates. Chapters 4,
5 and 6 summarise experiments carried out with targeted cells to develop the
best possible differentiation regime to isolate haemangioblastic cells and the







2.1. Molecular Biology Methods
2.1.1. Culture Media
2.1.1.1. Bacterial Growth Medium
For the routine growth of bacteria for the propagation of plasmid DNA Luria Bertani
(LB) medium was made up as follows: 10% (w/v) tryptone, 5% (w/v) yeast and 5%
(w/v) sodium chloride (NaCl) were dissolved in deionised water and autoclaved in an
airtight container. If selection for bacterial cells containing plasmid DNA was
required, the medium was supplemented with an antibiotic for which the plasmid
being propagated conferred a resistance - commonly ampicillin (50pg/ml) or
kanamycin (33pg/ml)
2.1.1.2. LB Agar Plates
For selective growth of bacterial cells containing plasmid DNA agar plates were
used. Plates were supplemented with an antibiotic for selection of bacterial cells
containing a plasmid with a resistance gene for the antibiotic being supplemented.
(LB medium components supplemented with 0.15g/ml agar, mixed and made up to
one litre in an airtight container and autoclaved) with the appropriate antibiotic
selection added to the agar - commonly either ampicillin (100pg/ml) or kanamycin
(33pg/ml). Agar plates were supplemented with filtered antibiotic solutions either
after autoclaving or once solidified agar had been melted in a microwave oven. The
agar was cooled until the container was hot to touch but so much that it could be
handled - approximately 50-55°C. At this point, the appropriate concentration of
antibiotic was added to the agar and mixed. The agar was poured onto sterile plates
in a laminar flow hood or by a Bunsen burner flame, covered, and stored at 4°C for
up to a month.
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2.1.2. Plasmid DNA propagation
2.1.2.1. Transformation
In order to propagate plasmid DNA, the circular DNA was transformed into a line of
Eschericia coli suitable for simple transformations or efficient subcloning steps:
Subcloning Efficiency DH5a™ Chemically Competent E.coli (Invitrogen™).
[Genotype: F"(j)80/acZA AM 15(/acZYA-arg¥)\]169 deoR recA\ endAl hsdR\l(ry,
m^) phoA supRAA thi-1 gyrA96 relAl A,"].
lOOpl of competent cells were thawed on ice, placed in a 1.5ml microcentrifuge tube
and gently mixed with a pipette tip. 10-20ng of DNA (in a maximum volume of 5pl)
were added to the cells and mixed in. This mixture was incubated on ice for 30
minutes. The cells were then heatshocked for 45 seconds in a 37°C water bath. This
action temporarily permeabilised the cell membrane of the cells, thus allowing the
passage of the plasmid DNA into the cells. The cells were placed on ice for a
minimum of 2 minutes to recover. 900pl of pre-warmed (37°C) LB medium was
added to the microcentrifuge tube, which was then incubated for 1 hour in a 37°C
water bath. 25 and 50pl of the transformation culture were plated on LB agar plates.
The plates were incubated upside down (to prevent drying of the plates) at 37°C
overnight. The following day, the plates were checked for colonies of bacteria.
Surviving colonies had antibiotic resistance conferred upon them by the selection
marker in the transformed plasmid. Single colonies could then be picked and grown
in LB medium for plasmid propagation.
2.1.2.2. Isolation of High Concentrations of Plasmid DNA
The QIAGEN® Maxi kit for plasmid purification was used. This kit is designed for
the isolation of up to lOOpg of plasmid DNA using an anion-exchange resin that both
binds and allows the elution of DNA depending on the pH and salt concentrations of
the buffers passed through the resin at the time. The advised procedure outlined in
the handbook was adhered to.
A single colony was picked from an agar plate of bacterial cells transformed with the
desired plasmid using sterile micropipetter tips and placed in 15ml tubes containing
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3ml of LB medium and the appropriate antibiotic selection. The tubes were
incubated at 37°C with moderate (200-250 revolutions per minute (rpm)) shaking for
approximately 8 hours. This starter culture was then poured into 400ml of sterile LB
medium with the same selection. The flask used for growth had a volume of at least
4 times the volume of the culture medium that it contained. This ensured that the
bacterial culture was provided with sufficient oxygen for growth. The culture was
incubated for 12-16 hours (overnight) at 37°C with shaking.
The bacterial cells were harvested by centrifugation at 6000g [=6000rpm] for
15minutes at 4°C (Du Pont Instruments Sorvall® RC-5B refrigerated superspeed
centrifuge, F-l6/250 rotor). The supernatant was poured away and the pellet
resuspended in 10 ml of Buffer PI (50 mM Tris(hydroxymethyl)aminomethane-
hydrochloride (Tris-HCl), pH 8.0; lOmM ethylenediaminetetraacetic acid, disodium
(EDTA), lOOpg/ml RNase A). 10ml of Buffer P2 (200mM sodium hydroxide
(NaOH); 1% sodium dodecyl sulphate (SDS) (w/v)) was added for cell lysis and the
container inverted 4-6 times to mix the solutions. The vessel was left at room
temperature for 5 minutes. 10ml of chilled (4°C) Buffer P3 (3M potassium acetate
pH 5.5) was added to the container and mixed through immediately by inverting the
tube 4-6 times to neutralise the lysis buffer. It was incubated on ice for 20 minutes
before centrifugation at 20000g [12000 rpm] for 30 minutes at 4°C. The supernatant
was collected after centrifugation and passed through Whatman 3MM filter paper to
remove all traces ofprecipitated proteins.
A QIAGEN-tip 500 was equilibrated by the addition of 10 ml of Buffer QBT
(750mM NaCl; 50mM 3-(N-morpholino)-propanesulphonic acid (MOPS), pH 7;
15% isopropanol (v/v)) to the column and letting it pass by gravity flow. Once the
equilibration buffer had emptied from the column, the filtered supernatant was added
to the column and also allowed to pass through completely. The column was washed
with two 30ml applications of Buffer QC (1M NaCl; 50mM MOPS, pH 7.0; 15%
isopropanol (v/v)). The DNA was eluted in 15ml of Buffer QF (1.25M NaCl; 50mM
Tris-HCl, pH 8.5; 15% isopropanol (v/v)) in a glass Corex tube. To this, 10.5 ml of
isopropanol was added and mixed by inversion of the tube in order to precipitate the
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DNA. The tube was centrifuged immediately at 15000g [10000 rpm] for 30 minutes
at 4°C (Du Pont Instruments Sorvall® RC-5B refrigerated superspeed centrifuge, HB-
6 rotor). The supernatant was carefully decanted off and the pellet washed with 70%
ethanol (v/v) and re-centrifuged at 15000g [10000 rpm] for 10 minutes at 4°C. The
ethanol was pipetted off carefully and the pellet left to air-dry at room temperature
until the edges of the pellet looked transparent under light. The dried pellet was
resuspended in an appropriate volume of TE buffer (lOmM Tris-HCl, pH 7.5; ImM
EDTA, pH 8), usually 500pl and quantified using UV spectrophotometry.
2.1.2.3. Isolation of Low Concentrations of Plasmid DNA
When small-scale propagation of plasmid DNA was required e.g. to obtain enough
DNA to carry out digests to check multiple colonies for successful ligation events
from a subcloning step, the Wizard® Plus Miniprep DNA Purification System
(Promega) was used. This kit relied on the binding capability of DNA to a silica
membrane to purify plasmid DNA.
As with the maxiprep cultures, single colonies of bacteria were picked off agar
plates. Each colony was put into 3mls of LB medium in a 15ml screw-capped tube.
The cultures were incubated overnight at 37°C with moderate shaking. The
following day the cultures were spun down in a centrifuge (Eppendorf centrifuge:
5810R) at 3220g [4000rpm] for 10 minutes. The supernatant was poured off and the
pellet resuspended in 300pl of Cell Resuspension Solution (50mM Tris-HCl, pH 7.5;
lOmM EDTA; 100pg/ml RNase A). The resuspended pellet was transferred to a
1.5ml microcentrifuge tube. 300pl of Cell Lysis Solution (0.2M NaOH; 1% SDS
(w/v)) was added and mixed by inverting the tube several times. 300pl of
Neutralization Solution (1.32M potassium acetate, pH 4.8) was added immediately
after and mixed by inverting the tube, as before. The lysate was centrifuged at
13000g [13000rpm] in a microcentrifuge1 for 5 minutes. Meanwhile, a vacuum
manifold (Promega Vac-Man®) was set up. The minicolumns designed for use with
the vacuum manifold were attached to the apparatus together with the syringe barrel
1 Various different microcentrifuges were used. Each had a radius (r) of approximately 70mm.
Conversions from revolutions per minute (rpm) to relative centrifugal force (rcf) were carried out
using the following equation: rcf=l.ll x 10"6(rpm)2r (Sambrook & Russell, 2001)
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attachment for the minicolumns. One column was required for each miniprep. 1ml
of resuspended resin (40% (v/v) isopropanol, 4.2M guanidine HC1) was pipetted into
each minicolumn barrel. The cleared lysates from the bacterial cultures were loaded
into the barrels and allowed to flow through the column with the resin using the
vacuum. 2ml of Column Wash Solution (80mM potassium acetate; 8.3mM Tris-
HC1, pH 7.5; 40pM EDTA; 55% (v/v) ethanol) were then applied to the barrels and
allowed to pass through. The vacuum was maintained on the columns for 30 seconds
to dry the resin in the columns. The barrels were removed from the columns and
discarded. The minicolumns were placed in 1.5ml microcentrifuge tubes and spun in
a microcentrifuge at 13000g [13000rpm] for two minutes to ensure that there was no
liquid remaining in the columns. The minicolumns were then transferred to new
microcentrifuge tubes. 50pl of sterile ddfLO (distilled and deionised water) were
added to each column and left for one minute to enter the resin. The microcentrifuge
tubes and minicolumns were then spun for one minute at 13000g [13000rpm] to elute




UV Spectrophotometry works on the principle that both purines and pyrimidines are
able to absorb ultraviolet light. The Beer-Lambert law states that for a parallel beam
of monochromatic radiation passing through a homogeneous solution the absorbance
is proportional to the product of the concentration and pathlength. Nucleic acids
absorb UV light maximally at 260nm wavelength so the optical density (OD) i.e. the
drop in light detected as a result of absorption by the nucleic acid molecules was
measured at this wavelength. A UNICAM 5625 UV/VIS spectrophotometer was
used. At the 260nm wavelength, an OD measurement of 1 corresponds to 50gg/ml
for double-stranded DNA and 40pg/ml for single-stranded DNA or RNA. To derive
the actual concentration of a DNA solution from a spectrophotometer reading, the
following calculation was carried out:
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OD260 x Reading Adjustment* x Dilution factor = Number pg/ml
*(dsDNA=50; ssDNA/RNA=40)
By determining the ratio from absorbance readings at 260nm and 280nm, a measure
of DNA purity can be determined. DNA and proteins absorb light differently at
these wavelengths therefore their relative measurements give an estimate of the
amount of protein contaminating a DNA sample. Conventionally an OD260/OD280 of
greater than 1.6 is desirable. UV spectroscopy was suitable for quantification of
DNA at high concentrations: typically at least lpg/ml. This requirement for
accuracy limited its use to the quantification of maxipreps of plasmid DNA and the
quantification of genomic DNA.
For routine quantification of small amounts of plasmid DNA, between 1-5pi of
plasmid DNA was run on an ethidium bromide agarose gel alongside a size marker,
typically the BIOLINE Hyperladder 1 1 kilobase pair (kb) ladder was used. The
band intensity of the DNA being quantified was taken to have the same concentration
as the band on the standardised size marker, which had the most similar level of
fluorescence under UV light, indicating a similar incorporation of ethidium bromide
within the DNA structure and thus a similar concentration of DNA.
2.1.4. Electrophoresis
2.1.4.1. Horizontal Agarose Gel Electrophoresis
Agarose gel electrophoresis was used to visualise DNA being manipulated and to
isolate particular DNA fragments for cloning steps or electroporation into cells, as
well as a way of quantifying DNA concentrations. Powdered agarose was mixed
with lx TAE (Tris-acetate-EDTA) electrophoresis buffer (40mM Tris base
(tris(hydroxymethyl)methylamine), ImM EDTA, pH 7.7 (with glacial acetic acid))
and heated to melt the agarose in the TAE buffer. By altering the concentration of
agarose used in the gel, the density of the agarose gel matrix was modified for better
separation of large (low percentage) or small (high percentage) fragments. For
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routine gels, 1% agarose (w/v) was used. Once the agarose was fully melted and
allowed to cool until the agarose seemed more viscous, ethidium bromide
(0.25fig/ml) was added to the solution before it was poured into a gel-casting tray
and left to set with combs inserted into the agarose to form the wells. For the
resolution of DNA fragments that were smaller than 1 kb in size, 2%-4% (w/v)
agarose gels were made and run in TBE (Tris-borate-EDTA) buffer (89mM Tris,
2mM EDTA, pH to 8.3 with orthoboric acid). TBE has a higher buffering capacity
but a lower conductivity than TAE. Whereas TAE is better at resolving fragments
larger than 2.5kb where size separation is faster, TBE is more suited to the resolution
of smaller fragments as TBE gels can be run successfully at higher voltages. The
gels were immersed in lx TAE or TBE buffer before the DNA samples and
appropriate size marker were loaded and the gel run in electrophoresis apparatus.
Both the DNA samples and markers (if not prepared with loading buffer) were first
mixed with gel-loading buffer (0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene
cyanol FF, 15% (w/v) Ficoll, dissolved in water) to increase the density of the
samples and ensure that DNA was weighted down into the wells and did not disperse
into the running buffer. Gels were typically run at 80-100 volts (V) until good band
separation was achieved.
2.1.4.2. Pulsed Field Gel Electrophoresis (PFGE)
DNA separation was problematic on conventional agarose gel electrophoresis
apparatus with a linear charge field for DNA fragments of 15-20 kb and greater
which are hard to resolve due to their mobility through an agarose matrix being
similar. Fragments of this size therefore tended to migrate together. In PFGE, the
DNA is forced to change direction continuously during electrophoresis due to a
constant shift in the direction of the current in the gel. Each time the electric field is
changed in direction, slightly smaller DNA fragments are more likely to move
towards the new anode than larger ones. Carried out frequently over a long period of
electrophoresis, separation of large DNA fragments from each other is enhanced and
individual bands become more discrete. The contour-clamped homogeneous electric
field (CHEF) (Chu et al., 1986; Chu et al., 1990) apparatus (CHEF-DR® III System,
BIORAD) was used. 1.2% (w/v) TAE gels were used in 0.5x TAE buffer. Ethidium
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bromide staining was carried out after the run as incorporation of ethidium bromide
into large fragments of DNA could have distorted the migration of the fragments
during electrophoresis. Pulsed field gels to resolve fragments of 17 and 18 kb in size
were run at 9V, 120° reorientation gradient, 0.1 second pulse time for 6 hours at a
constant temperature of 14°C.
2.1.5. DNA Purification Methods
2.1.5.1. Purification of DNA from Agarose Gels
A conventional agarose gel of a restriction enzyme digest isolating the required piece
of DNA was run until the desired DNA fragment was clearly separated from all other
fragments. Under long wave UV light (365nm) which is less damaging to the DNA
than short wave UV light (302nm) which is conventionally used to visualise
ethidium bromide stained DNA, the agarose was cut to isolate the band. DNA
fragments isolated from gels were usually needed for subcloning steps and the
integrity of the fragments' ends needed to be maintained if the overhangs were to be
used in a ligation step, so the procedure was carried out as quickly as possible to
ensure minimal damage to the DNA. The agarose containing the DNA was weighed
and divided into 1.5ml microcentrifuge tubes - each with a maximum agarose weight
of 380mg.
If the size of the DNA fragment to be purified was below 10 kb the QIAquick® Gel
Extraction Kit (QLAGEN®) was used for gel purification. This kit made use of a spin
column lined with a silica-gel membrane that binds DNA under high salt
concentrations and low pH allowing DNA contaminants to pass through the column.
Elution is favoured under low salt concentrations and high pH. Three volumes of
buffer QG (components not given) were added to the gel fragment (lg weight of
agarose was taken to represent 1ml). The microcentrifuge tube containing the gel
fragment was incubated at 50°C for 10 minutes or until the agarose had completely
dissolved. Throughout this incubation, the tube was inverted regularly to help the gel
dissolve. After the agarose had dissolved, one gel volume of isopropanol was added
to the sample. This was to aid the yield of DNA fragments either smaller than 500
bp or larger than 4 kb as it enhanced the binding properties of the column. A
59
QIAquick spin column was placed in a 2ml collection tube provided with the kit.
The dissolved agarose and DNA mixture were applied to the column, which was then
centrifuged for 1 minute at 13000g [13000 rpm] in a microcentrifuge. This bound
the DNA to the spin column whilst allowing the dissolved agarose to pass through
the column. The flow-through was discarded and 500pl of buffer QG was added to
the spin column and the column spun again. This step ensured that all residual
agarose was removed from the spin column and hence the DNA. The column was
washed with 750pl of buffer PE (components not given) and recentrifuged for 1
minute. The flow-through was discarded and the spin column replaced in the
collection tube and re-spun to ensure that the resin in the spin column was dry and
free from any ethanol remaining from the wash buffer. After this spin, the column
was placed in a new 1.5ml microcentrifuge tube. To elute the DNA, 30pl of buffer
EB (lOmM Tris-HCl, pH 8.5) was added to the column and left to soak into the resin
for 1 minute. The column was then spun at 13000g [13000rpm] for one minute and
the DNA collected in the microcentrifuge tube.
If the fragment was greater than 10 kb in length, the use of this kit was not as
efficient, possibly due to the risk of shearing larger DNA fragments during the
procedure so the Schleicher and Schuell Elu-Quik DNA Purification Kit which was
suitable for the purification of fragments up to 200 kb in length was used. It works
by exploiting the ability that DNA has to bind glass in sodium perchlorate. After
isolation of the DNA fragment in agarose, binding buffer (sodium perchlorate -
molarity not given) was added at 2.8x the volume of agarose to the agarose in the
microcentrifuge tubes. The tube was incubated in a 50°C water bath for 5 minutes,
or until the agarose had completely melted in the binding buffer. The tube was
periodically inverted during this time. The glass concentrate stock (glass beads in
sodium perchlorate - molarity not given) was resuspended by vigorous pipetting
before 20pl/100mg of agarose was added to the melted agarose suspension. The tube
was placed on a rotator (Stuart Scientific, Rotator SB1) at room temperature for 10
minutes to ensure the glass beads circulated throughout the tube. The tube was
centrifuged at 5000g [8000rpm] for 1 minute in a microcentrifuge. The supernatant
was discarded and 500j.il of wash buffer (ethanol based - exact components not
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given) was added to the tube. Using pipetting, the glass bead pellet was resuspended
in the wash buffer and the tube inverted several times. The tube was centrifuged as
before and the supernatant discarded again. Another 500pl wash was carried out and
the tube was centrifuged for 1 minute once more. 500pl of salt reduction buffer
(ethanol based - exact components not given) was added and the pellet resuspended
in the buffer. The tube was inverted several times and centrifuged at 5000g
[8000rpm] in a microcentrifuge for 1 minute. The supernatant was discarded and the
pellet centrifuged again to draw out as much liquid from the pellet as was possible.
Any extra supernatant that was drawn from the pellet was removed with a
micropipettor. The tube was left open for 20-30 minutes at room temperature to dry
the pellet. lOpl of sterile ddH20 per 20pl of glass bead concentrate added previously
was added to the glass bead pellet. The pellet was resuspended in the water by
flicking the tube several times. The mixture was incubated at 50°C for 5 minutes
with occasional flicking of the tube to release the DNA from the glass beads into the
water. The tube was centrifuged at 5000g [8000rpm] for one minute to separate the
DNA in the supernatant from the glass bead pellet. The supernatant was removed to
a new 1.5ml microcentrifuge tube and spun again to pellet any residual glass
concentrate that would have been carried over when the supernatant was removed
from the glass pellet. The supernatant was removed from any pellet that may have
formed and placed in a new microcentrifuge tube. The DNA was stored at -20°C.
2.1.5.2. PhenokChloroform Purification of DNA
To remove any proteinaceous matter from a sample of DNA, a phenokchloroform
extraction was carried out. Phenol binds to any protein in the sample, the
chloroform, when mixed with phenol, forms an organic mixture of high enough
density to be drawn down when centrifuged forming 2 distinct phases, a lower
organic one of high density, the upper one being a purified DNA solution. The
protein - having been drawn away from the DNA sample by the phenol forms a
visible interphase between the organic and pure DNA phase. Typically DNA
samples were made up to 200pl with TE buffer in a 1.5ml microfuge tube. lOOpl of
phenol and 1 OOpl of chloroform were both added to the DNA sample. The mixture
was vortexed for 30 seconds to thoroughly mix the solvents and the DNA sample.
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The mixture was spun at 13000g [13000rpm] in a microcentrifuge for 10-15 minutes.
The top aqueous phase was removed from the tube. Great care was taken not to
interrupt the interphase containing the protein contaminant or the lower organic
phase. When very high purity DNA was required, a second step was carried out. An
equal volume of chloroform was added to the isolated aqueous phase from the
previous step. The mixture was vortexed as before and centrifuged. Again the top
aqueous phase was retained. As the volume of aqueous phase containing the DNA
was usually large, the phenol:chloroform step was usually followed by an ethanol
precipitation step to concentrate the DNA sample.
2.1.5.3. Ethanol Precipitation of DNA
To the DNA sample being precipitated, O.lx the volume of 3M sodium acetate, pH
5.2 was added and mixed in a 1.5ml microcentrifuge tube. To this mixture, 2
volumes of -20°C 100% ethanol was added and mixed with the tube. The sample was
incubated at -20°C for 1-2 hours to ensure maximal precipitation of DNA. The
sample was then spun at 13000g [13000rpm] for 10 minutes to pellet the precipitated
DNA. The supernatant was removed and the pellet washed in room temperature
70% ethanol (v/v). The sample was spun again at 13000g [13000rpm] for 5 minutes.
The ethanol was removed from the pellet, which was left to air dry in the
microcentrifuge tube until the edges of the pellet had turned transparent under light.
The DNA pellet was resuspended in an appropriate volume of sterile distilled,
seionised water (ddEEO) or TE buffer.
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2.1.6. DNA Manipulation and Modification
2.1.6.1. Restriction Endonuclease Digestion
Restriction endonuclease digests were used for the excision of fragments for
subcloning steps, for verification of successful ligations, propagation steps or in
Southern blotting to identify targeting events. The manufacturer's instructions were
followed (Roche in most instances) however, despite the fact that 1 unit (U) of
standard enzyme is shown to cleave one pg of DNA at optimal temperature for
cleavage (37°C for the majority of enzymes) in 1 hour, often a 5-10 fold excess was
used in the reactions (enzymes came in a minimum lOU/pl concentration so it was
more convenient for individual digests to pipette an excess) and incubation times
were greater to ensure good digestion. Restriction enzymes are preserved in a 50%
glycerol solution. An enzyme volume maximum of 10% of the total reaction volume
was never exceeded so as to avoid a glycerol concentration of greater than 5%, which
may have inhibited the digestion of DNA. Typical reaction examples for both
plasmid and genomic DNA are given below.
GENOMIC DNA
(e.g. for Southern analysis)
lOpl Genomic DNA (lpg/pl)
3 pi 1 Ox reaction buffer (Supplied by enzyme manufacturer)
2pl High Concentration (40U/pl) Restriction Enzyme
15pl ddH20
TQTAL=30ul
Incubation was carried out in a water bath set at the optimal temperature for enzyme
activity. The reaction was spiked the next day with lpl of 40U/pl enzyme and left for
3-4 hours.
NB. A small reaction volume needed to be maintained in order for the entire sample
to be loaded into one well on an agarose gel.
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PLASMID DNA
(e.g. for subcloning steps)
lOpl Plasmid DNA (lpg/pl)
5pi lOx reaction buffer (Supplied by enzyme manufacturer)
lpl Restriction enzyme (lOU/pl)
34gl ddH20
TQTAL=50ul
Incubation was typically for 1-2 hours at the optimal temperature for enzyme
activity.
Often it was required that a plasmid be digested with two different enzymes. If the
two enzymes did not share the same reaction buffer for optimal digestion, it was
sometimes possible to find a buffer that would cut both to at least 75% efficiency,
which could be used. In such cases, the compromised enzyme was added at a higher
concentration. However, sometimes this was not the case and the two enzymes could
not be used together in digests. In these instances, sequential digests needed to be
carried out whereby one reaction was carried out and the sample purified by
phenohchloroform purification and ethanol precipitation before the next enzyme
digestion could be carried out. Most restriction enzymes could be heat inactivated
with a 15-minute incubation at either 65°C or 75°C. The few that could not be
inactivated, required a phenohchloroform extraction followed by an ethanol
precipitation for the removal of the enzyme to stop the activity.
2.1.6.2. Partial Digestion
When ablation of one of several identical restriction endonuclease sites is required, a
partial restriction digest needs to be carried out to isolate a DNA fragment where the
required restriction site is the only one cleaved. The linear fragment ends are blunted
before ligation to ablate the restriction site. Successful ligation events are then
screened for the ablation of the correct restriction site. The probability of the desired
site having been cleaved is inversely proportional to the total number of the target
restriction sites. Conventional plasmid restriction enzyme digests were set up.
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Digestion was ceased at regular intervals between 1-30 minutes with the addition of
2)0,1 of 0.5M EDTA, pH 8, and incubation on ice. The samples were all run on an
agarose gel alongside a sample of linearised DNA for accurate sizing. The linear
fragments from each of the partial digests were cut out of the gel and extracted
before the appropriate blunting procedure was carried out followed by ligations of
the blunted fragments before transformation into bacteria and screening for the loss
of the desired restriction site.
2.1.6.3. Blunting of Overhangs
When a restriction site needed to be ablated, or a subcloning step using incompatible
restriction sites was carried out, unwanted overhangs created by restriction enzyme
cleavage needed to be ablated. For blunting 5' overhangs, the Klenow fragment of
E.coli DNA polymerase I (Roche) was used. The Klenow fragment possesses strong
5'-3' polymerise activity and 3'-5' exonuclease activity but lacks the 5'-3'
exonuclease activity of DNA polymerase I. For each pg of DNA in the reaction 2U
of Klenow enzyme were added - a 2-fold excess to what is optimal for the
incorporation of sufficient nucleotides to fill in a restriction enzyme overhang. The
enzyme was added directly to the blunting reaction with 200pM dNTPs
(Invitrogen™). A high concentration of dNTPs was added as a precautionary
measure to prevent the possibility of the exonuclease activity being stimulated by a
lack of nucleotides for the polymerase activity to predominate. Reactions were
carried out at room temperature for 30 minutes. The enzyme was inactivated at 75°C
for 15 minutes before phenokchloroform extraction and ethanol precipitation were
carried out to ensure the removal of the enzyme from the DNA solution.
For 3' overhangs, bacteriophage T4 DNA polymerase (Roche) was used. Like
Klenow enzyme, T4 DNA polymerase has a 5'-3' polymerase activity and a 3'-5'
exonuclease activity, however, T4 DNA polymerase's exonuclease activity is
approximately 200 times stronger than Klenow's and is ideal for the removal of 3'
overhangs. The enzyme was provided with a 5x reaction buffer to be used at a lx
final concentration with the enzyme. The restriction enzyme digests were first
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purified with phenohchloroform and an ethanol precipitation. The reaction also
required the addition of 33pM of each dNTP (final concentration). This was done to
reduce the extremely strong exonuclease activity that would otherwise have the
potential to degrade the DNA beyond the overhang. 4U of enzyme (2U/pl) were
used for blunting 0.5pg of DNA with 3'overhangs. The reaction was incubated for 1
hour in a 12°C water bath. The enzyme was removed by purification of the DNA
from the reaction as with the Klenow enzyme.
2.1.6.4. Dephosphorylation of DNA Ends
In subcloning steps when the vector receiving a DNA fragment is cleaved at a single
site, or at two different sites that are subsequently blunted, the overhangs produced
are always dephosphorylated prior to a ligation step being varied out. This is to
reduce the likelihood of the compatible overhangs or blunt ends of the vector
religating rather than ligating with the fragment added for insertion into the open site
of the vector because at least one phosphate group on DNA ends is required in a
ligation step to form a phosphodiester bond to link the nucleotides together. If the
phosphate groups are missing from both ends of the linear vector, the vector can no
longer religate but can still accept and ligate with the insert, which has not been
dephosphorylated. To carry out this dephosphorylation step, calf intestinal alkaline
phosphatase (CIP) (New England Biolabs® Inc.) was used. Alkaline phosphatase
catalyses the removal of 5' phosphate groups from nucleic acids. The enzyme was
supplied with an appropriate lOx reaction buffer. The DNA had to be suspended in
lx buffer at a final concentration of 0.5pg/10pl. The reaction was supplemented
with lOOpg/ml bovine serum albumen (BSA) to enhance the efficiency of the
reaction. For each pg of vector DNA being dephosphorylated, 0.5 units of CIP were
added to the reaction mix. The reaction mix was incubated at 37°C for 1 hour. CIP
cannot be heat inactivated. To remove the enzyme, a phenol:chloroform extraction
followed by an ethanol precipitation was carried out.
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2.1.6.5. DNA Ligations
To link linear strands of DNA in subcloning steps, T4 DNA ligase was used in the
Rapid DNA Ligation Kit (Roche). T4 DNA ligase catalyses the formation of
phosphodiester bonds between compatible 3'hydroxyl and 5'phosphate termini of
linear DNA. The vector and insert DNA were combined in a total volume of 9pl if
possible. For simple ligation steps, a 5:1 insert:vector molar ratio was used for
optimal ligation efficiency. In cases where the insert was close to the size of the
vector or even larger than the vector, a 10:1 or 20:1 insert:vector ratio was used to
compensate for a lowered insertion frequency of larger DNA fragments. Typically
100-200ng total DNA concentrations were used in ligation reactions depending on
the volume and concentration of DNA available for use in the ligations. To the 9pl
DNA mix, 10pl of 2x ligation buffer provided with the kit was added and mixed, lpl
of T4 DNA ligase (5U/pl) was added to the mixture, which was incubated at room
temperature (15°C-25°C) for at least 5 minutes. If the DNA being used for ligation
was not very concentrated and the 20pl reaction size had to be scaled up, the reaction
was allowed to proceed for 30 minutes to allow for the increase in volume. For each
ligation carried out an insert and a vector control was also carried out where the same
concentration of each of the DNA components was placed in a ligation reaction on
its own. This was to assess what proportion of ligation events in the reaction were
due to religated vector or contamination from uncut vector and the uncut insert
containing plasmid.
2.1.6.6. Transformation of Ligation Reactions
Ligation reactions were screened for success by transformation into XLIO-GOLD®
Ultracompetent cells (Stratagene) (Genotype:Tetr D(mcrA)183 D(mcrCB-hsdSMR-
mrr)173 endAl supE44 thi-1 recAl gyrA96 relAl lac Hte [F0 proAB lacl qZDM15
TnlO (Tef) Amy Camr]). Ultracompetent cells have far higher transformation
efficiencies than the DH5a™ competent cells used for easy transformations. As
successful ligations in subcloning steps were highly inefficient, by using bacterial
cells that were more likely to accept plasmids, the likelihood of isolating a successful
ligation event was increased. One vial of XLIO-GOLD® Ultracompetent cells was
thawed on ice. The cells were mixed by flicking the tube gently. lOOpl of the cells
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were pipetted into prechilled 1.5ml microcentrifuge tubes for each transformation
reaction to be carried out. 4pl of p-mercaptoethanol (concentration not given)
supplied with the cells, were added to the cells and mixed by pipetting. The cells
were placed on ice for 10 minutes and swirled gently every 2 minutes. Between 0.1
and 50ng of ligation mix in a maximum volume of 2pi were added to the cells and
mixed. The tubes were incubated on ice for 30 minutes. The cells were heatshocked
for 30 seconds in a 42°C water bath and placed on ice for 2 minutes to recover.
900pl of LB medium were added to the tubes, which were then incubated for 1 hour
in a 37°C water bath. lOOpl of the cell suspension were plated on LB agar plates
with the appropriate selection. The remaining 900pl were spun in a microcentrifuge
at 4000g [7000rpm] for 3 minutes. All but 50pl of the supernatant were removed.
The pellet was resuspended in the remaining supernatant and plated on the
appropriate LB agar plates as well, in case the 1 OOpl plated for each sample did not
yield many colonies. The plates were incubated overnight at 37°C. The following
day, if colonies were present on the ligation plates, they were picked, expanded in
LB cultures and lysed for plasmid DNA that were analysed by restriction enzyme
digestion to see if the subcloning step had been successful.
2.1.7. Extraction and Analysis of RNA
2.1.7.1. RNA Isolation
In order to isolate total RNA from tissues and cells, the RNeasy® Mini kit
(QIAGEN®) was used. Attempts were made to use more simple extraction methods
however this kit provided the most consistent results with respect to low RNA
degradation and high yield. The kit works using steps to lyse the cells followed by
denaturation in guanidine isothiocyanate, which inactivates any present RNases, the
RNA samples were bound to a silica gel membrane before any DNA (the silica
membrane has been optimised against DNA binding), and other cellular
contaminants were washed through the column before RNA elution.
For each 107 cells to be lysed, 600pl of Lysis buffer RLT (guanidine thiocyanate
based, exact components not given) were added to the cells - either directly if the
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cells were growing as a monolayer, or to a cell pellet if the cells were in suspension.
The cells were pipetted to ensure complete lysis and applied to a QIAGEN®
QIAshredder column. The column was spun for 5 minutes at 13000g [13000rpm] in
a microcentrifuge in order to homogenise the sample and shear the genomic DNA
present in the cell lysate. To the homogenised lysate, an equal volume of 70%
ethanol, made up in diethyl pyrocarbonate (DEPC) treated water (to remove any
RNases) was added and mixed with pipetting. The sample was applied to an RNeasy
mini column placed in a 2ml collection tube and spun at 8000g- [lOOOOrpm] for 15
seconds. The flowthrough was discarded and the process repeated if the entire
sample could not be deposited in the column with a single application. 700pl of
buffer RW1 (ethanol based, exact components not given) were added to wash the
column. The column was spun again at 8000g [lOOOOrpm] for 15 seconds. The
flowthrough was discarded again. Next, 500pi of buffer RPE was added to the
column. The column was spun at 8000g [lOOOOrpm] for 2 minutes. The RNeasy
column was carefully transferred to a fresh 2ml collection tube avoiding any contact
with the buffer. To elute RNA, 50pl of RNase-free water were applied to the silica
in the column. The tube was spun for 1 minute at 8000g [lOOOOrpm]. The eluate
was pipetted back onto the column and centrifuged through a second time to ensure
the greatest yield possible. RNA samples were quantified using a spectrophotometer
and stored at -80°C to ensure minimal RNase activity.
2.1.7.2. Complementary DNA Synthesis
Before complementary DNA synthesis, RNA samples were treated with DNase to
eliminate any contamination by genomic DNA that could affect reverse transcriptase
PCR (RT-PCR) accuracy and sensitivity. To 15pl RNA, 1.8pi of lOx DNase buffer
and lpl DNase I (Promega) were added in an RNase-free 1.5ml tube. The reaction
was incubated at room temperature for 15 minutes. 2pl of Stop Solution (lOx)
supplied with the enzyme were mixed in with the reaction, which was then incubated
at 65°C for 10 minutes after which the tube was put on ice.
The Superscript™ First-Strand Synthesis System for RT-PCR (Invitrogen™) was
used for the synthesis of cDNA. All the following reagents used in the synthesis of
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cDNA were part of the kit and purchased from InvitrogenT . To the DNase-treated
RNA, 2(il of lOmM dNTP mix and 2pi oligo(dT) mix (0.5pg/pl) were added. The
tube was incubated at 65°C for 10 minutes and placed on ice for 1 minute. To this
reaction, 4pl of lOx RT buffer was added, 8gl MgCl2 (25mM), 4pl 0.1M
dithiothreitol (DTT) and 2pi RNaseOUT™ Recombinant RNase Inhibitor were added.
The tube was incubated at 42°C for 2 minutes. To each tube, 2pl (50U/pl) of
Superscript™ II reverse transcriptase (RT) were added and mixed well. The tubes
were maintained at 42°C for 1 hour. The reactions were heat-inactivated by
incubation at 70°C for 15 minutes and then chilling on ice. For each reaction, an RT
control was carried out. All the reagents for the reaction were included except the
RT. This checked for remaining DNA contaminants in the reaction that would go
undetected past the cDNA synthesis stage and which could give false positive RT-
PCR results. For each set of reactions carried out at the same time, a reagent control
was also carried out. This involved the replacement of the initial RNA sample with
RNase-free DEPC-treated water. This checked the reagents in the kit for
contaminating RNA or DNA that could contaminate the RNA samples being used
with the kit and could affect the cDNAs synthesised and the RT-PCR accuracy.
If the reactions were scaled up in volume, the addition of reaction reagents was
scaled up correspondingly as were the incubation times.
2.1,8. Polymerase Chain Reaction
2.1.8.1. Primer Design
In the design of primers, several parameters needed consideration. Through
convention, PCR oligonucleotides were designed to be approximately 20 nucleotides
in length. The oligonucleotides needed to have similar Tms (melting temperatures) to
other primers intended for use with each other so that the reaction conditions suited
both primers in the annealing step of a PCR reaction. The Tm was ideally below
70°C to allow the annealing and extension steps to work effectively. A region of
sequence that was not too G/C rich was preferential as the annealing step would be
more efficient and the Tm of the primer was likely to be lower. Primers used together
were checked for any opportunity for dimerisation or the formation of other
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secondary structures as these could easily result in the failure of the PCR reaction, as
the primers would anneal with each other and not the DNA template. Primers were
obtained from MWG Biotech.
2.1.8.2. Optimisation
Platinum® Taq (Invitrogen™) or BIOTAQ (BIOLINE) were used for all PCR
reactions carried out. To optimise the PCR reaction, a range of annealing
temperatures needed to be tested. The optimal annealing temperature is usually
several degrees below the lowest primer Tm of the primers being used in the reaction,
although on occasion, it can be the same as the Tm of the primers. Usually,
optimisation of the annealing temperature was sufficient to obtain a stringent PCR
protocol and the addition of magnesium chloride (MgC^) was maintained at 1.5mM.
However, if the adjustment of the annealing temperature was insufficient to
propagate the PCR product alone, a reaction buffer without the addition of MgC^
(200mM Tris-HCl pH 8.4, 0.5M potassium chloride (KC1)) was used and different
concentrations of MgC^ (between lmM-4mM) added in optimisation reactions to
ascertain what reaction conditions gave the best reaction stringency and
amplification of the desired band. By trying a combination of annealing
2+
temperatures and supplemented Mg ions, most PCR reactions could be optimised
to give high specificity for amplification of the desired band with low to no
background. If background could not be eliminated with reaction optimisation, the
possibility that the primers were not behaving as they should have done was
addressed and new ones needed to be considered. Reactions were carried out in a
thermal cycler with the provision of a gradient block enabling the optimisation of the














































Forward 5 '-GCACACACG G GATTCTG -3'
Reverse 5'-GAATTCAGGGTCTTCCTTAG-3'
58 321
Table 2.1 PCR primers used and their optimised annealing temperatures.
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2.1.8.3. PCR Procedure
A typical PCR reaction mix would be as follows:
5 pi 1 Ox PCR buffer -Mg2+ (Invitrogen™)
1.5 pi 50mM MgCb (final concentration 1.5mM) (Invitrogen™)
0.5pl lOmM dNTPs (Invitrogen™)
0.5pl Forward Primer (lpM final concentration)
0.5pl Reverse Primer (1 pM final concentration)
l-2pl DNA/cDNA template
0.4pl Platinum® Taq DNA Polymerase (Invitrogen™)
To 50pl with ddH20
Typical Reaction Conditions:
1. 3 minutes 95°C denaturation
2. 30 seconds 94°C denaturation
3. 30 seconds 60°C annealing
4. 45 seconds 72°C extension
5. Repeat steps 2 to 4 for 30 cycles
6. 10 minutes 72°C extension
7. Maintain samples at 10°C thereafter
lOpl of the reaction were run on a 2-4% agarose gel to check the success of
amplification.
2.1.8.4. RT-PCR Analysis
RT-PCR reactions were carried out as with PCR reactions. However, to ensure no
contamination with genomic DNA and to normalise the concentration of template
used in subsequent PCR reactions, a PCR reaction of a housekeeping gene, typically
P-actin was carried out. A positive band of the correct size was expected in the
cDNA synthesis reactions that included RT whereas no band would be expected in
reactions that had omitted RT, thus showing a pure cDNA sample. The band
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intensities from the p-actin reaction served to quantify the cDNA samples so that
equivalent starting concentrations could be used in comparative PCR reactions.
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2.2. Cell Culture Methods
2.2.1. Culture of Murine Embryonic Stem Cells
2.2.1.1. Complete Media
The optimal medium used for the routine maintenance of all murine ES (mES) cells
consisted of Glasgow's Modified Eagle's Medium (GMEM)(Sigma) supplemented
with: 5% (v/v) Foetal Calf Serum (FCS) (Globepharm), 5% (v/v) Newborn Calf
Serum (NBCS) (Sigma), 2mM L-glutamine (Invitrogen™), 0.1 mM non-essential
amino acids (Invitrogen™), ImM sodium pyruvate (Invitrogen™), 0.1 mM [L
mercaptoethanol (Invitrogen™), 500U/ml Leukaemia Inhibitory Factor (LIF) (LIF-
ESGRO) (Chemicon).
All the components to be added to the GMEM were placed in a sterile bottle and
(It)
mixed. Using a vacuum pump and a 0.2pm bottle-top filter unit (VacuCap 60,
Gelman Laboratory), the components were filtered into the GMEM bottle. The
bottle was clearly labelled with the medium type and the date before being stored at
4°C. The components of the medium were only stable up to 4 weeks after addition to
the medium (L-glutamine converted to glutamic acid after 4 weeks) so if the bottle
had not been used after this period of time had elapsed, it was discarded and a fresh
bottle of medium made up.
2.2.1.2. Passaging mES Cells
When a flask of cells was confluent or sub-confluent i.e. covering the flask fully or
almost fully, the cells required passaging. A medium change was carried out 1.5-2
hours prior to passaging to prime the cells for the procedure and induce growth in
them. The flask was washed with sterile Dulbecco 'A' PBS (no magnesium or
calcium ions) (0.15M NaCl, 0.003M KC1, 0.008M disodium hydrogen
orthophosphate (Na2HP04), 0.001M potassium dihydrogen orthophosphate
(KH2PO4)) (100X tablets purchased from Oxoid). To a 25cm2 flask, 1ml of TEG
(Trypsin/EGTA (TEG) solution (107.8mM NaCl, 0.845mM Na2HP04, 1.59mM
KH2PO4, 4.47mM KC1, 5mM D-(+)glucose, 22.29mM Tris, 0.0009% (w/v) phenol
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red, 0.25% (v/v) trypsin (Invitrogen™), 1.05mM ethyleneglycol-bis-(P-aminoethyl
ether) N,N,N',N'-tetraacetic acid (EGTA), 0.000105% (w/v) polyvinyl alcohol))
was added and the flask placed in a 37°C incubator for 1-2 minutes for the trypsin to
break intercellular protein bonds between the cells. The trypsinised flask was
knocked several times to displace the cells from the gelatin and to break up the cell
aggregates to a single cell suspension. The TEG was inactivated with serum by the
addition of 5ml of ES cell medium to the flask. The cells in the medium were
pipetted several times to attain a good single cell suspension before being transferred
to a 15ml tube and being spun in a centrifuge (Jouan B4) at 166g [lOOOrpm] for 5
minutes. Most of the medium was removed from the cell pellet. The pellet was
resuspended in the remaining medium by agitation. 5ml of fresh medium were
added to the resuspended pellet which was mixed by pipetting. If the cells were being
2 •
expanded, the resuspended pellet was transferred to a gelatinised 75cm in 15-20ml
of medium. If the cells were being maintained or seeded at a low density, a fraction
of the resuspended medium was transferred to a fresh gelatinised flask with an
appropriate volume of medium.
2.2.1.3. Freezing of mES Cells
To freeze flasks of cells in vials, a medium change was carried out on the flask 1.5-2
hours prior to freezing to induce growth in the cells. The cells were trypsinised in
the conventional manner and spun down to form a pellet. The cells were
resuspended in 50% (v/v) ES cell medium and 50% (v/v) 2x freezing mix (60% (v/v)
ES cell medium, 20% (v/v) FCS, 20% (v/v) dimethyl sulfoxide (DMSO) and placed
in prechilled cryovials. The vials were placed at -80°C overnight and then
transferred to -150°C for indefinite storage. The number of vials that the flasks were
frozen in depended on the size of the flask and the confluence of the cells: confluent
25cm2 flasks were frozen to 1 vial, 75cm2 flasks to 3 vials and 150cm2 flasks to 9
vials.
2.2.1.4. Thawing of Cells
ES cells were kept frozen at -150°C. They require rapid thawing as they were frozen
with DMSO, a cryopreservant to which they are sensitive once thawed. A vial of
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frozen cells was removed from a -150°C freezer and immediately immersed in a
beaker of 37°C water. Once thawed, small volumes of the vial were gradually added
to 5ml of complete ES cell medium in a 15ml screw-capped tube. The tube was spun
at 166g [lOOOrpm] for 5 minutes. All but a trace of the medium was aspirated off
with a Pasteur pipette. The cell pellet was dispersed by flicking the tube. 5ml of
medium was added to the resuspended pellet. The medium was pipetted several
times before being added directly to a gelatinised 25cm2 tissue culture grade flask
(Nunc). The flask was marked with the cell type, date of thawing and the passage
number of the cells before being placed in a 37°C humidified incubator with 5%
CO2. If filtered caps were used, they were tightly screwed onto the flasks, however,
if vented caps were used, they was left loose to ensure good circulation of CO2 in the
flask.
Cells frozen in suspension in multiwell plates were thawed in a similar way.
Warmed medium was added to the wells immediately after the plates were removed
from cold storage. As soon as the media in the wells had thawed, the contents of
each well were transferred to wells in new gelatinised multiwell plates that had wells
with a larger surface area. Care was taken to replicate the order and labelling of the
wells. Once all the cells had been transferred, the wells were filled with fresh ES cell
medium and incubated at 37°C for 5 hours to attach to the gelatinised surface before
being given a medium change to remove the DMSO cryopreservant that was still
present after they had been thawed.
When multiwell plates with cells frozen as a monolayer had to be thawed, the plates
were removed from -80°C storage as quickly as possible. Warmed (37°C) medium
was added to the sides of the wells as quickly as possible after removal from -80°C.
This medium was then aspirated off to remove the now-thawed freezing mix and
fresh medium was added to the wells. Thawing of plates was best done in the




When cell numbers needed to be calculated, a haemocytometer (Assistent) was used.
Cells were trypsinised, pelleted and resuspended in 5ml medium. Using a Pasteur
pipette, some cell suspension was taken up and dropped under either side of the
haemocytometer coverslip. The 4 corners of the haemocytometer consisting of 16
square grids were counted and the mean average taken of the 4 counts. This count
multiplied by 104 represented the number of cells present in 1ml of the cell
suspension.
2.2.1.6. Counting Viable Cells
When a low cell number needed to be seeded or if the method of disaggregation was
particularly harsh, cells being counted were also checked for viability. 50pl of the
cell suspension being counted was mixed with an equal volume of 0.4% (w/v)
Trypan Blue Solution (Sigma) and left at room temperature for 1-2 minutes. This
mixture was applied to a haemocytometer. Viable cells appeared white and were
counted whereas dead cells took up the blue stain and appeared blue and were
ignored, in order to get an accurate estimate of the number of live cells present. The
counting was carried out as described before except that the 1:1 dilution with the
stain was accounted for by doubling the cell number to get an accurate cell count.
2.2.1.7. Karyotyping of mES Cells
A confluent 25cm flask of ES cells was trypsinised and 20% of the cells were
replated. The following day, lOpl/ml of culture medium of colcemid solution
(KaryoMAX® Colcemid® from Invitrogen™) were added to the flask and mixed. The
split was necessary to ensure the active growth and division of the cells. The
colcemid acted to arrest the cells in the metaphase stage of mitosis. The cells were
harvested one hour later by trypsinisation. The cells were washed in 2-3mls of PBS
before being spun at 280g [1300rpm]. All but a trace of the PBS was removed. The
pellet was resuspended in the remaining medium. lOmls of ice-cold hypotonic
solution (0.65% (w/v) KC1, made fresh each time) were added to the resuspended
pellet. The cells were left in this solution for 10 minutes at room temperature. The
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cells were pelleted by centrifugation at 280g [1300rpm], the hypotonic solution was
decanted off and the pellet of cells resuspended. The first fix solution (75% (v/v)
methanol, 25% (v/v) acetic acid) was added carefully; drop wise, to the resuspended
pellet. As the fix was added, the tube of cells was mixed slowly on a vortex mixer.
The pellet was resuspended in lOmls of fix solution. The cells were pelleted as
before. The cells were washed in fix solution twice more and spun again to be
pelleted. They were resuspended in 1ml of fix solution.
Glass slides were cleaned in 70% (v/v) ethanol and moistened with cold water. 1-2
drops of the cells in fix solution were dropped onto a wet slide at a 45° angle with a
fine-tipped Pasteur pipette, and allowed to run down the slide. For each cell line
being karyotyped, 10 slides were prepared. The slides were left to air dry and
viewed under a phase contrast microscope to check that a complete karyotype was
present.
2.2.2. Differentiation Protocols
The standard medium used to carry out basic non-directed differentiation contained
all the components of standard ES cell medium (as detailed in section 2.2.1.1) except
LIF which was omitted from the medium. As LIF is the key supplement in the
maintenance of pluripotency in ES cells, its absence was enough to allow the ES
cells to differentiate freely to many lineages.
2.2.2.1. Generation of mES-Derived Embryoid Bodies in
Suspension
EBs were generated for the differentiation of ES cells or as part of more complex or
specific differentiation protocols. ES cells maintained as a monolayer were
trypsinised, pelleted, resuspended in an appropriate volume of ES cell medium and
counted. Unless following a defined differentiation protocol, 106 cells were plated in
10ml differentiation medium in bacterial grade 10cm dishes. The cells formed
embryoid body aggregates by the second day of maintenance in suspension in the
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absence of LIF. The length of incubation of EBs in suspension depended on their
designated purpose. In order to prevent their attachment to the plastic plates, the EBs
were pipetted every 2-4 days and the medium changed as required. To carry out a
medium change, the EBs were collected in a 15ml tube. If the EBs were not yet
cystic, they were centrifuged at 166g [lOOOrpm] for 2 minutes. If the EBs included
cystic EBs, they were allowed to settle in the tube for 10 minutes. The medium was
aspirated off and fresh medium added to the EBs before they were transferred to a
new petri dish.
2.2.2.2. Generation of Embryoid Bodies in Hanging Drops
To obtain EBs of a uniform size and cell density, hanging drop cultures were set up.
Cells were trypsinised and counted in the usual manner. 6xl05 cells were
resuspended in 20ml ES cell medium and pipetted repeatedly to ensure an even
distribution of cells in the medium. Using a multi-channelled pipetter, 20pl drops of
the cell suspension (corresponding to a cell count of 600) were placed on the inside
of the lid to a 15cm dish. This was repeated until evenly spaced 20pl droplets of the
cell suspension covered the inner surface of the lid. 10ml PBS were added to the
dish to maintain moisture and the lid was flipped over onto the dish so that the drops
were hanging down over the PBS and incubated at 37°C. After 2 days of
maintenance as droplets, the ES cells formed tight aggregates of ES cells. These
were then washed into basic differentiation medium in non-tissue culture treated
10cm petri dishes and treated as the suspension cultures were.
2.2.3. Haematopoietic Differentiation
Haematopoietic differentiation was carried out in a methylcellulose culture. The
methylcellulose provided a 3 dimensional matrix that haematopoietic progenitors
thrived in and provided the easiest way to score and identify different haematopoietic
cell types which are frequently non-adherent to growth substrates. The protocol used
was devised by Dr Lesley Forrester and adapted from Wiles and Keller 1991.
The methylcellulose growth medium consisted of 1% (v/v) methylcellulose (3%
(v/v) ES-Cult® methylcellulose base medium, Stem Cell Technologies), 10% (v/v)
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FCS which has been verified for its ability to support haematopoietic differentiation
(Anonymous2004), 340pM monothioglycerol (MTG)(Sigma), lU/ml erythropoietin
(Roche), 1 Opg/ml insulin, 100pg/ml murine interleukin 3 (IL3), 2mM L-glutamine
(Invitrogen™) all made up in Iscove's modified Dulbecco's medium
(IMDM)(Sigma). The components were combined and shaken to mix. The
methylcellulose was left to settle for 10 minutes. 2-3ml of the methylcellulose mix
were pipetted into 3.5cm non-tissue culture treated dishes and placed at 37°C until
required. The cells or EBs to be plated were disaggregated and counted. The
appropriate number of cells to plate in each dish was calculated empirically for each
cell line used as there was much variation observed between different ES cell lines.
The plating efficiency of a robust ES cell line was approximately 10% and a colony
count of 100/3.5cm plate was optimal. Cells were therefore usually seeded at around
1000 cells per plate.
2.2.3.1. Dispase Disaggregation of Embryoid Bodies
Dispase was used to dissociate EBs for protocols that required the growth of
disaggregated EB cells in methylcellulose. It was believed to be a gentler method of
dissociation than the trypsin based TEG used otherwise and gave better plating
efficiencies and differentiation potential (see Chapter 4 for experimental details of its
use).
EBs were collected from suspension by either centrifugation or allowing the EBs to
settle by the action of gravity. The EBs were washed once in PBS and suspended in
lml PBS or IMDM and 1ml dispase (Roche). 140pg of DNase (Sigma) was added to
the dispase mix to break down any DNA from cell lysis that would otherwise prevent
the attainment of a good single cell suspension of EB cells. The cells were incubated
at 37°C with gentle agitation for one hour after which time the EBs were broken up
by gentle pipetting of the EBs. 5ml of differentiation medium were added to the
cells, which were left to recover at room temperature for 5-10 minutes. The cells
were pelleted by centrifugation at 166g [lOOOrpm] and washed once in PBS. They
were resuspended in an appropriate volume of differentiation medium or Iscove's
modified Dulbecco's medium (IMDM) to be counted.
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2.2.3.2. Scoring of Haematopoietic Colonies
Haematopoietic colonies were identified based on their phenotypic characteristics as
described in the Stem Cell Technologies procedure manual
(http://www.stemcell.com/technical/28415_esmanual%20H.pdf) for colony assays of
murine cells using methylcellulose-based medium.
2.2.4. Directed Differentiation Enriching for flk-1
Expression
2.2.4.1. Differentiation on Collagen IV
Nishikawa et al., 1998, devised this protocol. ES cells were trypsinised, Trypan Blue
stained for viability and counted. 104 cells were plated in each well of 6-well plates
coated in Collagen IV (BIOCOAT®, BD Biosciences). The cells were grown in
Alpha modified minimum essential Eagle's medium (a-MEM) (Sigma)
supplemented with 10% (v/v) FCS, 2mM L-glutamine and 0.05mM 0-
mercaptoethanol. If growth factors were added to the differentiation medium,
50ng/ml of VEGF was added to the growth medium. To select for HPRT-expressing
cells, the growth medium was supplemented with HAT. Care was taken at the time
of plating to mix the cells well with the medium in each well to ensure an even
distribution of the cells being plated.
2.2.4.2. Differentiation in Methylcellulose: The BL-CFC
Culture
This protocol was evolved over many years by Gordon Keller's laboratory for the
optimal generation of the BL-CFC: the suggested in vitro equivalent of the
haemangioblast (Wiles & Keller, 1991; Keller et al., 1993; Kabrun et al., 1997;
Kennedy et al., 1997; Choi et al., 1998; Schuh et al., 1999; Faloon et al., 2000). ES
cells were maintained in DMEM supplemented with 15% (v/v) FCS (Globepharm),
0.15mM monothioglycerol (MTG) (Sigma), 2mM L-glutamine (Invitrogen™) and
5000U/ml LIF (LIF-ESGRO) (Invitrogen™) for at least two passages. Embryoid
"3
bodies were generated in suspension by plating 4.5 x 10 cells/ml in IMDM
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supplemented with 15% (v/v) FCS, 0.45mM MTG, 50pg/ml ascorbic acid (Sigma),
200pg/ml iron saturated (holo-) transferrin (Sigma), lOpg/ml insulin (Sigma) in
10cm bacterial grade dishes.
Embryoid bodies were collected at precise time-points ranging from 2 to 4 days after
generation (See Chapter 4 for experimental details) and disaggregated using either
trypsin or dispase as disaggregation enzymes. Cells were tested for viability and
counted. Cells were plated in a 1% (v/v) final concentration of methylcellulose in
IMDM (3% (v/v) ES-Cult™ methylcellulose base medium, Stem Cell Technologies)
supplemented with 15% (v/v) FCS which has been verified for its ability to support
haematopoietic differentiation, 2mM L-glutamine (Invitrogen™), 0.45mM MTG,
25pg/ml ascorbic acid (Sigma), 200pg/ml iron-saturated (holo-) tranferrin (Sigma),
5ng/ml VEGF (Sigma), lOOng/ml Stem Cell Factor (Sigma) and 25% (v/v)
conditioned medium from the D4T endothelial cell line (Kennedy et al., 1997) (See
2.2.4.2.1 for details of D4T maintenance and conditioning). The number of cells
plated varied between 650 and 104 per 3.5 cm plate. 2-3ml of the methylcellulose
mix were pipetted into low-adherence 3.5 cm dishes (Anonymous2004) ensuring an
even coverage. The cell suspension to be plated was pipetted into the
methylcellulose with a micropipetter and mixed vigorously to ensure as even a cell
density across the plate as was possible. 3.5 cm dishes were incubated within 15 cm
dished with an open reservoir of PBS to ensure a highly humidified environment.
Methylcellulose cultures were incubated as with all other forms of tissue culture at
37°C in 5% CO2. The methylcellulose cultures were checked regularly for the
growth and development of haematopoietic and haemangioblastic colonies.
2.2.4.2.1. Producing Conditioned Medium from the
D4T Endothelial Cell Line
The D4T endothelial cell line is an ES cell-derived endothelial cell line transformed
with the polyoma middle T oncogene (Williams et al., 1988). It was used to
condition medium for haemangioblastic differentiation (Kennedy et al., 1997; Choi
et al., 1998) was maintained on gelatinised tissue culture flasks in IMDM
supplemented with 5% (v/v) FCS (Globepharm), 2mM L-glutamine (Invitrogen™)
and 50pg/ml of endothelial cell growth supplement (ECGS). Cells were fed every 2-
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3 days. For conditioning purposes, cells were grown to confluence and conditioning
was carried out for between 1-3 days in the maintenance medium with or without the
added ECGS. The medium obtained was filtered before use in the BL-CFC cultures.
2.2.4.2.2. Testing the Potentiality of Possible
Haemangioblastic Colonies
After 4-6 days in the BL-CFC culture, potential BL-CFCs were identified (Kennedy
et al., 1997; Faloon et al., 2000) and picked out of the methylcellulose cultures and
plated on Matrigel™ coated 12 well plates in IMDM supplemented with 10% (v/v)
FCS, 10% (v/v) horse serum, 2mM L-glutamine (Invitrogen™), 0.45mM MTG,
5ng/ml VEGF (Sigma), 2U/ml erythropoietin (Roche), lOng/ml bFGF (Sigma),
50ng/ml IL-3 (Sigma) and lOOng/ml granulocyte-colony stimulating factor (G-CSF)
(Sigma).
Colonies were cultured for 5 days. At this time, the non-adherent cells in the culture
were removed. These cells were viability stained, counted and plated in a basic
haematopoietic culture (as described in 2.2.4) and assessed for their ability to
differentiate to form the various haematopoietic colonies.
The adherent cells were cultured to confluence, fixed with 4% (w/v)
paraformaldehyde and immunostained with endothelial, haemangioblastic and
muscle markers to ascertain if these cells were capable of differentiation down these
lineages proving the potentiality of the BL-CFCs picked.
84
2.2.5. Gene Targeting in mES Cells
2.2.5.1. Preparation of targeting vector DNA
150pg of the targeting vector was digested with the linearising restriction enzyme for
2-3 hours to attain as near a complete digest as possible. A small aliquot of the
digest was run on a gel to see whether it had gone to completion. After confirmation
of good digestion, the linearised DNA was condensed and purified with an ethanol
precipitation. After the 70% ethanol wash, the DNA pellet was handled under sterile
conditions in a tissue culture hood for the ethanol to be removed and the pellet to be
air-dried. The pellet was resuspended in 200pl of sterile Hepes Buffered Saline
(HBS) (20mM Hepes, pH 7.0; 137mM NaCl; 0.7mM Na2HP04; 6mM D-
(+)glucose).
2.2.5.2. Electroporation
A confluent 75cm2 flask of mES cells was trypsinised and resuspended in 5ml
medium in a 15ml tube. A cell count was carried out and a volume of the cell
suspension corresponding to 107 cells was pipetted into a new 15ml tube and spun at
166g [lOOOrpm] for 5 minutes to pellet the cells. The medium was aspirated off the
pellet carefully with a Pasteur pipette and the pellet resuspended in 600pl HBS. The
cells and targeting vector DNA were mixed and carefully pipetted into the cavity of
an electroporation cuvette (BIORAD) with an electrode gap of 0.4cm. The
electroporator (BIORAD Gene Pulser™) settings used were: 800V, 3pF. The cuvette
was pushed between the electrodes and electroporated. An electroporation time
constant of 0.1 was desirable for ES cells. A "No DNA" control of 107 cells only
was also carried out to assess the effect of the electroporation procedure on the
viability of the cells. The cells were left for 10-15 minutes at room temperature to
recover after which time the cells were mixed in with 100ml of complete ES cell
medium and plated out on ten 10cm gelatinised tissue culture grade plates. 20%
(160pl) of the electroporation mix for the "No DNA" control was taken and added to
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Figure 2.1 Diagram showing the procedures involved in a gene targeting experiment.
2.2.5.3. Selection of Potential Targeted Clones
The plates of the electroporated ES cells were maintained in complete ES cell
medium for 48 hours after the electroporation. If the cells had stuck down and begun
to proliferate, selection for an inserted selection cassette could be introduced to the
cells via their medium. Typically, the targeting vectors possessed a PGK/ieo
(phosphoglycerate kinase promoter driving the neomycin antibiotic resistance gene)
cassette for selection. The neomycin analogue G418 was used for selection of cell
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populations that had the PGKneo resistance gene integrated in their genome at a
concentration of 300|j,g/ml in initial experiments. The level of selection was dropped
to 150p.g/ml because the stringency of the selection regime was excluding targeted
cells from the colony pool at 300jag/ml. One targeted plate was maintained without
selection to compare cell survival with the plates in selection. Also, one of the
control plates electroporated without any DNA was kept without selection and one
was placed in selection to assess the rate of cell death in response to the antibiotic
analogue when no homologous recombination could have taken place due to the
absence of any DNA. Plates were fed at least every other day until enough cell death
had taken place for colonies of antibiotic resistant cells to be clearly defined and
growing. Once these colonies ofpotentially targeted clones were visible to the naked
eye, they were picked for expansion in wells for DNA (for Southern Blot analyses)
and to freeze an adequate cell stock while the DNA samples were analysed to
identify any targeted clones.
2.2.6. Confirmation of Targeting Events
2.2.6.1. 25cm2 Flask Screening
Single colonies were picked with a micropipettor set to lOOpl into 1.5ml
microcentrifuge tubes. The colonies were disaggregated by pipetting several times
after which the cells were transferred to a gelatinised well in a 24-well plate. The 24
well plates were grown to confluency. The wells were washed with 2ml PBS and
trypsinised with 500pl of TEG. The cells were incubated at 37°C for 1 minute. The
cells were disaggregated by repetitive pipetting and put directly into a gelatinised 6
well plate with 2ml of selection medium per well. Once the 6 well plates were
confluent, the cells were trypsinised in the same manner as with the 24 well plates.
This time, the trypsinised cells were split between two 25cm flasks for each colony.
Both were allowed to reach confluency. One was lysed for genomic DNA for
Southern blots and the other vial was frozen so that if a particular colony was
targeted, the corresponding vial of cells could be thawed and expanded. In a
targeting experiment, the pelleting step usually carried out when cells are passaged is
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omitted due to the sheer number of colonies being dealt with. If diluted out in
enough serum-containing medium, TEG does not affect the viability of ES cells.
2.2.6.2. Isolation of Genomic DNA from ES Cells in Flasks
Once a flask had reached confluency, the medium was aspirated and replaced with
lysis buffer (lOOmM Tris-HCl, pH 8.5; 5mM EDTA; 0.2% SDS; 200mM NaCl;
100gg/ml Proteinase K) (Laird et al., 1991). A 25cm2 flask required 3ml lysis
buffer. The flasks were incubated overnight at room temperature with slow shaking
(Luckham R100 Rotatest Shaker). The following day, an equal volume of
isopropanol was added to the flask and incubated on the shaker at room temperature
for 4-5 hours. The DNA from this number of cells was usually visible and was
therefore removed from the flasks using a disposable inoculating loop and placed in a
1.5ml microcentrifuge tube containing 250pl of TE buffer. An ethanol precipitation
procedure was carried out for the samples to remove any traces of isopropanol in the
sample. After precipitation, the DNA pellet was again resuspended in 250pl of TE
buffer. If the DNA concentration was very high, and resuspension in this volume
was incomplete, the volume of TE was gradually increased until the viscosity of the
DNA was reduced and the DNA had dissolved in the buffer.
2.2.6.3. High Throughput Screening
This method of colony processing and analysis limits the expansion of individual
colonies to 96 well plates therefore it has the advantage of being far less labour
intensive than the more established method of growing colonies up to two 25cm2
flasks. The disadvantage is that not as much DNA is obtained from the lysis of a 96
well plate so there is less scope for error in the Southern analysis of the genomic
DNA. There is also a higher risk of loss of a colony frozen in 96 well plate format.
As before, once the colonies from cells used in a targeting experiment plated on
10cm plates became visible to the naked eye, they were picked. The colonies were
rinsed with PBS and a further 10ml of PBS was added to each of the plates. The
colonies were picked with a 20pl micropipetter into wells of a gelatinised 96 well
plate. This was carried out until either 45 minutes had elapsed, or the 96 well plate
had been filled with picked colonies. If 45 minutes passed and a plate still had
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colonies to be picked, the plate was refilled with ES cell medium and left to recover
while another plate was picked for 45 minutes, before PBS was reapplied to the first
plate and the picking resumed. Using a multi-channelled pipetter (Finnpipette®,
Labsystems), 25pi of TEG were delivered to each well on the plate and incubated at
37°C for 1 minute. 150pl of ES cell medium were then added to each well and
pipetted vigorously several times to attain a single cell suspension. This was carried
out until all colonies had been picked or if there were many hundreds of colonies,
until 6x 96 well plates had been filled. The plates were fed the subsequent day, and
every day thereafter until each single plate had attained the best overall confluency
i.e. until most of the wells were confluent but before some had become over-
confluent. When this point was reached, the medium was aspirated and the wells
washed with 200pl PBS. This was removed and 25pi of TEG were added to each
well. The 96 well plate was incubated at 37°C for 1 minute. The TEG was
inactivated with the addition of 75pl of "Quench" medium (50% (v/v) ES cell
medium, 50% (v/v) FCS, filtered). When the Quench medium was added, the
dislodged cells were pipetted several times to disaggregate them. 50pl of the cell
suspension were removed from each well and placed in another gelatinised 96 well
plate. A multichannelled pipette was used and great care was taken to replicate the
positions and the labelling of the wells in the plates. To each well of this plate, lOOpl
of ES cell medium were added and the plate was incubated at 37°C with 5% CO2. To
the original plate - also containing 50pl cell suspensions per well, 50pl of 2x
freezing mix (60% (v/v) ES cell medium, 20% (v/v) DMSO, 20% (v/v) FCS, all
filtered) were added. The mix was mixed in with the cell suspension by gently
tapping the 4 corners of the plate. The lid to the plate was taped in place and the
plate was incubated at -80°C immediately.
2.2.6.4. Isolation of Genomic DNA from ES Cells in 96
Well Plates
The plate in the incubator was fed daily and allowed to reach confluency. This plate
was used to isolate genomic DNA from the ES cells so as each well reached
confluency, the medium was replaced with 50pl of lysis buffer (lOOmM Tris-HCl,
pEl 8.5; 5mM EDTA; 0.2% SDS; 200mM NaCl; 100pg/ml Proteinase K) and
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incubated at 37°C to allow the other wells to catch up. Once all the wells that had
growing cells in them had reached confluency and they had been left to lyse for at
least one overnight incubation with lysis buffer, the cell lysates were transferred to
V-bottomed 96 well plates. 50pl of isopropanol were added to each well and the
plates were incubated on a shaker for 10 minutes. The plates were then spun at
3220g [4000rpm] (Eppendorf centrifuge: 581 OR) for 5 minutes to pellet the DNA.
The lysis buffer was removed from the wells and the pellets were washed with 70%
ethanol with great care so as not to dislodge and lose the pellet. The pellets were left
to air dry for a very short period of time before they were resuspended in 50pl of TE
buffer at 65°C.
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2.3. 2.3 Analytical Methods
2.3.1. Southern Blotting
For confirmation of the occurrence of a targeting event in ES cells, Southern blots
were carried out (Southern, 1975). This technique works by the transfer of DNA
from a gel to a nylon membrane via capillary action. Genomic DNA was first
extracted from ES cell colonies, which were candidates for targeting. Low volume
overnight and day digests were carried out with restriction enzymes that would result
in fragments that, when probed, would clarify whether targeting had taken place or
not - in accordance with the designed screening strategy. The digests were loaded on
a gel with a size marker e.g. Lambda/Hind III and run until the samples had migrated
all the way down the gel. The gel was photographed under UV light. This was
carried out to ensure that each sample loaded on the gel contained a high enough
concentration of genomic DNA for the Southern to work.
The gel was first incubated in enough 0.25M HC1 to cover the gel with shaking for
20-30 minutes. This was carried out to depurinate the DNA in the gel i.e. to break
some purine bonds in the DNA molecules to allow better transfer of the DNA onto a
blot membrane. The gel was washed in deionised water. The gel was placed in
denaturation solution (1.5M NaCl; 0.5M NaOH) for two 15-minute washes. The gel
was washed in water again and placed in neutralisation solution (1.5M NaCl; 0.25M
Tris-HCl, pH 7.5; ImM EDTA, pH8) for two 15-minute washes. 20x SSC (1.5M
NaCl; 1.5M trisodium citrate) was poured into a basin which had a glass plate on top
- bridging from one end to the other; one that was narrow enough to have gaps on
either side yet large enough to hold the gel of the DNA to be blotted. A large double
layer of blotting paper (Schleicher and Schuell) was bent over the glass plate and
dipped, from either side of the glass plate, into the 20x SSC. Some 20x SSC was
also poured over the top of the glass plate to fully wet the blotting paper. Using a
glass pipette rolled over the paper, all air bubbles were removed from beneath the
layers of paper. The denatured and neutralised gel was flipped onto the blotting
paper - wells-side down. Any exposed blotting paper beneath the gel was carefully
covered with Parafilm to prevent the bypassing of the gel when capillary transfer of
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20x SSC up into the Southern setup took place. A piece of positively charged nylon
membrane (Roche) was cut to the same size as the gel and wet in 2x SSC. The nylon
was kept as clean as possible, for even transfer of DNA from the gel onto it, so it was
handled with clean blunt forceps at all stages. It was placed on top of the gel and
rolled with the pipette to eliminate air bubbles from under the membrane. A piece of
blotting paper the same size as the gel was wetted in 2x SSC and placed onto the
nylon membrane and rolled. On top of that, 2 sheets of dry blotting paper of the
same size were added. A stack of paper towels was added to the setup so the
membrane and blotting papers were completely covered. A second glass plate was
placed over the stacked towels to evenly distribute the weight, and a 0.5-lkg weight
was added on top. The blotting setup was left overnight. The capillary uptake of
20x SSC through the blotting paper and the gel transferred the DNA onto the nylon
membrane - the 20x SSC being drawn up through the setup and soaked up in the
paper towels.
Paper
Figure 2.2 Southern blot setup
The next day, the blotting apparatus was carefully taken apart. The nylon membrane
and gel were flipped over and the wells of the gel marked onto the membrane with a
blunt pencil through the gel. The gel was stained in lx TAE with added ethidium






membrane itself was incubated in 3x SSC to reduce the salt content in the membrane
and dried on blotting paper. Once dry, the blot was placed on a new piece of blotting
paper and covered in Saran wrap. The DNA on the blot was crosslinked onto the
membrane in a UV Stratalinker® 2400 (Stratagene®) using the autocrosslink
program. The blot was subsequently hybridized with a radiolabeled probe and laid
down on X-ray film to produce an autoradiograph of the probe's hybridisation.
2.3.1.1. Production of a Radiolabeled Probe
Two probes were made, one for the genomic DNA to bind to a restriction fragment
that would indicate whether targeting had taken place, and a weaker radiolabeled
probe for the Lambda/Hind III size marker. The probe for the genomic DNA was
purified from an agarose gel and quantified.
A total concentration of 25ng of probe was required for the labeling reaction. 25ng
of the Lambda/Hind III marker was also used for labelling. The Rediprime™ II
random prime labelling system (Amersham Pharmacia Biosciences) was used for the
labelling reaction. The protocol is based on one devised by Feinberg and Vogelstein
(1983; 1984) where random hexanucleotides are used to prime DNA synthesis off
denatured DNA strands using Klenow enzyme's 5'- 3' polymerase activity. The use
of radioactive nucleotides in this reaction enables a radiolabeled DNA probe to be
made, which on denaturation, can bind to DNA on the nylon membrane. This kit
was used in conjunction with Redivue™ a[32P] dCTP (Amersham Pharmacia
Biosciences). The probe DNA was diluted to 25ng/45pl in TE buffer. The double-
stranded DNA was denatured by heating in a boiling water bath for 10 minutes after
which it was snap cooled by incubation on ice. The tube of probe DNA was spun
briefly to draw any condensed liquid in the lid back down to the bottom of the tube.
The DNA sample was added to one reaction tube of Rediprime™ mix. To the
genomic DNA probe, 5pi of Redivue™ a[ PjdCTP were added and the mixture
pipetted several times to resuspend the components of the Rediprime™ pellet. The
priming reaction was incubated for 10 minutes in a 37°C waterbath. The
Lambda/Hind III probe needed to be weaker because the multiple copies of the
Lambda/Hind III fragments had a much higher binding frequency to the probe and
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could have interfered with the genomic probe in the Southern blot hybridisation due
to a disproportionately strong signal from the size marker. For this probe, only 1 pi
of Redivue™ a[32P]dCTP was used. The remaining 4pl of dCTP were unlabelled
nucleotides added to the reaction at a concentration of 0.5mM. The two probes were
labelled identically otherwise.
A NICK™ Column (Amersham Pharmacia Biosciences) was used to purify each of
the labelled probes separately from any unincorporated nucleotides. The column
consisted of Sephadex® G-50 in distilled water that would separate out differently
sized molecules from each other and had been optimised for the removal of
unincorporated nucleotides. The column was rinsed in TE buffer once. The
Sephadex® gel equilibrated with the addition of 3ml of TE buffer to the column,
which was allowed to pass through the column. The labelled probe was added to the
column. When the probe had entered the gel, 400pl of TE buffer were added to elute
out the unincorporated nucleotides. Another 400pl of TE buffer were loaded onto
the column to elute the labelled probe from the column into a 1.5ml collection tube.
1 jliI of the eluted probe was spotted onto a piece of fiberglass paper and placed in a
scintillation bottle. The sample was quantified for radioactive emission in a
scintillation counter (Wallac 1410 Liquid Scintillation Counter; programme 1-8) to
ensure that the probe was radioactive enough to raise a signal once placed on film.
The probe was denatured with the addition of 40pl of 5M NaOH and added to the
hybridisation solution.
2.3.1.2. Hybridisation Procedure
The Southern blot was placed in a preheated (65°C) hybridisation tube with 20ml
preheated hybridisation solution (0.5M NaaHPCL; 7% SDS; ImM EDTA) in a 65°C
oven for 1 hour prior to hybridisation. The hybridisation solution was emptied from
the tube and replaced with 15ml of fresh preheated hybridisation solution and the two
labelled probes. The tube was placed at 65°C with constant rolling overnight. The
following day, two 15-minute washes with 20ml Wash 1 (2x SSC; 0.1% SDS) and
Wash 2 (0.2% SSC; 0.1% SDS) were carried out. Excess liquid was removed from
the membrane although care was taken so as not to allow it to dry out. The
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membrane was wrapped in Saran Wrap and placed on X-Ray film (Kodak Biomax™
MS) in an autoradiography cassette at -80°C for 1 week to develop the
autoradiograph of the Southern blot. The photographic film consists of a plastic
sheet covered with a light sensitive chemical emulsion e.g. silver nitrate or silver
halide that undergo a chemical change on exposure to light or any form of
electromagnetic radiation. The chemical conformation can be visualised after the
film is fixed and developed.
2.3.2. Immunohistochemistry
2.3.2.1. Immunostaining of Fixed Cells
Cells grown as a monolayer were first fixed before antibody staining. The growth
medium was aspirated and the cells were washed once in PBS. 4%
paraformaldehyde was typically used as the fixative. This chemically cross-links
cellular components to each other therefore stabilising antigens in place. Cells were
fixed with cold paraformaldehyde for 20 minutes at 4°C. The fixative was washed
off with 4 washes of PBS. One quick rinse followed by three washes of 5-10
minutes were carried out at room temperature with gentle agitation. If the antigen
being stained for was an intracellular antigen, the cells were permeabilised with a 2-
minute wash with 100% ethanol. This was followed by two 5-minute rinses with
PBS. If the antigen was a cell surface antigen this was not required.
Non-specific immunoglobulin binding was blocked by incubation in a 10% (v/v)
serum solution diluted in PBS for 1 hour at room temperature with gentle agitation.
If possible, serum from the animal in which the secondary antibody was raised in
was used as the blocking agent to reduce the possibility of background from the non¬
specific binding of the secondary antibody. Often this was not practical and BSA
(Invitrogen™) was used instead.
The primary antibody was applied directly after the blocking step. Typically,
polyclonal antibodies were used for cell staining as they are believed to give a better
signal intensity than monoclonal antibodies and are cheaper. In instances where
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background was a problem, monoclonal antibodies were used to reduce the
background staining. With each new antibody used, an initial optimisation step was
carried out with different antibody dilutions to see which gave the best specificity
and the least background. The antibodies were diluted in 1% (v/v) of the appropriate
serum made up in PBS. Dilutions usually ranged from 1/100 to 1/1000 (v/v). The
primary antibody was left on the cells overnight at 4°C with gentle agitation or at
room temperature for 1 hour. The antibody was washed off the cells with four PBS
washes as before.
A fluorescently tagged secondary antibody was applied at a dilution of 1/200 in 1%
(v/v) serum for 1 hour at room temperature, with agitation, and washed with PBS
washes as before. All steps from the point of application of a fluorescently labelled
antibody were carried out under darkness (Zwaginga & Doevendans, 2003). The
cells were mounted with Vectashield® mounting medium with 2-(4-amidinophenyl)-
6-indolecarbamidinedihydrochloride (DAPI) (Vector Laboratories) and a glass
coverslip. DAPI is a fluorochrome that binds DNA and will therefore allow the
nucleus of cells to be visualised. The edges of the coverslip were sealed with PANG
liquid sealant. Slides and plates were observed under a microscope with a DAPI
filter and the appropriate fluorescence filter.
2.3.2.2. Preparation of Cryopreserved Tissue Sections
Tissues of interest were isolated and fixed in 4% paraformaldehyde in PBS at 4°C.
The length of fixation was dependent on the density and size of the tissue. After
fixation, the tissue was washed 3 times in PBS and transferred to 0.12M phosphate
buffer (0.19M Na2HP04, 0.046M sodium dihydrogen orthophosphate-1 -hydrate
(NafLPCL.fLO)) supplemented with 15% (w/v) sucrose overnight at 4°C. Good
impregnation of the tissue with the phosphate buffer resulted in the tissue sinking in
the solution. If after an overnight incubation, the tissue had not sunk to the bottom of
the container, fresh phosphate buffer was added to the tissue sample and the tissue
incubated at 4°C until the tissue did fully sink in the solution. The tissue was next
incubated in pre-warmed 0.12M phosphate buffer supplemented with 15% (w/v)
sucrose and 7.5% (w/v) gelatin for 30-60 minutes at 37°C.
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In appropriately sized moulds, a cushion of 0.12M phosphate buffer supplemented
with 15% (w/v) sucrose and 7.5% (w/v) gelatin was poured and left to set. The
tissue was positioned on this cushion and immersed in more phosphate buffer with
sucrose and gelatin. The gelatin block was allowed to set at 4°C for 30 minutes
before being cut to a smaller cube encasing the tissue.
The gelatin block was fixed to a cardboard mount with embedding compound (Webb
et al., 2003). A beaker of isopentane was cooled to approximately -80°C in liquid
nitrogen. The gelatin block was immersed in the cooled isopentane for 1 minute
before being transferred to dry ice and long term storage in a -80°C freezer.
14pm thick sections were cut at -20°C with a cryostat (Bright OTF5000) and
collected on Superfrost plus electrostatically charged microscope slides (BDH). The
sections were stored at -20°C until use.
2.3.2.3. Immunostaining of Cryosectioned Tissue
Sections were removed from cold storage and allowed to rise to room temperature
and dry out by incubation at room temperature for 1 hour. Slides were rehydrated by
incubation in PBS for 5 minutes. Non-specific epitopes were blocked and the tissue
sections permeabilised by incubating slides in 2% (v/v) BSA (Invitrogen™), 0.2%
(v/v) polyoxyethylenesorbitan monolaurate (Tween20) in PBS for 15 minutes.
Primary antibodies were diluted in the blocking solution and applied to the slides for
an overnight incubation at 4°C. Following incubation with a primary antibody,
sections were washed in PBS supplemented with 0.1% (v/v) Tween20, three times
for 5 minutes each time. Fluorescently labelled secondary antibodies were used and
all steps following the application of the secondary antibodies were carried out in the
dark. The antibodies were diluted in PBS and applied to the slides for one hour at
room temperature. Three washes were carried out in PBS supplemented with
Tween20 as before. The slides were mounted in Vectashield® supplemented with a
DAPI stain and a coverslip and sealed with PANG. Slides were stored in the dark at
4°C.
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Table 2.2 Antibodies used for immunohistochemistry and their dilutions.
2.3.2.4. Preparation of Wax-Embedded Tissue
Tissues to be wax embedded were fixed in paraformaldehyde and washed as carried
out for cryopreservation. The tissue was placed in a plastic wax embedding cassette
and placed in an automated tissue processor (Shandon Hypercentre® XP) and









70 Ethanol 90 RT
96 Ethanol 90 RT
96 Ethanol 90 RT
100 Ethanol 90 RT
100 Ethanol 90 RT
50/50 Ethanol/PCA 90 RT
50/50 Ethanol/PCA 60 RT
100 PCA 60 RT
100 PCA 60 RT
100 PCA 60 RT
100 PCA 60 RT
100 Paraffin Wax 60 60
100 Paraffin Wax 60 60
Table 2.3 Dehydration and perfusion steps used in automated wax embedding. PCA,
paraffin-clearing agent; RT, room temperature.
The tissue was left in molten paraffin wax at 60°C for several hours before being set
in a block of wax in a mould. The block of wax was sectioned using a rotary
microtome (Microm HM325) and the sections affixed to polylysine coated slides
("Polysine" slides, BDH) by incubation at 55°C overnight.
2.3.2.5. Haematoxylin and Eosin Staining
Paraffin sections were de-waxed in xylene for 5 minutes. The tissues were
rehydrated with a 2-minute incubation in 75% (v/v) ethanol followed by a 2-minute
incubation in 65% (v/v) ethanol. The slides were immersed in water for 5 minutes.
The slides were stained in haematoxylin stain (BDH) for 2 minutes. The slides were
washed in a constant stream of water for 5 minutes or until the sections appeared
blue. The slides were counterstained in eosin stain (BDH) for 2 minutes and washed
in water for 5 minutes. The sections were dehydrated again with 1-minute
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incubations in 65% ethanol followed by 1 minute in 75% ethanol before being
transferred to xylene for 5 minutes. The slides were mounted in DPX (xylene (80%
(v/v) based mountant containing distyrene and tricresyl phosphate) and covered with
a coverslip. The slides were allowed to settle overnight before microscopy.
2.3.3. Western Blotting
Western blotting is a sensitive technique for detecting specific protein molecules
using antibody conjugation after a similar blotting method as that used to detect
DNA in a Southern blot. Approximately 20 femtomoles of a protein are detectable
with this technique approximating to lng depending on the molecular weight of the
protein (Harlow & Lane, 1988).
2.3.3.1. Cell Lysis
Initially, cells were lysed under denaturing conditions. This prevented solubilisation,
aggregation or coprecipitation of proteins (Sambrook & Russell, 2001), which may
have affected the accuracy of protein detection and quantitation. 1ml of protease
inhibitor cocktail (1 tablet (Roche) in 7ml PBS) were added to the cells. This
volume was suitable for up to approximately 107 cells. The volume added was
adjusted relative to the number of cells if there were more than 107 cells being lysed.
An equal volume of SDS lysis buffer (lOOmM Tris pH 6.8, 4% (w/v) SDS, 0.2%
(w/v) Bromophenol Blue, 20% (v/v) glycerol, 200mM dithiotheitol (DTT)(added
fresh to the other buffer ingredients each time)) was added to the cells. The cells
were scraped off the growth surface if they had been growing as a monolayer or
pipetted several times with a micropipettor if they had been growing in suspension,
to ensure good lysis.
The lysates were then loaded onto QIAGEN® QIAshredder™ columns and spun at
13000g [13,000 rpm] for 5 minutes to disrupt genomic DNA in the lysates. At this
point, samples were aliquoted into single use aliquots and stored at -80°C. If used
immediately, or once thawed from the stocks, the samples were boiled for 5 minutes,
either in a 100°C water bath or at 99°C in a PCR machine, in order to open the
secondary structures of the proteins. The samples were placed on ice to cool. To
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separate out the different sized proteins a SDS polyacrylamide gel was run. For ease
of use and consistency, pre-cast Nu-PAGE™ 4-12% Bis-Tris gels (Invitrogen™) were
used. 1 litre of lx MOPS running buffer (20x purchased from Invitrogen™) was
prepared. An XCell Surelock™ Mini-Cell electrophoresis unit (Invitrogen™) was set
up and the protein samples loaded. 10pl of Rainbow recombinant molecular weight
marker (Amersham Pharmacia Biosciences) were run alongside the protein samples
and when possible, a positive control sample, to ensure the western blotting
procedure had been successful. The gel was run at 200V for 50 minutes.
After the protein samples had run down the gel, the proteins had to be transferred to a
nitrocellulose membrane in order to be probed with the appropriate antibody. A
piece of Hybond-P™ polyvinylidene fluoride (PVDF) (Amersham Phramacia
Biosciences) membrane was cut to the size of the gel as were 4 pieces of blotting
paper. 1 litre of transfer buffer was prepared from a 20x stock with 10% (v/v)
methanol (20x NuPAGE transfer buffer purchased from Invitrogen™). The PVDF
membrane was pre-soaked in 100% methanol for 2 minutes and then washed in
transfer buffer. The blotting paper and the sponge pads for the transfer unit were all
thoroughly soaked in transfer buffer before assembly of the transfer cassette. The
transfer was carried out using the transfer apparatus of the XCell Surelock™ Mini-
Cell electrophoresis unit. The unit was set up as shown in the diagram below and
inserted into the mini-cell unit so that the direction of the flow of the electric current
was as shown below.
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Figure 2.3 Electrophoretic transfer setup ofproteins in Western blotting.
During the assembly of the unit, care was taken to eliminate any air bubbles between
the layers that could interfere with the transfer. The tank was filled with the
remaining transfer buffer; the transfer was carried out at 100 mAmps (25 volts
approximately) for 1.5 hours. The membrane was checked for good transfer by the
clarity of the rainbow marker transfer. The membrane was dried stored between
blotting paper sheets at 4°C until the probing could be done.
2.3.3.2. Immunoblotting
The membrane was rehydrated in 100% methanol for 2 minutes and rinsed in dffO.
To block non-specific antibody sites on the proteins on the membrane, it was
incubated in a blocking solution of 5% (w/v) powdered, low-fat milk (Marvel), 1%
BSA (v/v) in PBS. The membrane was left in this solution at 37°C for a minimum of
4 hours or overnight at 4°C with agitation. The membrane was washed in a solution
of 1% (v/v) FCS and 0.1% (v/v) Tween20 in PBS for 10 minutes. This wash was
repeated six times in fresh wash solution. This step was followed with two 5-minute
washes in PBS alone. The primary antibody corresponding to the protein of interest
was prepared to a pre-optimised concentration in freshly made blocking solution and
applied to the membrane overnight at 4°C. The membrane was washed as before and
a biotinylated secondary antibody was applied to the membrane at a 1/200 dilution in
blocking solution. The membrane was left at room temperature for 2 hours with
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agitation. Washes were done as before. Horseradish peroxidase (HRP) was
conjugated to the biotinylated secondary antibody using the DAKO AB
Complex/HRP system. The reagents were prepared according to the manufacturer's
instructions for use in immunohistochemistry. The mixture was diluted 1/50 in PBS
and the blot was bathed in the reagents for one hour at room temperature. Washes,
as done between each incubation, were repeated. The blot was developed using the
ECL Western Blotting detection kit (Amersham Pharmacia Biosciences). The
manufacturer's instructions were followed in preparing the reagents and the blot was
incubated in the mixture for one minute. The excess reagent was allowed to drip off
the blot. The membrane was then wrapped in Saran wrap and exposed to Kodak X-
OMAT™ LS film for several different exposure times varying from 10 seconds to 1
minute to get the best exposure and clarity as possible.
2.3.3.3. Stripping PVDF Membranes
In order to check that an equal quantity of protein was successfully loaded and
probed in the Western blots, the PVDF membranes were stripped and reprobed for a
ubiquitously expressed protein. Anti-mouse P-actin (raised in rabbit) (Santa Cruz
Antibodies) was used in all cases with an HRP conjugated anti-rabbit secondary
antibody (Sigma). The PVDF membranes were not allowed to dry out and if the
reprobing was not immediately carried out, the membranes were stored in Saran
wrap at 4°C. The membranes were immersed in 2% (w/v) SDS, 62.5 mM Tris,
lOOmM P-mercaptoethanol at 50°C for 30 minutes. The membranes were washed
three times in PBS supplemented with 0.1% (v/v) Tween20 for 5 minutes each time.
The membranes were blocked and reprobed following the same procedure as was
applied to the initial probing.
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Table 2.5 Antibodies used in Western blotting.
2.3.3.4. Quantification of Protein Concentration
To quantify the concentration of protein in relation to the total protein loaded, the
Quantity One densitometry programme was used on the developed X-ray films of the
blots using a BIO-RAD Fluor-S™ Multilmager.
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2.4. Embryo Manipulation and Dissection
2.4.1. Blastocyst Injection
Jim McWhir carried out all blastocyst injections. Timed matings were set up
between stud males and oestrus-selected female mice. Pregnant mice were killed by
cervical dislocation and the uterine horns removed. 3.5-day-old blastocysts were
flushed out of the uterine horns and collected by passing ES cell medium buffered
with 20mM HEPES through the uterine horns with a syringe and a fine needle. Up
to 15 ES cells were injected into the inner cell mass of the blastocysts which were
transferred back to pseudopregnant mice to continue to term or until the developing
embryos were collected to look at contribution of the ES cells.
2.4.2. Tetraploid Embryo Rescue
Tetraploid embryo complementation or tetraploid rescue involves the generation of a
tetraploid embryo, incapable of contributing to the epiblast and the embryo proper.
Tetraploid embryos are only able to contribute to the extraembryonic lineages.
Following aggregation or blastocyst injection of ES cells into the tetraploid embryo,
a tetraploid embryo-ES cell chimaera is generated with the ES cells obligated to form
all the epiblast-derived cells, thus forming a completely ES cell-derived embryo.
The cells from the tetraploid embryo are limited to the extraembryonic
trophectoderm and visceral and parietal endoderms. By using genetically altered ES
cells e.g. carrying a targeted locus, transgenic mice can be generated bypassing the
requirement for several rounds of breeding litters (Nagy et al., 1990; Nagy et al.,
1993). The viability of the ES-derived foetuses is dependent on the quality of the
cell line. In most instances, the technique is used to look at a gestational phenotype
and pregnancies are terminated prior to birth for examination. However, live births
have been seen with particularly virile ES cell lines of low passage (Nagy et al.,
1993). This technique is especially useful in the generation and study of mice with
multiple genetic mutations, which would take exponentially longer to generate via
conventional breeding.
Jim McWhir carried out the procedures involved in tetraploid embryo rescue as well.
Two cell embryos were released from the oviduct by tearing it apart. The embryos
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were washed in M2 medium (Sigma) three times and placed in an M2 drop under
mineral oil in a fusion chamber. The embryos were transferred to a drop of 0.3M
mannitol supplemented with 50pM calcium chloride (CaC^) and lOOpM MgCF also
in the fusion chamber. The embryos were placed between the electrodes, one at a
time. They were orientated so that the blastomere contact wall was perpendicular to
the electrodes.
The embryos were pulsed using the following settings: pulse amp 6.8, pulse length
0.8, AC amp 3, AC time 1 and number of pulses 1. The embryos were placed in
M16 medium (Sigma) under oil and placed in a 37°C incubator. After 30-60 minutes
had elapsed, the embryos were checked and any 2-cell embryos that had not fused to
form 1-cell embros were removed. The fused embryos were left to develop in the
incubator overnight.
The following day, 4-cell embryos were transferred through 3 washes with M2
medium (Sigma). The zona pellucida of the embryos was removed by washes in
acidified Tyrode's solution until the zona pellucida had dissolved. The embryos
were washed through 3 drops of Ml6 medium before being placed in individual
drops of Ml6 medium (Sigma) with indents. The ES cells intended for tetraploid
embryo rescue were lightly trypsinised so that they were disaggregated, but not quite
at a single cell suspension. The ES cell clumps were washed through 3 drops ofMl 6
before an ES cell clump of approximately 15 cells was placed beside an embryo in
the indent of the Ml 6 drop. A second embryo was placed on the other side of the ES
cell clump to produce an aggregation sandwich. The aggregations were incubated
overnight at 37°C. The following day, successfully rescued embryos should have
compacted and should begin to form a blastocoel cavity. The blastocysts were
transferred to uterine horns of pseudopregnant recipients. The embryos were
harvested at a suitable time in development: typically 11 dpc.
2.4.3. Embryo Dissection
Mice were sacrificed as described above and the uterine horns cut out. For the
purposes of this project, most dissections were carried out on post-implantation stage
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embryos between days 7.5-12.5 dpc. The individual decidua were cut whilst still
covered by the uterine horns. 10-12.5 dpc embryos could easily be isolated from the
deciduum and yolk sac by a single incision laterally into the deciduum to pierce the
yolk sac. Using forceps to enlarge this hole followed by the application of light
pressure onto the deciduum, the embryo was usually forced out of the deciduum and
yolk sac without any observed damage and with the torn yolk sac still attached. In
7.5-9.5 day old embryos, the yolk sac cavity was neither large enough, thin enough
or fluid filled enough to attempt this. For these embryos, the deciduum was cut out
of the uterine shell and prised apart very carefully with fine forceps.
2.4.4. Generation of Tumours in SCID Mice
Mice with severe combined immunodeficiency (SCID) (Harlan) were injected
intramuscularly in the hindlimb with 107 ES cells in a maximum volume of lOOpl of
PBS, to test the cell population's pluripotency or to look at ES cell contribution and
differentiation in tumour generation. Mice were sacrificed when a tumour was
detected growing in the hindlimb and the tumour was dissected out. The tumour was
sectioned and assessed for the presence of tissues from all three germ layers. If the
pattern of ES cell contribution to cell lineages was being assessed, the tumour
sections assessed for ES cell contribution, either by the detection of an ES cell
specific marker e.g. GFP (green fluorescent protein) or LacZ.
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CHAPTER 3
Generation of ES Cells Tagged at the Flk-1
Locus for Selection and Isolation
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Generation of ES Cells Tagged at the Flk-1
Locus for Selection and Isolation
3.1. Introduction
The flk-1 gene was first isolated in 1991 (Matthews et al., 1991). A multipotential
haematopoietic population from the foetal liver was enriched for by selection for
AA4.1 and Sca-1 and against LIN antibodies. From this population, tyrosine kinase
cDNAs were specifically amplified for the purpose of identifying molecules
important for haematopoietic proliferation and differentiation.
The flk-1 gene is expressed immediately after gastrulation leading to the direction of
a subset of mesodermal cells to differentiate to form vascular tissues that are
organised into the initially primitive blood vessels that serve the embryo. It is also
expressed during neovascularisation in adults after severe wounding or during
tumorigenesis. Flk-Vs importance was confirmed by gene targeting experiments,
which revealed its expression pattern in ontogeny and its role in vasculogenesis
(Shalaby et al., 1995; Shalaby et al., 1997). In homozygous mutants no blood islands
were seen, no blood vessels formed and the haematopoietic progenitor population,
although found not to be completely eliminated, was nonetheless almost undetectable
and nonfunctional. Homozygous mutants died between 8.5 and 9.5 dpc and were
resorbed by 10.5 dpc. It was clear that if vascular progenitors did not possess the
FLK-1 receptor, they were unable to migrate to an appropriate site of differentiation
where they would presumably receive further direction down the endothelial and
haematopoietic lineages. However, beyond this activity, and that of other receptors
such as flt-1, tie-1 and tie-2, the molecular patterns of expression that drive the
differentiation of mesoderm to the various cell types that eventually comprise the
fully formed vasculature, are superficial and poorly understood. Transgenic
approaches utilising flk-1 to identify and track this population of cells could shed
light on the mechanisms that are at play to direct cell fate beyond this stage of
lineage specification and elucidate the signalling pathways at play.
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Flk-1 is an ideal candidate to investigate the path of vascular development due to its
association with the emergence of the putative haemangioblast. Its expression at the
time of YS blood islands formation (7dpc), singles it out as a strong candidate to
mark precursors of the haematopoietic and vascular lineages, and potentially the
haemangioblast.
Flk-1 was chosen as the candidate marker of the haemangioblast. Transgenic
approaches were employed to identify and isolate a flk-1 expressing population of
differentiated ES cells that would enable the tracking of differentiation of ES cells
and potentially the haemangioblast.
3.2. Aims
To construct targeting vectors that allowed for the visualisation (using the viable
GFP (green fluorescent protein) reporter) and purification (using the selectable
HPRT gene) offlk-1 expressing cells from a mixed population of differentiated ES
cells.
To carry out homologous recombination in ES cells using the newly constructed
vectors to derive ES cell lines that have been targeted at theflk-l locus.
To ensure that any targeted ES cell lines used to isolate pure flk-l expressing cell
populations have maintained their pluripotency and karyotypic integrity after the
targeting experiment has been carried out.
3.3. Experimental Plan
The flk-l targeting construct used to generate theflk-l null mutant ES cells and mice
(Figure 3.1) was obtained from Dr Janet Rossant. It was modified so that a flk-l
expressing cell population could be isolated using a promoter-trap strategy to drive








Figure 3.1 The original targeting vector used to knock out flk-1 expression and track its
expression pattern (Shalaby et ai, 1995).
3.3.1. Flk-1 Promoter Trap Strategy with an HPRT
Reporter Gene
3.3.1.1. The Role of HPRT in Purine Biosynthesis
There are two biological pathways for purine biosynthesis. Purines can in most cases
be generated via a system of recovering purines already in use in the cell via an
existing salvage pathway of nucleotide conversion. However, there is also a less
energy-efficient de novo synthesis pathway for purine synthesis.
Hprt is a housekeeping gene essential for the generation of purines via the salvage
pathway. It catalyses the condensation of 5'-phosphoribosyl-l-pyrophosphate
(PRPP) and the purine bases hypoxanthine and guanine to form 5'-inosine
monophosphate (5'-IMP) and 5'guanosine monophosphate (5'-GMP) respectively
(See Figure 3.2)(Krenitsky, 1969; Stout and Caskey, 1985).
The hprt gene is X-linked and therefore displays functional hemizygosity in male
cells. This has simplified the generation of mutations that disrupt its function in male
cell lines because loss of function is directly selectable. This has proved to be a
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useful exercise in mammalian cell culture. The hprt gene has become a much-used
tool in transgenic research as HPRT function can be either selected for or against.
Hprt is able to bind to and ribosylate many purine analogues. This ability has been
exploited to develop selection against the expression of HPRT using toxic purine
analogues such as 6-thioguanine and 8-azaguanine (Stutts and Brockman, 1963). A
selection regime for the expression of functional HPRT was also developed at around
the same time. When exposed to a chemical cocktail of hypoxanthine, aminopterin
and thymidine (HAT), any HPRT deficient cells should be killed (Szybalski and
Szybalski, 1962). The hypoxanthine provides a purine source, the aminopterin acts
to block the de novo purine synthesis pathway and the thymidine is supplied due to
the additional inhibitory activity of aminopterin on the thymidine synthesis pathway,
which has to be alleviated by the addition of the base. This results in the exclusive





Figure 3.2 The purine salvage and interconvension pathway. APRT, adenine
phosphoribosyltransferase; ADA, adenosine deaminase; PNP, purine nucleoside
phosphorylase; PRPP, 5'-phosphoribosyl-1-pyrophosphate. (Figure adapted from Stout and
Caskey, 1985)
By placing hprt under the transcriptional control of the flk-1 promoter in the hprt
deficient ES cell line: HM1 (Selffidge et al., 1992), flk-1 expressing cells could be
isolated after differentiation by the application of HAT and the subsequent death of
all non-expressing cells (Figure 3.3).
3.3.1.1.1. Advantages of using HPRT as a Reporter
HPRT is preferable to other chemical selection methods such as drug resistance
because inhibition or selection for its activity has a notably faster mode of action as a
result of the inhibition of a key pathway involved in cell survival. The neomycin
phosphoribosyl transferase (neo) resistance cassette is probably the most
predominantly used selection cassette but selection can take 7 days or longer to
effectively kill all non-expressors of the resistance gene. Also, in recent years,
several accounts of the destabilising effects of PGK/zeo on the transcription or
regulatory control of adjacent genes to its site of integration have emerged that bring
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into question the use of neo as a reporter in targeting experiments (Ramirez-Solis et
al., 1993; Rijli et al., 1994; Fiering et al., 1995; Olson et al., 1996; Weissmann and
Aguzzi, 1999).
3.3.1.1.2. Disadvantages of using HPRT as a
Reporter
An issue that may present itself as a problem with this strategy is the short time
period of flk-1 expression and more importantly, the short time frame of the
haemangioblast's presence. The length of time required for HAT selection to take
effect will be crucial if the window foxflk-1 expression and haemangioblast isolation
is to be met. In EBs, the haemangioblast is believed to exist between 2.5 and 3.5
days after formation (Kennedy et al., 1997; Choi et al., 1998), so if HAT selection
takes several days to act, it may not be as effective a selective agent as desired.
Nonetheless, HAT selection is still preferential to the use of antibiotic selection
cassettes.
Flk-1 HAT Transplantation
Differentiation Selection into Embryos
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Figure 3.3 Schematic diagram showing how selection for HPRT function in flk-1 targeted ES
cells would enable the selection of a pure population of flk-1 expressing cells.
Another issue to consider in the use of the hprt selection strategy is the possible
bystander effect that could hamper the isolation of FLK-1 expressing cells.
Metabolic exchange between neighbouring cells could result in the "kiss of life"
phenomenon whereby phenotypically HPRT deficient cells are kept alive, despite
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selection against them in HAT, due to the metabolic cooperation and exchange of
purines from an adjacent HPRT expressing cell (Hooper and Subak-Sharpe, 1981).
It may therefore be difficult to isolate a pure population if high cell density becomes
an insurmountable problem. (If interaction, both via signalling or adherence to
supporting cell lineages appears to be a key factor in the maintenance and self-
renewal of a healthy FLK-1 expressing progenitor population, this bystander effect
may not be a disadvantage).
3.3.1.2. Flk-1 Promoter Trap Strategy with a GFP Reporter
Gene
In case the chemical selection forflk-1 expression with an hprt reporter presented the
problems mentioned above, a second targeting strategy was devised to place a
promoterless EGFP (enhanced green fluorecent protein) reporter under the
transcriptional control offlk-1. It was believed that this line could be a useful tool
for visualisation of the progression of FLK-1 expression through differentiation, both
in vitro and upon the generation of ES cell chimaeras in vivo. Also, using a GFP
reporter allowed for the selection of GFP expressing cells using fluorescence
activated cell sorting (FACS), thereby selecting for FLK-1+ cells.
3.3.1.2.1. Advantages of GFP as a Reporter
The easy visualisation of the GFP protein in situ enables a simple method for
identification of cells in which the protein has been transcribed and translated and
thus indicates the activation of the gene of interest. The fact that no chemical
interference is required for its detection means that GFP expressing cells can be
observed for the length of time that the promoter of the gene of interest is actively
transcribing the GFP reporter, without compromising the viability of the cells with
stains or fixatives that are required for other commonly used reporters. GFP also has
the advantage of being easily detected and selected for using FACS allowing for in
vitro selection of a pure GFP expressing cell population.
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3.3.1.2.2. Disadvantages of GFP as a Reporter
The half-life of the GFP protein is considered quite long (greater than 24 hours)
which means that if a sensitive and precise indication of gene expression is required,
it may not be ideal. However, several destabilised forms of the protein with
considerably shorter half-lives have been developed to address this problem. For the
purposes of this study half-life of the GFP protein was not a key issue as the focus
was on isolating the earliest possible FLK-1+ progenitor, not the dynamics of its
expression. Although no publications have appeared to indicate that the
phenomenon has been assessed quantitatively, anecdotal evidence (personal
communications with several scientists) suggests that if the GFP transgene is
expressed at high levels, it can have a cytotoxic effect on the expressing population.
If true, this would establish a selective pressure in favour of low expressers or cells
that have successfully silenced the transgene thus mitigating its advantages.
Although easy visualisation of the protein's expression is a major advantage of the
GFP reporter, autofluorescence is a common problem that arises that can either mask
true GFP fluorescence or result in the questionable validity of results if GFP
fluorescence cannot in some way be distinguished from autofluorescence. It is
commonly observed in highly refractile cells, large and fluid-filled cells and in
















Figure 3.4 Schematic representation showing how GFP under the transcriptional control of
the flk-1 promoter can be used to compare spontaneous and directed differentiation
protocols for induction of FLK-1, and how such cells could be purified and examined for other
markers of the haemangioblast using FACS or magnetic assisted cell sorting (MACS).
GFP expression can be both visualised and selected for using FACS (Figure 3.4).
The GFP reporter was first proved in mammalian cells in 1994 (Chalfie et al., 1994).
It has since been used as a tool for the visualisation of expression patterns for many
genes. It was therefore considered to be a good reporter gene to use for this project.
Other groups have also used it as a tool to track haemangioblastic differentiation
(Fehling et al., 2003; Gilchrist et al., 2003) since the inception of this project.
3.3.2. Targeting Vector Design
The initial targeting experiment carried out by Shalaby et al. (Shalaby et al., 1995)
replaced the translated part of the first coding exon of flk-1, together with the
proximal portion of the first intron with a promoterless lac Z gene and a PGK/ieo
(phosphoglycerate kinase promoter driving the neomycin phosphotransferase gene)
selection cassette upon homologous recombination. Homologous recombination
placed the lac Z gene under the transcriptional control of the flk-1 promoter and
disrupted flk-1 expression (Figure 3.5). An external probe (Figure 3.5, pink box)





HN APB P S P X NPP B SI H
3.4 kb ' 8.5 kb
: 1
H II APB PN BH HS P X IIPP B SI H





c—1 E xon 1
1=1 Probe
Figure 3.5 Targeting strategy adopted by Shalaby et at. (1995) to determine the function of
flk-1 during embryogenesis. Lac Z= /3-galactosidase gene from Escherichia coli; Neo=
neomycin phosphotransferase gene; tk, herpes simplex virus (HSV) thymidine kinase gene.
A= Asc I, B= Bam HI, H= Hind III, N= Nco I, P= Pst I, S= Sma I, Sl= Sal I, X= Xho I. Arrows
specify the direction ofpromoter activity. Figure adapted from Shalaby et al. (1995).
At the outset, the above targeting vector was to be modified by replacing the lac Z
reporter gene with GFP or HPRT that was to fall under the control of the flk-1
promoter upon targeting. However, the logistics of the cloning steps were
problematic especially with regards to a necessary partial digestion step that was
required to ablate a specific Hind III restriction site but which was never successfully
carried out despite many attempts over several months. Ultimately, the necessary
components from the above targeting vector were removed and the targeting
construct was rebuilt in pBluescript SK+ (Stratagene®) (see Appendix Ai (HPRT)
and Aii (GFP) for successful cloning strategies). The herpes simplex virus
thymidine kinase gene used by Shalaby et al. for negative selection was omitted, as
enrichment for targeted clones was deemed secondary to the speedy construction of
the targeting vector, especially following accounts of disappointing levels of
enrichment for targeting events. Initially, it was believed that enrichment factors
were in the order of lOOOx (Mansour et al., 1988) however the advantages of
positive/negative selection for enrichment have since been challenged with
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enrichment being observed to be in the region of 2-20 fold (Mombaerts et al., 1991).
This has also been observed in the MeWhir laboratory.
Figure 3.6 Maps of the flk-1 targeting vectors: FLK-1/GFP and FLK-1/HPRT. 3.6a the
targeting construct designed to place the expression of EGFP under the control of the flk-1
promoter upon homologous recombination. 3.6b the construct designed to enable the
expression of the hprt minigene driven by the flk-1 promoter.
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On completion of both targeting vectors, the reporter genes were sequenced
(DNASHEF) to ensure that no mutations had arisen during the subcloning steps. A
single base pair mutation or loss could result in a premature stop codon leading to a
truncated protein or a change in the open reading frame that would result in the
incorrect synthesis of the GFP protein. Both reporters were found to have
maintained their genomic integrity through the subcloning steps. The precise
sequence for the gfp reporter gene is known, however, for the hprt minigene isolated
from the DWM-1 plasmid (Melton et al., 1986; Selfridge et al., 1992) (See
Appendix Ai for a plasmid map) the precise intron-exon boundaries are not known.
The hprt minigene has been artificially constructed and only mRNA sequence,
available in the sequence databases, was useful for mapping the minigene. The lack
of information about the precise exon boundaries meant that the minigene sequences
obtained after sequencing the targeting vector could not be matched with the mRNA
sequence with complete confidence. There was a risk that a single base-pair loss or
mutation at the end of an exon had occurred but was undetectable. Although the
sequence information suggested the integrity of the minigene in the completed
targeting vector, the gene's functionality could only be proved after a targeted ES
cell clone had been isolated and tested for viability in HAT selection following
induction of the flk-1 gene.
Insertion of the reporter gene at the flk-1 locus, causes the deletion of the ATG
transcription initiation codon, the first exon and part of the first intron, leading to the
ablation of flk-1 expression at that allele, with the subsequent expression of the
reporter gene on activation of the flk-1 promoter. The remainingflk-l allele remains
active. Both transgenes incorporated a polyadenylation signal 3' to the coding
sequence for the reporters, ensuring appropriate transcription termination and
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Figure 3.7 Targeting strategies used with either HPRT and GFP vectors and the method of
detection of homologous recombination used in both. Either a promoterless GFP or HPRT
reporter cassette was inserted into exonl of the flk-1 locus incurring a deletion of the first
exon and the following intron. Recombinants were isolated by detection of the PGK-neo
selection cassette with G418 and successful targeting was detected using a 5' external
probe [pink box]. For both targeting strategies, following a Hind III restriction enzyme digest,
wildtype cells produced a 15kb detectable fragment and targeted cells produced a fragment
of 4.4kb and 4.5kb for the GFP and HPRT targeting strategies respectively. Figure adapted
from Shalaby et al. (1995).
The colonies were screened for targeting events by Southern blot following a Hind
III restriction digest using the 5' external probe as shown in Figure 3.7. Attempts
were made to devise a suitable 3' screening strategy to ensure single copy insertions
and transgene integrity, however, much difficulty was encountered in the retrieval of
the required sequence information. Despite the completion of the murine genome
sequencing project (Waterston et al., 2002), the genomic sequence for the flk-1 gene
is incomplete due to its location close to the centromere on the murine chromosome
5. Centromeric sequences are typically highly repetitive and difficult to sequence.
Without resolution of the intron-exon boundaries 3' of the insertion site, such a
strategy was not easily possible and therefore abandoned. Shalaby et al. also did not
use a 3' probe in their confirmation of targeting.












3.4.1. Initial Targeting Experiments at the Flk-1 Gene
Locus
All targeting experiments were carried out as described in the Materials and
Methods. The targeting vectors were linearised by a Not I restriction enzyme
digestion outside the arms of homology and insertion cassettes prior to the
electroporation procedure. In Table 3.1, all targeting experiments carried out have
been summarised along with their outcomes. The text that follows explains the



































R1 468 (576) 6(1.28)
Ed1 GFP 150 75 (96) 0
Ed2 171 (192) 0
Table 3.1 Tabulation of all targeting experiments carried out.
3.4.1.1. Targeting Using the Flk-1ILac Z Vector
While the flk-l/GFP and flk-1 fHPRT vectors were being constructed, the targeting
procedure was tested using the originally used (Shalaby et al., 1995) flk-1/Lac Z
targeting vector. A protocol for picking and analysing clones for targeting was used
which involved growing each picked clone up to a 25cm2 flask before freezing and
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analysis (See Materials and Methods for details). 100 clones were picked, grown and
analysed for targeting by Southern blotting, however no positives were found.
3.4.1.2. Targeting Using the Flk-7/GFP Vector
All targeting experiments from this point forth were carried out using a high
throughput analysis method. This procedure enabled the screening of many more
colonies, as the tissue culture maintenance of the picked clones was far less
demanding.
A targeting experiment was carried out with the flk-UGFV construct. 480 colonies
were picked and screened for targeting as described in the Materials and Methods
chapter. The G418 selection used was 300pg/ml. This was the standard
concentration used in the McWhir laboratory for selection of possible homologous
recombination candidates in murine ES cells. Out of these 480 clones, 378 survived
the picking and lysis procedures and generated a discernable result in a Southern
screen. The majority of the colonies grew well and survived trypsinisation for
freezing of cell stocks. The procedure for carrying out an ethanol precipitation of
genomic DNA was difficult in the 96-well plate format and resulted in the loss of
several precipitated DNA pellets at the 70% ethanol wash stage. Ultimately, as with
the targeting experiment with the original lac Z targeting construct, no positive
clones were identified.
3.4.1.3. Targeting Using the Flk-7/HPRT Vector
A targeting experiment was carried out using the HPRT targeting construct. 768
colonies were picked into eight 96-well plates and G418 selection was applied at
300pg/ml. 497 generated a result by Southern screen: 64.7% of the picked colonies.
Out of these, there were two targeted clones. The relative targeting efficiency
(measured as number of targeted cells out of all colonies picked) was therefore 0.4%.
Although targeted clones were obtained from this experiment, it was nonetheless at a
far lower level than expected. Shalaby et al. had reported a targeting frequency of 1
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in 7 (14.3%) using Southern blot screening in 1995 using a targeting construct from





Figure 3.8 A typical Southern blot screen of picked colonies from a targeting experiment at
the flk-1 locus using the flk-1/GFP vector. Following a Hind III restriction enzyme digestion,
wildtype colonies are detectable with a 15kb fragment. Targeted colonies [2, yellow
asterisks] are detectable with a 4.4kb probed fragment. Figure 3.4 shows a schematic of
the targeting strategy. The AHindlll marker was run at both ends of the gel and also probed.
Empty lanes are due to the loss of colonies or the DNA pellet prior to analysis.
To check whether the resistant colonies that had been picked were "true" neomycin
resistant colonies and not artefacts of a poor selection regime, two blots used to
check for targeting were reprobed for the presence of the PGK/zeo cassette. Over
90% (130/140 colonies were positive for VGKneo) of the colonies picked showed the
presence of the cassette (data not shown). It was hypothesised that the low targeting
efficiency arose because the high level of G418 used was selecting against targeted
clones and in favour of the random integration of the PGKneo selection cassette.
This is especially likely if the flk-1 locus has a downregulating influence on neo
expression levels.
The original Shalaby targeting papers did not indicate the level of selection that was
used to isolate candidate targeted clones. Dr Masatsugu Ema in Dr Janet Rossant's
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laboratory was able to confirm that a G418 concentration of 150pg/ml had been used
to isolate candidate colonies and that they carried out the majority of their targeting
experiments with this level of G418 selection.
3.4.2. The Effect of Reducing Selection Levels on
Targeting Efficiency
The targeting experiment using the flk-HGV? vector was repeated as no targeted
clones had been generated. At the same time, another targeting experiment was
carried out with the flk-l/YiVKT ES cell line despite the isolation of two targeted
clones from the first round of targeting experiments. By repeating targeting
experiments using both targeting vectors in parallel and a common source of ES cells
could help to ascertain whether the low frequency of homologous recombination
observed in the previous experiments were isolated incidents attributable to the state
of the cells used, or establish if there was a difference between the efficiency of the
targeting vectors which would implicate the reporters in determining the rate of
homologous recombination; both targeting experiments were therefore repeated. The
only variable that was altered between the previous experiments and these was the
level of selection that was applied to the cells which was reduced from 300pg/ml to
150pg/ml. For each of the targeting experiments 576 colonies were picked. These
were grown up for cryopreservation and the extraction of total genomic DNA as
before and analysed for homologous recombination at the flk-1 locus using the same
Southern screen. In the targeting experiment using the HPRT targeting construct, a
total of 330 colonies were successfully analysed with 3 positive colonies being
isolated. In the experiment using the GFP vector, 316 colonies were successfully
analysed with 3 positive colonies also being derived from this experiment (Table
3.1). Figure 3.8 shows a typical Southern blot with two colonies that were found to
be targeted.
3.4.3. The influence of DNA Isogenicity on Targeting
Frequency
Shalaby et al. (1995) reported a targeting frequency at the flk-1 locus of 1 in 7 of all
colonies analysed by a Southern screen: a percentage targeting frequency of 14.3%.
125
This is approximately 35 times greater than the frequency observed in these targeting
experiments carried out in HM1 ES cells.
The targeting vectors used in these experiments had exactly the same homology
taken from Shalaby's targeting vector that induced a very high level of homologous
recombination; it was unusual that there was such disparity between the efficiency of
homologous recombination. Shalaby et al. did use negative selection with HSV-TK
however they did not clarify how many colonies they obtained before the application
of gancyclovir or what level of enrichment they had or expected to have. They
would have to have gained a selective advantage of over 30 fold to explain the
paucity of targeting in this experiment.
The most plausible reason for the low efficiency of homologous recombination was
the use of a non-isogenic ES cell line for the targeting experiment. Theflk-1 arms of
homology originally used were drawn out of a 129Sv cDNA library (Shalaby et al.,
1995) and used to construct the targeting vector. Their targeting experiment was
carried out using R1 ES cells, which were derived from 129/Sv mice and were thus
syngeneic with the arms of homology used. The ES cell line used in this experiment
was the HM1 ES cell line. This was a rederivation of the E14TG2A ES cell line,
which in turn was derived from 129/Ola P2 mice (Selfridge et al., 1992). It appeared
unlikely that the DNA would not be syngeneic, firstly, because 129/Sv and 129/Ola
are substrains of the 129 strain of mice and therefore less likely to possess
polymorphisms between each other than other inbred mouse strains; secondly, as flk-
1 is essential for the development of the vasculature and is expressed throughout
ontogeny, it was likely to be highly conserved between species. However,
noncoding intronic regions, absent of regulatory elements could still be subject to
high mutation levels that would be uncontrolled due to their location but which could
still have a profound impact on the level of homology in the arms of homology of the
targeting vectors between intraspecies strains of mice (Kostyniak, 1980; Dizik et al.,
1982).
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The requirement for syngeneic DNA for the best homologous recombination
frequencies has been discussed (Hooper, 1991). To evaluate this possible
explanation of the low targeting frequency and to obtain additional targeted clones,
three more targeting experiments were carried one. Using only the ftk-l/GFP
targeting vector, R1 ES cells (used by Shalaby) were electroporated exactly as
before. Also two F1 lines: Edl and Ed2 isolated by Dr Ed Gallagher from
blastocysts obtained from matings of C57B1/6 and 129/Sv mice were electroporated.
Ideally a completely outbred ES cell line would have been best for carrying out this
experiment, or at least an F1 population from a cross that did not include a 129
mouse strain. However there was no access to such an ES cell line. Few non-129
strain derived ES cell lines exist in the murine system due to possible epigenetic
differences or other as yet unknown characteristics of other mouse strains that make
them less amenable to ES cell isolation. If genetic syngeneity had played a part in
the low level of homologous recombination, the number of targeted clones obtained
from the R1 ES cells would have been expected to be far greater than the number of
targeted clones obtained from HM1 ES cells, which in turn would be expected to
have had more successful homologous recombination than the outbred lines
(although the fact that the cross included 129/Sv may have meant that the flk-1 locus
had remained isogenic with the 129/Sv arms ofhomology).
Table 3.1 shows that the R1 ES cell line which was syngeneic with the DNA
sequences in the targeting vector homologies yielded 6 targeted clones with a
targeting frequency of 1.28%. In HM1 ES cells, the targeting frequency was 0.95 %.
For both these ES cell lines, many more colonies than were picked, appeared after
selection. This contrasted with the poor colony yield for the F1 ES cell lines Edl and
Ed2, which yielded 96 and 192 colonies respectively, all of which were picked and
analysed. No targeted colonies were isolated from these lines. The results of this
experiment comparing targeting frequencies in different ES cell lines did not clarify
the low targeting frequency observed in previous experiments. Although it did not
disprove the hypothesis that syngeneic DNA aids the efficiency of homologous
recombination, the number of clones screened was insufficient to yield enough
targeted clones to allow the results to be interpreted with statistical significance.
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3.5. Discussion
3.5.1. Possible Reasons for Low Frequency of
Homologous Recombination
A high targeting frequency of 14.3% had been observed when the flk-1 locus was
previously targeted with a vector sharing the same homology regions and selection
cassette as the vectors used in these experiments (Shalaby et al., 1995). The best
targeting frequency obtained using the modified flk-1 targeting vectors was 0.95%
despite the screening of over 500 colonies for each of the two developed targeting
vectors.
There were several possible reasons for the extremely low targeting efficiency. Once
the vectors had been constructed, the gfp and hprt reporter genes that would fall
under the control of the endogenous flk-1 promoter were sequenced to ensure that the
sub-cloning steps had not incurred mutations in the genes that could affect the
expression of the reporters. The PGKneo had not been sequenced, as the ability to
isolate a number of colonies after selection was applied in a targeting experiment was
a sufficiently good indicator of its integrity. The arms of homology were also not
sequenced. If mutations had arisen in the arms of homology during the subcloning
steps, they could have impacted on the frequency of homologous recombination.
However, the process of finding the homologous sequence is not rate limiting as
shown by Thomas et al., 1986 who showed that increasing the concentration of the
targeting vector or the number of target sequence copies did not increase the
efficiency of targeting. In retrospect, it is clear that the homologies should have been
sequenced to ensure that they had maintained their integrity through the cloning steps
in vector construction.
Despite the success of Shalaby and colleagues to target the flk-l locus, cell line-
specific variations could have led to the poor targeting frequencies achieved in these
experiments. It was assumed thatflk-l was not expressed in ES cells therefore it was
conceivable that the region in which the flk-l gene was situated was therefore
heterochromatinised. This may have left the flk-1 locus impenetrable by
recombinases and could have meant that homologous recombination was less likely
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to occur. However, experiments that will be discussed in Chapter 4 have since
elucided that the level of flk-1 expression in undifferentiated ES cells is quite
dynamic and varies noticeably without apparent differentiation or other identifiable
reason.
An additional possibility, referred to earlier, is that the PGRneo selection cassette
induced the heterochromatinisation of that region, including the cassette itself, thus
preventing the isolation of true targeted clones (Ramirez-Solis et al., 1993; Rijli et
al., 1994; Fiering et al., 1995; Olson et al., 1996; Weissmann and Aguzzi, 1999).
Random integration could still occur freely as it employs a different mechanism to
take place and integration in such instances would take place preferentially at open
sites that are favourable for recombination.
As already mentioned, it is known that the processes of random integration and
homologous recombination are favoured at two distinct phases of the cell cycle and
act independently of each other. Homologous recombination efficiency is believed to
be optimal at early to mid S-phase in the cell cycle (Wong and Capecchi, 1987)
whereas random integration is thought to peak at G2/M phase (Yorifuji et al., 1989).
Cotransfection experiments have shown that random integration and homologous
recombination rarely occur in the same cell (Reid et al., 1991). The pace of the cell
cycle may therefore have a significant influence on the rate of homologous
recombination independently of other possible influences. It is therefore possible that
if the cells used in the targeting experiments had been electroporated at the point of
the cell cycle when random integration was favoured, the frequency of homologous
recombination would be very low.
3.5.2. The Significance of Maintaining Genomic
Isogenicity in the Execution of Targeting
Experiments
It is known that sequence mismatches between the arms of homology of a targeting
vector and the endogenous site for homologous recombination reduce the targeting
efficiency, especially if the region of mismatch is large (Waldman and Liskay, 1988).
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It has also been observed that if the arms of homology between a targeting vector and
the genomic locus are not isogenic, the rate of targeting is affected. Homologous
recombination at the retinoblastoma susceptibility locus in E14 ES cells was 20x
more efficient with a targeting construct derived from the same strain 129 than with
one derived from a different strain BALB/c (te Riele et al., 1992). It is therefore
preferred if targeting vectors are designed using homologies derived from the same
strain of mouse.
As most ES cell lines are derived from the 129 strain of mouse, and in this particular
instance the arms of homology and the ES cell line were both from a 129-strain
mouse, this was not considered to be a problem. However, in light of the low
efficiency of homologous recombination, the possibility of there being
polymorphisms at the flk-1 locus between the 129/Sv and 129/Ola substrains of
mouse was considered.
Udy et al., 1997 reported that they found that there was an inverse relationship
between targeting frequency and cell doubling time with the R1 ES cell line showing
the highest level of homologous recombination with a targeting frequency of 1 in 50.
Contrary to other reports (Deng and Capecchi, 1992; van Deursen and Wieringa,
1992; te Riele et al., 1992) where isogenicity was reported to be able to increase the
frequency of homologous recombination from 4 to 25 times its rate otherwise, the
authors did not find that isogenicity of DNA between cell lines and vector DNA
impacted on the targeting frequency. They accounted for the observations others
made with respect to isogenicity by considering the cycling capabilities of various
cell lines and how this would affect the rate of homologous recombination.
The targeting experiments in the R1 (129/Sv) and F1 (129/Sv x C57B1/6) lines did
not clarify the importance of isogenicity. It was clear that the R1 ES cells were
more amenable to recombination with this vector as more colonies were generated
after selection for recombination events. Both Edl and 2 produced lower numbers of
colonies showing a lower level of recombination. However, this can be attributed to
their slower cycling capabilities as both lines grew much slower than HMls or R1
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ES cells. The total number of colonies screened for the R1 ES cells was comparable
with the number screened in the HM1 ES cells. As these results were not
corroborated with additional repeats, no statistically significant conclusions can be
inferred from the data. It is interesting to consider the possibility that the cycling of
the ES cells determines the efficiency of homologous recombination however as this
could account for the low frequency seen in HMls. Although this ES cell line is
comparatively stable and proliferates well, the R1 ES cell line, known to be less
stable karyotypically (Gao et al., 2002), proliferates noticeably faster so that at any
time that the cells are harvested for electroporation, you are likely to get some cells
in S-phase when homologous recombination is optimal. With a slower cycling
population, timing would be more critical as cell activity would be slower with fewer
cells in S-phase at any given time.
3.6. SUMMARY
• A previously used targeting vector used to target the flk-1 locus using a
promoter trap strategy to express Lac Z was modified so that upon activation
of flk-1 expression, either the gfp or hprt genes are transcribed.
• Targeting experiments in mES cells enabled the isolation of targeted ES cell
lines although the targeting frequency was surprisingly low.
• Investigations were carried out to establish whether the non-isogenic arms of
homology of the targeting vectors were responsible for the low targeting
frequency. These were inconclusive, as the observed rates of homologous
recombination were not confirmed by repetition of the experiments, which, if
carried out, would have allowed the statistical analysis of the data.
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CHAPTER 4
Analysis of Flk-1 Targeted Cell Lines
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Analysis of Flk-1 Targeted Cell Lines
4.1. Introduction
Different ES cell lines frequently display variations in cellular morphology, growth
behaviour and differentiation capacity and patterns. This is affected by the process
of ES cell isolation and the stresses associated with that together with potential
variation across the ICM at the time of ES cell isolation that could contribute to
incidental differences between lines. Targeted clonal ES cell lines display a similar
behavioural difference after being single-cell cloned. It is possible that individual
cells within a stem cell population accumulate phenotypic variations over time.
These could be associated with sporadic mutations incurred due to a gradual increase
in passage number and possibly a decrease in telomere length, or there could be
mutations favoured and therefore maintained in the cell population such as increased
proliferative capabilities due to loss of cell cycle checkpoints. The process of
targeting may also have induced a small chromosomal change e.g. a deletion or gene
conversion event that affects the behaviour of a single cell that is clonally isolated.
A mutant or aneuploid cell that has increased proliferative capabilities due to cell
cycle loss of checkpoints e.g. transformed cells can overtake an entire culture within
the course of a few passages. Before using any cell lines, it is therefore necessary to
check that they are karyotypically normal. Multiple random insertions of the reporter
that disrupt unknown genes are also a possibility that has to be considered as a cause
for clonal variation between targeted cell lines, however in the absence of a 3' screen
to check for this, there is no way to know if this has occurred. Multiple insertions are
commonly associated with transgene silencing.
4.1.1. Karyotype Analysis of the Targeted Cell Lines
Out of the total of 8 targeted clones identified by Southern blot analysis, only 6 were
successfully thawed from the 96-well plates. One clone for each of the reporters was
lost; the flk-1IH?KY one due to complete differentiation after being thawed and the










Figure 4.1 Southern blot confirming the targeting events in 4 flk-1/HPRT and 2 flk-1/GFP cell
lines. Figure 3.4 describes the targeting and verification strategy used to identify targeting
events. Wildtype DNA corresponds to a 15kb probed band. Targeted cells produce one
15kb band corresponding to the remaining wildtype allele and one 4.4kb (GFP) or 4.5kb
(HPRT) band corresponding to the targeted allele. M = A/Hindlll size marker. HM1 is the
parental wildtype cell line.
For each remaining targeted clone, 50 metaphase spreads were analysed for the
expected 40 chromosomes (Figure 4.2). Out of the 6 targeted clones only the flk-
7/GFP line, D12 and the flk-HHPRT line E9 were observed to have any aneuploid
chromosomal counts (Table 4.1). A low frequency of observed abnormalities such
as these, can be attributed to the chance loss of a chromosome in the preparation of
the slides. If a true chromosomal loss had taken place, it would be expected that the
abnormality would be far more prevalent in the cellular preparations due to the fact
that such aberrations commonly result in a loss of cell cycle control and thus
proliferative control leading to abnormal cells taking over a population of normal
cells.
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D12 GFP 48 1 (39), 1 (41)
F2 GFP 50 0
C11 HPRT 50 0
F8 HPRT 50 0
E9 HPRT 49 1(39)
F9 HPRT 50 0
Table 4.1 Karyotypic analysis of all targeted clones
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4.1.2. Vigour and Self-Renewal Capabilities of
Targeted Lines
Despite being derived from the same HM1 ES cell line, the various targeted clones
displayed noticeable differences in recovery after trypsinisation or growth at low
density. Three lines grew slowly in comparison to the others: the flk-l/GV? line F2,
and the flk-UHPRT lines Cll and F9. All three of these lines, as well as growing
slowly, had poor plating efficiencies after trypsinisation and readily differentiated if
they were seeded at and grown at low densities.
Initial experiments using all the targeted clones indicated that some lines were more
consistent than others with respect to speed and course of differentiation. The two
lines that were both vigorous and the most consistent were D12 for theflk-l/GTY line
and F8 for the flk-l/HPRT line. It was decided to focus on these lines in the more
complex experiments carried out so that observations could be accepted and
interpreted with the greatest level of confidence possible.
4.1.3. Pluripotentiality of the Targeted Cell Lines
In order to ensure that the ES clones had retained their pluripotency following
homologous recombination, the most robust of the isolated clones for each of the
targeting experiments: D12 for the flk-l/GPP lines and F8 for the flk-l/HPRT lines,
were used to generate tumours in SCID mice as outlined in Chapter 2.
D12 tumours were generated in 4 mice in 2 separate trials. In all instances, they
consistently produced fluid-filled cystic tumours with poor cohesive structure. It is
not clear why this was the case or whether it could have been due to the stress of
targeting or an aberration brought on by the process. F8 tumours were generated in 2
animals in a single trial and were more typical of other ES lines producing solid
tumours that could be easily dissected and sectioned with a variety of tissue types
forming.
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Figure 4.3 Haematoxylin and eosin stained sections obtained from tumours generated in
SCID mice from the injection of the targeted ES cell lines F8 (flk-1/HPRT). a epithelium, b
muscle and collagen fibres, c cartilage, d gut epithelium typical of jejunum, e secretory
ducts, f vein surrounded by muscle and connective tissue , g bone, h gut mucosa typical of
ileum, i cells of the brain stem . Scale bar represents 100pm.
In both the tested ES cell lines, cells from each of the 3 germ layers was observed
(Figure 4.3). Mesoderm was frequently observed with muscle and collagen fibres
(b), cartilage (c), and blood vessels (f). Endodermal lineages including epithelia (a,
d) and secretory glands (e) were also seen. Least frequently observed were
ectodermal cells although cells from the brain were identified (i).
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4.1.4. Generation of Chimaeras from D12 flk-1/GFP ES
Cells
Both the D12 and F2 flk-1/GYV targeted ES cell lines were used in blastocyst
injection to generate chimaeras that could transmit the flk-1 targeted allele through
the germline to generate heterozygous mice for the flk-UGYY allele.
Male chimaeras were successfully identified from coat colour chimaerism. The
embryos used were C57B1/6 embryos, which give rise to animals with a dark coat
colour; the HM1 ES cell line is derived from 129/Ola P2 mice that have a paler
chinchilla coat colour. Figure 4.4 shows coat colour chimaerism following
blastocyst injection with the targeted ES cells. One chimaera was a 100%
transmitter, generating a completely chinchilla coloured mouse (no photograph
available).
Figure 4.4 Coat colour chimaerism after blastocyst injection of CBA mice (coat colour:
agouti) with flk-1/GFP ES cells is derived from HM1 ES cells from 129/Ola P2 mice (coat
colour: chinchilla).
4.2. Faithful Expression of Transqenes upon Flk-1
Promoter Activation
4.2.1. Introduction
To check that the gfp transgene was being correctly expressed and regulated, flk-1
expression was stimulated in vitro and observed to see whether the transgene was
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being expressed appropriately. HPRT-tagged cells could not be visualised in vivo,
however, differentiation of the HPRT-tagged cells down haemangioblastic lineages
would allow for the selection of HPRT expressing cells from non-expressers that
could be eliminated with HAT selection.
In order to check that the gfp and hprt transgenes were behaving as expected under
the transcriptional control of the flk-1 promoter, some simple differentiation
experiments were carried out.
4.2.2. Results
A general differentiation protocol to check that the gfp transgene was behaving
appropriately in both flk-l/GFF targeted lines was carried out. Ideally, specific
differentiation protocols that maximised the direction of differentiation for flk-1
activation would have been used however, at that stage of the project they had not
been optimised. It was anticipated that some flk-1 activation would occur in early
EBs. This assumption was based on the observations made by Gordon Keller's
group when developing their culture for the BL-CFC (Kennedy et al., 1997; Choi et
al., 1998).
4.2.2.1. GFP Detection After Differentiation
EBs were generated using both suspension differentiation and the hanging drop
methods (as outlined in Chapter 2) and observed daily with an appropriate GFP filter
for visualisation of any GFP expressing cells.
In both the suspension and hanging drop cultures of EBs (Figure 4.5), patches of
green fluorescent cells were seen between two and six days of differentiation.
Eventually, as the EBs grew larger and developed fluid-filled cavities, true cellular
fluorescence that can be focused upon using phase-contrast microscopy, could no
longer be seen due to the masking effect of the high levels of autofluorescence.
Autofluorescence could not be focused on, typically lit up all dense patches and any
refractile, highly fluid filled cells.
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Figure 4.5 4-day-old EBs showing GFP fluorescence, a, c and e show phase contrast
images of EBs, b, d and f are the corresponding images with a GFP fluorescence filter.
Scale bar represents 100pm.
A basic haematopoietic differentiation culture in methylcellulose as well as
differentiation on collagen IV were also carried out. Differentiation in
methylcellulose or on collagen IV provide the basis of the two main haemangioblast
culture protocols that were being optimised at the time (Kennedy et al., 1997; Choi et
al., 1998; Nishikawa et al., 1998 a and b). Growth of ES cells in these differentiation
systems was attempted with the flk-l/GFP targeted cells to see whether, despite no
optimisation of the differentiation procedures having been carried out yet,
differentiation on these growth substrates would result in higher levels of GFP
expression correlating with activation of the flk-1 promoter.
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Figure 4.6 Early colonies (day 7) from a haematopoietic culture in methylcellulose. a, c and
e show phase contrast images of the colonies, b, d and f are the corresponding images with
a GFP fluorescence filter. Scale bar shows 100pm.
In haematopoietic cultures (Figure 4.6), green colonies were seen. However, unlike
the EBs which typically showed patchy expression of GFP on the EB surface, in the
haematopoietic cultures, colonies were generally either totally green or not green at
all, with mixed colonies being the rarity. The ratio of green to non-green colonies
was approximately 7:1. Non-green colonies were almost all EBs and did not have
haematopoietic colony morphologies.
Cells were also differentiated on collagen IV coated plates in the absence of LIF.
GFP was rarely detected visually on collagen IV differentiating cells. The cells that
differentiated from the ES cells on collagen IV all possessed a high cytoplasm to
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nucleus ratio with a tendency to grow as a monolayer. Most three-dimensional dense
clumps, were highly autofluorescent and would not photograph well. They
comprised very small, uniform, circular cells that were believed to be potential
haematopoietic cells. The low level of background fluorescence observed was
attributed to the high cytoplasmic volume of the differentiating cells. If GFP was
being produced at relatively low levels in cells with high cytoplasm content, the GFP
fluorescence might have been diluted beyond visual detection. The collagen substrate
provided high levels of autofluorescence, which may have confounded GFP
visualisation and masked low-level fluorescence from the cells.
4.2.2.2. Detection of Autofluorescence
An unfortunate drawback of using a GFP reporter, especially when attempting to
detect it in three-dimensional structures such as EBs, was the level of
autofluorescence that was observed (Figure 4.7).
To gauge the level of autofluorescence that could be expected from these cultures,
wildtype HM1 ES cells were differentiated alongside the GFP targeted ES cell lines.
Although observed at a far lower level than in the targeted lines, unexplained
autofluorescence was seen in the HM1 EBs. Autofluorescence was only seen in
large, dense or highly refractive, fluid-filled cells. Through the regular comparison
of fluorescence between differentiating cells containing and lacking the GFP
reporter, experience was gained in identifying cases where autofluorescence was a
possible explanation for fluorescence according to the EB form and the size of the
cells fluorescing in relation to surrounding ones that were not. In instances where
such observations were insufficient to determine the authenticity of the observed
fluorescence, closer examination at a higher magnification aided the identification of
cases of autofluorescence.
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Figure 4.7 HM1 ES cells displaying autofluorescence. a, b, c and d show EBs differentiated
in suspension, e, f, g and h show colonies differentiated in methylcellulose. Scale bar
represents 100pm.
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4.2.3. Loss of GFP Detection
After promising initial investigations that indicated that GFP was being expressed
upon differentiation (with the assumption being that the flk-1 promoter was
activating its expression), more detailed and controlled experiments were set up to
measure GFP levels at different timepoints using the various differentiation protocols
under investigation both visually and via RT-PCR.
Unfortunately, GFP could no longer be detected visually in any of these experiments.
Several instances of very obvious fluorescing colonies were seen, however, none that
could, for certain, be distinguished from autofluorescing colonies.
4.2.3.1. Transcriptional Detection of gfp
Flk-1 expression, and in turn gfp expression may have occurred at such low levels so
as not to be detectable. To see whether this was the case the D12 flk-1/GFP ES cell
line was differentiated as EBs in suspension. RNA was obtained from pooled 5-day-
old EBs and total cDNA was produced from them. Using GFP-specific primers, an
RT-PCR screen was carried out to see whether the gfp transcript could be detected at
all.
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Figure 4.8 RT-PCR showing the corresponding expression of flk-1 and gfp in the D12 fik-
1/gfp targeted ES cell line against the parental HM1 ES cell line. D4T is an immortalised
endothelial cell line with low level flk-1 expression; TNG is an ES cell line that expresses
GFP constitutively; D12 Diffl and Diff2 correspond to two separately conducted basic
differentiation experiments generating EBs which were collected for total RNA after 5 days of
differentiation; MOUSE represents total 11 dpc mouse embryo RNA derived cDNAs.
Figure 4.8 shows that both undifferentiated and differentiated D12 ES cells express
flk-1 and gfp transcriptionally. Although this PCR was not quantitative,
differentiated D12 cells did appear to express flk-1 at a higher level than
undifferentiated ES cells as would be expected. This consistent result showed that the
gfp transgene was being transcribed and that its transcription appeared to correspond
to the activation offlk-l as expected. Reactions without reverse transcriptase were
set up for all PCR reactions to ensure that no false positive results were obtained
from DNA contamination (data not shown).
Although in this example, HM1 ES cells appear not to express flk-1, it has been
observed that different populations of HM1 ES cells, like the D12 ES cell clone, can
express low levels offlk-1. It is unclear whether this is because this ES cell line as a
whole population expresses flk-l at low levels or whether at times it is a consequence
of the cells being at a particular stage of the cell cycle, or there being a slightly
differentiated cell population present that expresses it. Certainly no phenotypic
differences were observed that could explain this and it appeared not to relate to the
length of time in culture or passage number of the cells.
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4.2.3.2. Detection of Translated GFP Protein in Targeted
Cells
Although a gfp transcript was successfully detected in targeted cells, this was not
indicative of whether the GFP protein was also being synthesised efficiently or
correctly. In order to find out whether the GFP protein was being synthesised in the
cells, a Western blot using total protein lysates isolated from the differentiated D12




Figure 4.9 Western blot of total protein lysates taken from GFP negative (HM1), GFP
expressing (TNG) and the flk-1/GFP targeted ES lines D12 and F2. Lysates were taken
from both undifferentiated cells and from 4 day old EBs.
At first, it appeared that GFP was not being expressed in either the D12 or F2 cell
lines (Figure 4.9), however, as the level of GFP being produced, as a percentage of
the total protein content of the cells, was likely to be low in differentiated D12 and
F2 cells but very high in the TNG positive control which constitutively expresses
GFP under the transcriptional control of the CMV (cytomegalovirus) viral promoter,
the sensitivity of this Western blot was called into question.
For a more constructive positive control, the TNG ES cell line was diluted by several
orders of magnitude (1:100, 1:1000, 1:10000) with wildtype HM1 ES cells and then




Figure 4.10 Repeated Western blot showing dilutions of the positive control TNG line with
non-expressing HM1 cells alongside the GFP non-expressing HM1 line and both the flk-
1/GFP ES cell lines D12 and F2 both undifferentiated and differentiated to 4 day-old EBs.
Figure 4.10 confirms that GFP is not being expressed at detectable levels at the
protein level despite its apparent transcriptional activation. Although a background
band is present in the Western blot, if it is accept that the HM1 band intensity
represents no GFP protein, it is clear that neither the F2 nor D12 flk-l/GYV targeted
lines express the GFP protein, either in the undifferentiated or differentiated states.
4.2.3.3. Tetraploid Embryo Rescue Using flk-1/GFP ES
Cells to Detect the Expression of GFP
In order to see whether GFP could be detected in an in vivo setting and how the flk-
1/GFP ES cells would behave in an environment where the flk-1 gene is activated
maximally, tetraploid embryo chimaeras were generated by Jim McWhir.
Embryos were collected at 10 dpc. At this stage flk-1 expression in a normal embryo
would be maximised due to the angiogenic remodelling of the primitive vasculature.
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Embryos at this stage were also easier to dissect out of the decidua than at earlier
stages of development when flk-1 is expressed.
Figure 4.11 Tetraploid embryo rescue embryos generated using flk-1/GFP ES cells. 10
embryos were successfully assessed for GFP fluorescence, however no signal could be
detected for any of them.
None of the 10 embryos analysed showed any sign of GFP expression in the vascular
network or elsewhere.
4.2.3.4. Immunohistochemical Detection of GFP
Expression in vivo
It was decided to look for GFP expression in heterozygous embryos at a stage in their
development when FLK-1 would be highly expressed. The chimaeras generated
from the flk-1/GFP ES cell line D12, were backcrossed to generate potential
heterozygotes. The foetuses were removed at 11 dpc. The yolk sacs from these
embryos were lysed for RNA to carry out a PCR screen (using neo primers) to
identify heterozygotes that would be expressing gfp on activation of the flk-1 gene.
Only 2 out of the 10 embryos screened were heterozygotes. These embryos were
cryopreserved immediately after isolation from the uterus and sectioned for staining
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of the vasculature for the presence of GFP. However, in these embryos, no GFP
protein was detected either visually or following immunohistochemistry for the GFP
protein (in case the GFP protein was undetectable visually due to it's degradation as
a consequence of the embedding and cryosectioning procedures).
4.2.4. HPRT Expression
To test the ^-/-specific function of the HPRT gene, the flk-1/HPRT ES cells were
differentiated on collagen IV and placed under HAT selection to kill all HPRT" cells.
Cells were seeded at a very low density as suggested by Nishikawa et al., (98a and
b). For the first three days of differentiation, little proliferation or differentiation was
seen in any of the targeted colonies. 4 days after the differentiation regime was
initiated, the cells experienced a dramatic population explosion seemingly concurrent
with differentiation of cells from islands of dense ES cells.
Figure 4.12 shows the course of differentiation and the effect of HAT selection.
Phenotypically, the cells that survived the selection regime were very similar to the
cells from the D4T endothelial cell line. The cells were allowed to differentiate to
near-confluence (7 days of differentiation) before being subjected to HAT selection.
This was maintained for 3 days by which time it was clear that all the targeted cell
lines were exhibiting resistance to the effects of the selection whereas the cells from
the parental HM1 ES cell line had almost all died and those cells remaining appeared
unhealthy and non-dividing. The targeted lines were responding to the selection,
however, cells grown in the absence of HAT selection had formed a densely packed
monolayer of endothelial-like cells by 10 days of differentiation.
149
FMc-1/HPRTtargetedc lllin s:7daysifferentiationNOHAT,3daysfurtherdiff rentiation+HAT Non-TargetedCellsiSelectionUnselectedC llsD4TEnd helialC lLi e Figure4.12ourflk-1/HPRTEScelllin sdiffer ntiatedor0daysncol genIV( -d).Thcellsw reu tu diHATs lectionf rtl t3days.TheHM1parentalESc llinegrownunderthamec nditionsiphotographed( ),llF8c l sgr wnit bsencefHAT selection(f).TheD4Tndothelialc lliisin ludedasmorphologicalc mp rison(g).Scaleb rshows100pm.
To ensure that the phenotype correlated with the expression of flk-1,








Figure 4.13 Immunohistological detection of the FLK-1 receptor after 8 days of differentiation
of ES cells on collagen IV followed by 2 days of selection (b). Immunohistochemical
detection of FLK-1 was also carried out on the D4T cell line (a) and undifferentiated HM1 ES
cells (c) as a comparison. Scale bar shows 100 pm.
Cells in and out of selection, grown on a collagen IV substrate were found to show
high levels of FLK-1 expression, comparable with D4T endothelial cells (Figure
4.13a). Undifferentiated HM1 cells did not stain for FLK-1 (Figure 4.13c).
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4.3. Discussion
4.3.1. Characterisation of Targeted Lines
All of the ES cell lines that were targeted had normal chromosome counts (Figure
4.2). However, the clones could have acquired more subtle chromosomal mutations
that would need more detailed analysis to discover. From preliminary culture and in
vitro differentiation analyses, the F2, Cll and F9 lines were found to grow poorly
and were more prone to growth crises if cultured at low densities or allowed to reach
confluence. These phenomena are frequently seen in instances of single cell cloning
of a cell from what is a heterogeneous population, even if the cell line in question
was itself single-cell cloned. This heterogeneity manifests itself over time as a result
of the accumulation of advantageous mutations that affect the growth, or morphology
of a cell but which allow it to be maintained in the cell population or even overtake it
(Jim McWhir, personal communication).
4.3.2. Expression of Transgene Reporters in Flk-1
Targeted Cell Lines
4.3.2.1. Flk-1 IGFP Targeted ES Cell Lines
Following some preliminary differentiation experiments to induceflk-1 expression, it
appeared that the gfp transgene was being induced (Figures 4.5, 4.6). Care had been
taken from the start to ensure that the observed instances of cell fluorescence could
not be attributed to autofluorescence of three-dimensional structures in the cultures,
or fluorescence from the different growth media or substrates. Follow-up
experiments quickly indicated that fluorescence was no longer being observed.
Attempts were made to establish whether any growth conditions had changed or
whether any reagents could have been responsible for the absence of fluorescence,
however, no clear reason was found.
In the initial differentiation experiments that showed GFP expression, RNA for
analysis of gene expression that could have elucidated any changes at the molecular
level had not been obtained. However, in later experiments in which GFP was not
detectable visually, the gfp transcript could be detected using RT-PCR (Figure 4.8).
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If the entire flk-1 expressing population was expressing gfp, then
heterochromatinisation of the modified flk-1 locus could be ruled out as a possible
cause. However, the sensitivity of PCR means that this result, indicating that gfp was
being transcribed together with flk-1 induction could represent a very small
percentage of the total number of flk-l expressing cells, the remainder of which
could have been subject to sufficient gene silencing to prevent the observation of
green cells. The potential disruptive implications of the presence of the PGKneo
cassette has already been discussed and is a possible cause for GFP silencing due to
the induction of heterochromatinisation (Ramirez-Solis et al., 1993; Rijli et al., 1994;
Fiering et al., 1995; Olson et al., 1996; Weissmann & Aguzzi, 1999) as is the process
of homologous recombination itself.
Another somewhat conjectural possibility is the cytotoxic effect of high GFP
expression. Although not published, this possibility has been discussed and cannot
be ruled out. If a level of transcriptional regulation is lost as a consequence of the
targeting event resulting in overexpression of the GFP reporter, cell death could
result. Of course, this could apply to the overexpression of any protein but is more
likely to be problematic if the protein is exogenously derived and not easily
metabolised. It is difficult to view this possibility objectively, however, given the
success of the GFP reporter in numerous examples and with GFP tagged chimaeras
displaying a normal developmental course and viability. However, it is a possibility
that GFP-expressing cells cycle more slowly than cells that do not express the protein
due to silencing and were diminishing in the cell population over time therefore
being inadvertently selected against.
Neither of the flk-l/GW targeted ES cell lines produced detectable levels of GFP
protein (Figure 4.10) in vitro and in vivo with the D12 cells having been used in
tetraploid embryo complementation (Figure 4.11) and the generation of
heterozygotes after germline transmission. The GFP reporter seemed to have been
initially switched on and subsequently lost in both cell lines (although the F2 flk-
1/GFP line never differentiated well and was not observed as closely or as frequently
as the D12 line). Ideally, a FLK-1 Western blot should have also been carried out to
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ensure expression of FLK-1 could be detected rather than assuming the likelihood
that the levels of FLK-1 induction in EBs would be detected at the protein level. The
fact that both GFP targeted clones underwent transgene silencing hinted that the GFP
targeting vector design could have been responsible for the loss.
If GFP expression had truly been observed in the initial experiments and lost, this
may signify some sort of instability at the flk-1 locus brought on by the targeting,
however, it would be difficult to establish what exactly occurred especially as the
initial observations of GFP expression were taken visually and not corroborated by
molecular analysis of some form. Others have also had success in generating flk-
7/GFP targeted cells (Dr Alexander Medvinsky, personal communication), showing
that it is possible. In this instance, a different targeting strategy and vector were used
with different homologies used. The vector was constructed so that no deletion was
incurred upon gene targeting. There was also no additional insertion of a
polyadenylation signal for the transgenic reporter, thus relying on the capture of the
endogenous polyadenylation signal.
4.3.2.2. The Effect of Targeting Vector Design on the
Success of Gene Targeting
4.3.2.2.1. Deletion of a Key Regulatory Element
Through Homologous Recombination
It has been shown that sequences 5' to theflk-1 gene contain cis-acting promoter and
enhancer elements (Ronicke et al., 1996; Patterson et al., 1995). These promoter
elements were shown to be insufficient for expression of a lacZ reporter gene in
murine embryos. However, when coupled with sequences from the first intron in the
flk-1 gene, the lacZ gene was successfully driven by the flk-1 promoter (Kappel et
al., 1999). The first intron of the flk-1 gene contains an autonomous endothelium-
specific enhancer. Unlike other genes, flk-l lacks CAAT and TATA boxes in its
promoter region that are typically responsible for controlling accurate transcriptional
initiation of their corresponding genes (Ronicke et al., 1996). Binding sites for
GATA transcription factors and SCL/TAL1 have since been identified indicating the
possible presence of a cluster of regulatory elements even though there has been no
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observed influence of SCL/TAL1 on FLK-1 (Kappel et al., 2000). SCL/TAL1"7"
mice do exhibit vascular defects however (Visvader et al., 1998).
Kappel and colleagues found that part of the first intron that is deleted in the
targeting vector used by Shalaby et al. (1995) contained this regulatory element and
was required for the expression of the knock-in reporter gene in the YS in later stages
of vascular development and that deletion of this region reduced the expression
frequency of the reporter gene. As the Shalaby construct was used in these targeting
experiments, this intronic regulatory element has also been lost from all the isolated
targeted lines. Shalaby and colleagues reported high levels of lacZ expression
despite the absence of this enhancer; nonetheless, the absence of this enhancer
through homologous recombination should be considered as a possible cause of the
loss of GFP expression in the flk-llGFP targeted cell lines.
4.3.2.2.2. The Influence of Intron Sequences on
Normal Transgene Expression
A similar approach to studying potential haemangioblasts, as was used in this
project, was carried out by Fehling et al. (2003). In this instance, the EGFP reporter
was targeted to the early mesodermal marker: brachyury. Their intention was to
isolate mesodermal cells at the earliest stage possible from differentiating ES cells
via the brachyury/GFP reporter, sort potential haemangioblastic cells by their
expression ofFLK-1 and analyse the expression profile of these cells.
They used two different designs for targeting vectors. One made use of the EGFP
cDNA alone; the other incorporated a splice donor site and an artificial intron before
the SV40 polyadenylation sequence in order to ensure no transcription of
downstream sequence taking place. A translational stop codon was also incorporated
downstream of the added intron. This was to prevent the possibility of the primary
transcript being recognised as an aberrant message and thus degraded as has been
reported (Maquat, 2002b).
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Two thirds of the first exon was deleted during targeting. The neo cassette was
flanked by loxP sites and was subsequently removed from the targeted cell lines
using Cre-mediated recombination (Gu et al., 1993) to ensure that it was solely
influenced by the regulatory elements of the native brachyury gene, and that the
expression of the GFP cassette was not impacted upon by the unnecessary presence
of foreign DNA sequence (Fehling et al., 2003). Fehling et al. observed the highest
expression levels of the EGFP transgene from cells transfected with the EGFP vector
comprising the artificial intron and regulatory elements. This indicates that a
transgene capable of undergoing post-transcriptional modifications typical of a cell
may be more likely to result in it being more highly expressed as a consequence. In
this study, theflk-lfHPRT targeting vector differed from the flk-HGFP vector solely
in the structure of the transgene, i.e. the EGFP transgene was a cDNA, whereas the
HPRT transgene was a constructed minigene. There was a possibility that the
absence of a set of coherent instructions (e.g. intron excision) for post-transcriptional
modifications could lead to the loss of expression of the transgene. The importance
of introns in transgene expression has been highlighted previously (Choi et al., 1991;
Franklin et al., 1991; Brooks et al., 1994).
Most mRNAs produced in eukaryotes pass through several systems that have
evolved to identify and degrade aberrantly produced RNA molecules before the
translation of what could potentially be mutant proteins with unknown and
potentially deleterious functions. Such mechanisms exist during transcription, at the
pre-mRNA processing and transport stages right up to the translation of the mRNA
message (Maquat & Carmichael, 2001).
One type of mRNA surveillance is called nonsense-mediated mRNA decay (NMD)
and results in decapping and degradation of mRNAs that show signs of premature
termination and frameshift or nonsense mutations (Maquat and Carmichael, 2001).
The process can also detect inefficient or inaccurate RNA splicing in the generation
of the mRNA molecules (Maquat, 2002a).
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The process of splicing induces the deposition of protein complexes at approximately
20-24 nucleotides upstream of exon-exon junctions. These complexes are called
exon junction complexes (EJC). These EJCs are retained on the mRNA molecules
following transfer to the cytoplasm for translation. Typically in mammals, the
natural termination codon is found in the last exon. Nonsense codons, inducing
premature termination are often found to occur more than 50 bases upstream of the
last exon-exon boundary. If translation is terminated more than 50-55 nucleotides
upstream of a junction bearing an EJC, some of constituent proteins in the EJC can
initiate the NMD response resulting in mRNA degradation (Mango, 2001; Maquat,
2002b).
It is possible that the insertion of the EGFP cDNA together with its polyadenylation
sequence into exon 1 could have resulted in splicing errors especially as a splice
donor/acceptor site was not incorporated into the targeting vector to ensure that the
cassette was not spliced out or that key regulatory elements present in the intronic
sequences of the flk-1 gene downstream to the site of insertion (Kappel et al., 1999)
were not spliced out by changes in the splicing pattern. This could have led to the
transcription of the inserted transgenes upon flk-1 activation but the degradation of
the primary transcript before translation. This could explain why the GFP transgene
was detected transcriptionally but not translationally. Also, the presence of two
polyadenylation sequences may have triggered mechanisms that either affected the
splicing pattern of the transcript or which caused the recognition of the transcript as
aberrant, resulting in its degradation.
It is unclear if any of these factors affected the silencing of the GFP transgene in
these targeted lines. It is clear however, that more care and attention should have
been afforded to the initial design and construction of the targeting vectors in the
initial stages of this project. The fact that both GFP-tagged cell lines lost detectable
GFP expression hints that the targeting vector may have been the root of the
problem. However, if this were the case, it would be expected that GFP would have
been silenced or degraded and therefore undetectable from the outset. The fact that
GFP was initially detected does point to there having been some sort a selective
157
pressure against GFP expression and for GFP silencing or loss of the GFP-expressing
cells in another way.
4.3.2.3. Flk-1MPRJ Targeted ES Cell Lines
The expression of the selectable HPRT gene in y/£-.//HPRT lines was more easily
discerned and all four lines gave rise to HPRT-resistant cells upon differentiation.
They too exhibited vastly variable behaviours as far as growth and rate of
differentiation were concerned, adding emphasis to the genetic heterogeneity that
exists in non-clonal populations of cells.
However, all four of the flk-llHPRT targeted lines responded well to the application
of HAT selection following directed differentiation for the induction of flk-1
expression. Whereas drug selection, such as that for antibiotic resistance, can take
over a week to be effective, within 48 hours of selection being applied, most non-
targeted HM1 parental cells had been eliminated and only endothelial-like cells
remained in the differentiation cultures of the targeted cell lines (Figure 4.12).
When such cultures were fixed and stained for the expression of FLK-1, patchy
expression was seen in differentiation cultures that were not in selection. Cells
surviving HAT selection all stained positively for FLK-1 provisionally indicating
that the HPRT transgene was behaving as desired at theflk-1 locus.
Further optimisation of jlk-l/HPKY cells to isolate a pure progenitor population is
investigated in Chapters 5 and 6.
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4.4. Summary
• The 4 flk-lfHPRT and 2 flk-1/GFP targeted ES cell lines were found to be
variable with respect to proliferation, differentiation and vigour as a
consequence of single-cell cloning but were all karyotypically normal.
• The pluripotency of the most vigorous clone from each reporter, D12 (flk-
//GFP) and F8 (/7&-//HPRT), were tested with the generation of tumours in
SCID mice. Tissues from all three germ layers were observed in the tumours.
Additionally, the D12 ES cell line was successfully used in the generation of
chimaeric mice.
• The GFP reporter was found to be silenced or inactive although the cause was
undetermined.
• The HPRT reporter was confirmed to be functional and successfully used to
select for a cell population with endothelial cell morphology.
• The flk-HHPRT lines will be used to optimise the isolation of a FLK-1
expressing progenitor population capable of contributing to the vascular
lineages upon in vivo engraftment.
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CHAPTER 5
Directed Differentiation for Flk-1
Expression I: Keller Protocol
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Directed Differentiation for Flk-1
Expression I: Keller Protocol
5.1. Introduction: Haemanqioblast Differentiation
The differentiation of "blood" from ES cells is one of the most studied differentiation
programmes. It is not a rarity to see patches of red cells on cystic embryoid bodies
grown in suspension, with only LIF having been omitted from the ES cell growth
medium, and with no stimulatory factors having been added (Figure 5.1). However,
to differentiate a definitive haematopoietic cell rather than the primitive erythroid
cells seen in embryoid bodies, several stages of differentiation have to be carried out,
typically incorporating the addition of growth factors.
Figure 5.1 Cystic EBs formed from simple suspension cultures of ES cells in the absence of
LIF. Scale bar represents 1mm. The erythroid patches observed are magnified x10.
A 2.5-3.5-day-old EB contains cells that are believed to be haemangioblastic and can
be harnessed to differentiate to cells of the haematopoietic system (Kennedy et al.,
1997; Choi et al., 1998). Beyond this window of differentiation, other signalling
events and pathways will emerge and predominate as the receptor profile of the
differentiating cellular population changes and the potential to respond to
haematopoietic ligands is lost.
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5.1.1. Three-Dimensional Differentiation on
Methylcellulose
The methylcellulose culture regime devised for the culture and differentiation of cells
with haematopoietic potential (Wiles and Keller, 1991) has been modified for the
culture of progenitors with the capability to differentiate to endothelial as well as
haematopoietic cells (Keller et al., 1993; Kabrun et al., 1997; Kennedy et al., 1997;
Faloon et al., 2000; Robertson et al., 2000; Fehling et al., 2003). It had been found
that EBs generated in suspension culture, had the largest potentially
haemangioblastic cell population (as measure by the number of FLK-1+ cells) at 2.75
days in the 24-hour window of their existence in EBs (Kennedy et al., 1997). This
modified culture regime involves the propagation of 2.75-day-old EBs, their
disaggregation and replating of a defined cell number in a methylcellulose mix
containing high levels of the growth factors Stem Cell Factor/c-KIT ligand and
VEGF.
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Figure 5.2 The Keller protocol for the isolation of haemangioblastic progenitor colonies. The
diagram shows the basic procedure for differentiation. The boxes show the components of
the growth media involved at each stage. MTG, monothioglyceroi; LG, L-glutamine; Asc
Acid, ascorbic acid; sFCS, FCS tested for its ability to support haematopoietic differentiation;
D4T conditioned medium, conditioned medium from the D4T endothelial cell line.
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The protocol shown in Figure 5.2 was developed by Gordon Keller and his research
team (Wiles and Keller, 1991; Keller et al., 1993; Kabrun et al., 1997; Kennedy et
al., 1997; Faloon et al., 2000; Robertson et al., 2000; Fehling et al., 2003).
Wiles and Keller found that by culturing ES cells in a three-dimensional
methylcellulose matrix, the growth and differentiation of haematopoietic colonies
from differentiating ES cells was far better supported than haematopoietic
differentiation of EBs in suspension culture. Erythroid cells in growing colonies
were seen after 7-8 days in culture. By 10 days, 40-60% show signs of
erythrogenesis and the colonies rupture to release the erythroid cells in the periphery.
Further investigation into the effects of added supplements led to discoveries that
ascorbic acid acted as a reducing agent and increased the number of macrophage
colonies seen, erythropoietin increased the number of erythroid cells differentiating
and IL3 increased the number of erythroid cells associating with EBs and prolonged
their survival. IL3 also increased the appearance of macrophage-like colonies and
affected the kinetics of their appearance as they appeared 2 days earlier than they
would in the absence of IL3 (Wiles and Keller, 1991).
Initially, only erythroid and basic haematopoietic colonies were obtained from
methylcellulose cultures (Wiles and Keller, 1991) however the protocol was refined
and elaborated to enable the propagation of more complex haematopoietic progenitor
types (Kennedy et al., 1997). Incorporated into the protocol was an initial step when
EBs were generated in suspension prior to disaggregation and plating in
methylcellulose. In the haematopoietic cultures, "blast" morphological colonies
were identified and were distinguishable from secondary EBs, which had far denser
structures. The blast colonies were identified when 3-3.5 day old EBs were
disaggregated and plated in methylcellulose with KL and VEGF. When picked after
4-6 days from this methylcellulose-based medium and replated in methylcellulose
medium supplemented with haematopoietic cytokines, many different
haematopoietic lineages were observed including both primitive and definitive
haematopoietic colonies (Kennedy et al., 1997).
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Kennedy and colleagues found that the best growth of blast colonies was achieved
when the cultures were set up with conditioned medium obtained from an EB-
derived endothelial cell line called D4T (Williams et al., 1988). It was also observed
that an increase in the frequency and size of blast colonies was dependent on the
inclusion of kit-ligand and VEGF in the cultures along with the synergistic influence
of the D4T conditioned medium but that omitting the growth factors rendered most
of the plated cells unresponsive to the effects of the conditioned medium (Kennedy et
al., 1997). The added growth factors must therefore have had an inductive influence
on the cells, priming them for differentiation to haematopoietic lineages and
rendering them responsive to the elements in the conditioned medium that
augmented their potential to form blast colonies. Individual blast colonies were
found to be able to form cells from a variety of haematopoietic lineages.
Blast colonies did not express brachyury whereas EBs did, indicating that EBs were
from an earlier developmental stage. Many blast colonies expressed both primitive
and definitive globin genes. All blast colonies expressed FLK-1, CD34, SCL/TAL1
and GATA1.
The necessity for VEGF in the isolation of BL-CFC to stimulate the expression of
the endothelial marker flk-1, suggested that the BL-CFC might also have had
endothelial potential. This was confirmed by Choi et al. (1998) who showed that the
BL-CFC was clonal and had the ability to differentiate to both the haematopoietic
and endothelial lineages. A haemangioblast differentiation experiment was carried
out using a mixture of two different cell populations, each bearing a different
antibiotic selection cassette. Individual haemangioblastic blast colonies were further
differentiated down both endothelial and haematopoietic lineages. It was found that
endothelial and haematopoietic cells derived from the same blast colony always had
a common selection gene expressed. Coexpression rarely occurred and was
attributable to contamination (Kennedy et al., 1997; Choi et al., 1998).
These observations led to the belief that the BL-CFC represented the in vitro
equivalent of the haemangioblast with the same bipotentiality to differentiate further
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down both the haematopoietic and vascular lineages (Choi et al., 1998). Further
work has since shown that this basic culture can be enhanced with the addition of
bFGF and activin A that have a synergistic influence on the efficiency of blast
colony formation (Faloon et al., 2000) with bFGF stimulating the proliferation of
haemangioblasts and VEGF inducing their maturation (and migration in vivo).
5.1.2. Stepwise Conversion of a Haematopoietic
Culture to the BL-CFC Culture Regime
Many attempts to replicate the BL-CFC culture protocol were carried out without
success (data not shown). The following experiments describe the steps initiated to
convert a basic haematopoietic colony culture to the haemangioblast-specific BL-
CFC culture regime. Individual variables were modified in basic haematopoietic
cultures using disaggregated EBs to adjust the haematopoietic methylcellulose
culture to the full BL-CFC culture regime by introducing individual elements of the
BL-CFC culture to the methylcellulose in steps.
Success of the differentiation regimes were assessed from 7 days post-plating by
counting the total number of colonies present in each 35mm dish as well as scoring
the colonies for signs of differentiation to colonies typically seen in a haematopoietic
culture.
5.1.2.1. Comparison of Different Disaggregation
Techniques on the Viability of EB-Derived Cells used in
Methylcellulose Cultures
Initial experiments suggested that cell viability after disaggregation was affecting the
success of the methylcellulose cultures. Two different disaggregation enzymes were
therefore compared for their effect on cell viability: TEG, a trypsin based
disaggregation solution that had been used until then for all disaggregation steps in
the culture of cells and dispase. Dispase is a bacillus-derived neutral metalloprotease
that is believed to have an effective but much more mild proteolytic action than
trypsin. It is a highly selective protease and cleaves fibronectin, collagen IV, and to
a lesser extent collagen I, but not collagen V or laminin. Trypsin is a serine
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peptidase that preferentially cleaves at lysine and arginine residues and is therefore
more indiscriminate than dispase. Bearing in mind that the EBs would have to be
exposed to the proteases for a longer period of time than a monolayer would be to
obtain a good single-celled suspension, it was conceivable that prolonged exposure
to trypsin, coupled with the added mechanical disaggregation that is necessary to
break up three-dimensional EBs, could result in cell viability and growth being
affected by the disaggregation technique.
5.1.2.1.1. Experimental Outline
Parallel experiments were set up to compare trypsin disaggregation and dispase
disaggregation. Both 3 and 4-day-old EBs were generated from four different ES
cell lines (one flk-l/GVP cell line, one flk-l/HPRT cell line, the parental HM1 line
and the non-parental R1 ES cell line) and disaggregated, using either trypsin or
dispase. 1000 viable disaggregated cells were placed in haematopoietic cultures in
methylcellulose. The methylcellulose plates were examined after 7 days and again
after 14 and 21 days culture and assessed for the number of growing colonies as well
as their differentiation status by scoring the colonies according to their morphology
as shown in Figure 5.3.
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The data presented in Figure 5.4 show that the dispase treatment resulted in a higher
yield of secondary EBs forming in the methylcellulose cultures than the trypsin
disaggregation when 3-day-old EBs were used in the culture regime. 4-day-old EBs
showed very low haematopoietic capabilities in comparison, and no conclusion with
respect to the disaggregation techniques can therefore be made. Analysis of variance
was used to look at the effects of treatment (trypsin and dispase), cell line (HM1, Rl,
D12, F8) and day (7, 14, 21) on the numbers of EBs observed. For day 3 EBs dispase
disaggregation yielded significantly more EBs than trypsin disaggregation (p<0.001)
and the number fell significantly from 7 to 14 and then to 21 days (p<0.05) as the
EBs differentiated to haematopoietic colonies. The Rl cell line produced the most
EBs followed by F8, D12 and HM1. The differences between individual lines were
significant (P<0.05). For day 4 EBs the interactions between treatment, day and cell
line are all significant and no general statements can be made about the significance
of these effects. The trend is for numbers of EBs to decrease as day increases from 7
to 21 and for Rl to produce the highest numbers of EBs, as was the case for day 3
EBs. There is no clear difference between trypsin and dispase, unlike day 3 EBs,
probably due to the overall paucity of secondary EB generation from 4-day-old EBs.
The paucity of older EBs to form haematopoietic colonies supports the observation
of Kennedy et al. (1998) that the window for differentiation down the haematopoietic
lineage (more specifically, the haemangioblastic lineage) is early and limited to a 24-
hour window between 2.5 and 3.5 days after EBs are generated. These data also
show an interesting level of variation between the different ES cell clones. The Rl
ES cell line was seen to be the most vigorous. Rl ES cells grow faster than HMls
when being maintained in a pluripotential state (personal observations) and
interestingly, the HM1 parental ES line was the poorest performer in all the
haematopoietic cultures carried out, yielding far fewer colonies than the D12 and F8
lines. This was likely to be due to the HM1 line being a heterogeneous cell
population, whereas the targeted lines were clonally isolated from it, thus bearing
slightly different growth characteristics.
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At each time interval, the number and type of haematopoietic colonies observed were
noted. After 7 days of culture, only secondary EBs were observed, however, over
time the total number of secondary EBs declined as the EBs became more
differentiated and mature haematopoietic colonies emerged (Figure 5.5).
—*—Secoiidaiy EB
■ H a emato|x> ietic
Colonies
Daysof Haematopoietic CUIUre
-^—Secondary EB Haematopoietic Colonies
Figure 5.5 The means of all secondary colonies and all haematopoietic colonies over a 3-
week observation period. Data points on line graph represent the mean of 6 replicates. The
data for both trypsin and dispase dissociation were combined. Standard error bars are
shown in red for secondary EBs and orange for haematopoietic colonies.
The raw data showed that there was a high level of variability in the colony yield in
methylcellulose and that only a small percentage of cells plated were surviving to
proliferate and differentiate to form colonies. This was in part typical of
methylcellulose colony cultures and also partially due to the harsh nature of the
disaggregation methods used. To disaggregate EBs, the exposure to both the
proteases had to be prolonged in comparison to the typical incubation time required
to disaggregate cells growing as a monolayer, which is 1-3 minutes. The exposure to
dispase was 1 hour, after which time, the EBs had to be disaggregated mechanically.
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4-day-old EBs were beyond the time frame for maximal haematopoietic
differentiation as was seen from the general poor yield of secondary EBs (Figure
5.4). It was decided to carry out the dispase and trypsin disaggregation methods
using 2.75 and 3.5 day old EBs. If the HM1 ES line and its derivatives behaved as
the CCE ES cells that the Keller group had used to optimise this protocol, the 2.75-
day-old EBs would be expected to differentiate into haematopoietic lineages more
successfully than the older 3.5-day-old ones. Apart from the age at which the EBs
were disaggregated, the plating experiment was carried out as the previous one.
171






























IHM1 1D12 OF8 QR1








12 13.3 0 8.3
23.7 23 0 62.7
12.3 18 0 347












■ HM1 0 16.3
■ D12 0 20.3
□ F8 0 13.3










iHfvtl 1D12 oF8 dR1
Figure 5.6 Haematopoietic culture after either trypsin and dispase disaggregation of 2.75-
day-old (a, c) and 3.5-day-old (b, d) EBs. The mean average of three replicates of each
variable were calculated for each ES cell clone and plotted against each other. Figures a
and b show the number of secondary EBs seen in the haematopoietic cultures after 7, 14
and 21 days in the methylcellulose. Figures c and d show the number of differentiated
haematopoietic colonies that were observed in the cultures at the same time points. Bars
represent the mean of 3 replicates. Error bars show standard errors.
For 2.75-day-old EBs there was a significant interaction between the method of
disaggregation and the cell line. This is due to the fact that HM1 parental cell line has
almost the same number of EBs under trypsin disaggregation and dispase
disaggregation compared with Rl, D12 and F8, which yielded more secondary EBs
when initial EB preparations were disaggregated treatment than with trypsin
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disaggregation. The effects of treatment and day are both significant (p<0.01).
Dispase is superior to trypsin disaggregation and the numbers of EBs decreases
approximately linear as the number of days in differentiation increases from 7 to 21.
For 3.5-day-old EBs there is a significant interaction between treatment and cell line.
There is no consistency between the treatments. Trypsin disaggregation was superior
for F8 and HM1 cell lines, dispase was superior for R1 and D12, which yielded
higher numbers of EBs on both treatments than the other 2 cell lines. If you do not
look at the data from each cell line individually, there was no statistically significant
difference between the two treatments. However, given the low number of
secondary EBs generated from 3.5-day-old EBS, the
Figure 5.6 shows data that supports previous observations that dispase disaggregation
has an influence on the viability of cells and in turn the efficacy of methylcellulose
haematopoietic cultures. However, it was found that individual cell lines did respond
differently to the disaggregation methods tested. EBs from the F8 and HM1 cell
lines did not yield more secondary EBs when disaggregated with dispase, however
this was likely due to the fact that both these lines responded poorly to the
differentiation protocol and that the method of disaggregation of F8 and HM1 EBs
was overridden by this poor response. Overall, these data do indicate that dispase is
a better enzyme for disaggregating the EBs for methylcellulose differentiation.
When the cells were being counted after disaggregation, the dispase treated samples
often had a noticeably large amount of cell debris, presumably from lysed cells. It
was therefore assumed that the treatment was very harsh which makes this result all
the more surprising. Although the trypsin treated cells appeared healthier when
counted, their viability over a longer period of time may have been affected resulting
in cell death after the set-up of the cultures. It was decided to use dispase to
disaggregate the EBs from that point forth. By replacing the PBS used to dilute the
dispase with IMDM base medium (see Chapter 2 for the procedure), the level of cell
lysis was also reduced.
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These data (Figure 5.6) again showed that earlier EBs have a greater potential for
haematopoietic differentiation than more differentiated ones. It seems that the HM1-
derived targeted ES cell lines have more haematopoietic potential at 2.75 days than
older EBs and could have a similar potentiality within the 24 hour window for
haematopoietic and haemangioblastic differentiation suggested by the Keller group
(Kennedy et al., 1997). Dispase disaggregation of EBs yielded significantly more
haematopoietic colonies than trypsin disaggregation when the variation between cell
lines was omitted from the analysis (p<0.01). See Appendix B for the full statistical
analyses of these data.
5.1.2.2. Addition of D4T Conditioned medium
The next step towards optimising the methylcellulose culture for BL-CFCs was to
add the D4T conditioned medium and see what effect it had on the growth of
colonies in the methylcellulose. It was possible that the disaggregation method had
not been the only reason for the failure of the BL-CFC cultures, it was also
considered possible that the preparation of the D4T conditioned medium was either
toxic, thus preventing growth, or the D4T cells had not conditioned the medium
sufficiently to allow for the differentiation of BL-CFC with the recommended
concentrations of the added SCF and VEGF.
5.1.2.2.1. Experimental Outline
Previously when the BL-CFC culture had been carried out, either 1 or 3 day-old
conditioned medium had been generated by placing the standard culture medium for
D4T cells minus the ECGS onto the cells for the appropriate length of time. The
cells were only used for conditioning once and the medium was used fresh from the
cells after filtration. To test for the efficacy of different preparations of D4T, 3
different preparations were compared to 3-day-old conditioned medium from a
previous experiment that had been frozen. The conditioned medium was added to
the basic haematopoietic differentiation medium at the BL-CFC culture
recommended concentration of 25% (v/v).
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Old (frozen CM) 3 days conditioning medium -ECGS
1 day conditioning medium -ECGS
3 day conditioning medium -ECGS
3 day conditioning medium +ECGS
The D4T cells were in this instance used at high confluence. Three replicates with
1000 cells in each using dispase disaggregation of 2.75-day-old EBs were plated for
each medium type and left for 10 days before a colony count was carried out.
5.1.2.2.2. Results
Conditioned Medium Type
|HM1 »R1 □ D12 □ F8
Figure 5.7 Bar charts of the proliferative effect of different preparations of D4T conditioned
media on ES cells in basic haematopoietic cultures in methylcellulose. CM1, old 3 day CM;
CM2, 1 day conditioning -ECGS; CM3, 3 days conditioning -ECGS; CM4, 3 days
conditioning +ECGS. Bars represent the mean of 3 replicates. Error bars show standard
error.
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Statistically there is no significant difference between the different media and it is
not easy to decide which one is best in any sense. CM1 has the highest overall
average (the other 3 have very similar overall averages) and maintains R1 and, D12
cells well but supports HM1 and F8 differentiation cultures. CM4 is perhaps the
worst because it does fairly badly for all the cell lines except R1.
If a judgement is made based on the relative performance of the media for a subset of
the cell lines i.e. R1 and D12 (given that these cell lines were more resilient in all
previous comparisons), then CM1 better.
These results therefore indicated that the old, frozen preparation of D4T conditioned
medium was marginally better overall at increasing the survival and colony
formation of the plated cells in the haematopoietic cultures (Figure 5.7). However,
as this conditioned medium was the same as "CM3" (freshly prepared 3-day
conditioned medium in the absence of ECGS), the variability can be attributed to the
better conditioning state of the D4T cells when the old conditioned medium was
prepared, or it may be due to the inherent variability of the methylcellulose cultures.
An interesting possibility arises when it is considered that the old conditioned
medium had been frozen and thawed for use in this experiment whereas the other
samples were fresh preparations. The freeze-thaw process may have resulted in the
degradation of inhibitory growth factors that could otherwise result in diminished or
retarded growth of colonies in the methylcellulose culture medium.
As the different preparations of conditioned medium did not have a significant
bearing on the success of the haematopoietic cultures. It was decided to use the 3-
day conditioning regime in the absence of ECGS for the BL-CFC cultures.
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5.1.3. Identification of the BL-CFC
After having ensured that the disaggregation method and the added conditioned
medium were as favourable as possible, the published conditions for the BL-CFC
culture regime were tested (Kennedy et al., 1997; Choi et al., 1998).
The BL-CFC culture was set up using 2.75-day-old EBs disaggregated using dispase
and plated at 1000 cells per 35mm dish. The optimisation procedures were
eventually successful in rectifying the underlying problem with getting this culture
system to work and eventually, colonies that matched the description provided of the
BL-CFC (Kennedy et al., 1997; Choi et al., 1998; Faloon et al., 2000; Robertson et
al., 2000; Kennedy and Keller, 2003) were observed (Figure 5.8).
Figure 5.8 A typical blast colony from a BL-CFC (bl) and a secondary EB (eb) in a BL-CFC
culture assay after 5 days of culture. Scale bar represents 2 mm.
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Keller identified the BL-CFC by morphology alone. Whereas EBs exhibited a tight
cohesive morphology and dense packing of small cells, BL-CFCs had a less uniform
morphology consisting of larger cells that were less densely packed. The
methylcellulose cultures were checked after 4-6 days and all colonies that did not
have the dense, compacted and morphologically uniform structure of a secondary
EB, was, at this stage, designated a BL-CFC. These colonies were picked and
individual colonies were checked for their ability to differentiate divergently to both
the haematopoietic and endothelial lineages.
5.1.3.1. Assessment of the Potentiality of the BL-CFC
As following a morphological description of a colony type relies on good
observation and accurate qualitative assessment, it was insufficient to simply identify
the BL-CFC in this way. To prove the validity of their successful culture, the
suggested BL-CFC had to be proved to possess the bipotentiality expected of the in
vitro equivalent of the haemangioblast.
The blast colonies were picked and each placed in a well of a 12-well plate coated
with Matrigel. The cells were grown as described in the Materials and Methods and
after 5-6 days of culture, non-adherent and thus, potentially haematopoietic cells
were removed and plated in a haematopoietic culture for 7 days to check potentiality
for the haematopoietic lineages. To see whether the BL-CFC could differentiate to
endothelium, the Matrigel cultures were maintained for an additional 7 days before
endothelial markers were detected via immunohistochemistry.
Both primitive EBs and erythroid EBs, as well as more mature CFU-GM and CFU-
GEMM were seen in the cultures of non-adherent cells showing that outgrowths
from BL-CFCs were able to differentiate down the haematopoietic lineage (see
Figure 5.3 for examples of observed colonies).
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Figure 5.9 Outgrowth of BL-CFCs on Matrigel after 5 days of culture at which time all non¬
adherent cells (as seen in a) were removed to haematopoietic cultures. Adherent cells of
varying morphology (b,c) were cultured on to confluence and stained for markers of
differentiation. Scale bar represents 100pm.
The Matrigel outgrowths of the BL-CFCs were maintained as recommended (Choi et
al., 1999) after the removal of the non-adherent cells after 5 days in culture. Figure
5.9 shows typical wells from the 12 well plates used to grow the BL-CFCs. As can
be seen, there were a wide variety of cellular morphologies observed between
different outgrowths of the BL-CFCs. Figure 5.9a shows the non-adherent cells
sitting on the underlying adherent cells before their removal to haematopoietic
cultures. A variety of different cell morphologies were seen (Figure 5.9b and c)
although most were typically endothelial cells with varying growth patterns. The
Keller group recommended that the Matrigel cultures be maintained for an additional
1-2 weeks, however it was found that the wells were nearly all confluent after a
further 5 days in culture (Figure 5.10).
Figure 5.10 Outgrowths of BL-CFCs grown in Matrigel for 10 days. Although endothelial-like
cells were still present in the cultures (a), some wells only had cells that resembled muscle
cells (b). The majority comprised a mix of the two cell morphologies (c). Scale bar
represents 100pm.
By this time, the majority of the wells contained a mix of both endothelial, and
muscle-like cells (Figure 5.10c), although the endothelial cells were outnumbered by
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those with muscle morphology (Figure 5.10 b). Most cultures also had non-adherent
cells that had budded off the adherent cells subsequent to their removal after 5 days
in culture. As the wells differed greatly in morphology, the cells were fixed and
stained for endothelial and muscle-specific markers to ascertain the cell types
present.
As a control, EBs from the BL-CFC cultures had also been plated in Matrigel to see
how these differentiated in comparison to BL-CFCs. Although the EBs did grow, no
non-adherent cells that looked like haematopoietic cells (uniform circular shape and
small size) were seen and the cells growing were disorganised and varied greatly in
morphology within cultures of individual EBs (Figure 5.11). This would be
expected of EBs containing a heterogeneous population of differentiating cells and
not a committed progenitor with a determined and already limited cell fate.
Figure 5.11 Typical outgrowths of non-blast-like EBs taken from the BL-CFC methylcellulose
cultures on Matrigel after 5 (a) and 10 (b) days of culture. Scale bar represents 100pm.
5.1.3.2. Immunohistochemical Analysis of Blast Colony
and EB Outgrowths
To confirm the haemangioblastic potential of blast colonies, immunohistochemistry
using specific markers was used to analyse BL-CFC outgrowths. Outgrowths from
secondary EBs were used as controls. Blast colonies derived from BL-CFCs were
grown for 5 and 10 days on Matrigel, the cultures were fixed and stained for FLK-1
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as well as typical cell surface markers for endothelial (VE-Cadherin), muscle (a-
Smooth Muscle Actin (aSMA)) and haematopoietic (SCL/TAL1) lineages.
Where possible, double staining with FLK-1 and one of the other lineage markers
was carried out to assess the expression pattern of FLK-1 in the endothelial,
haematopoietic and mural lineages.
At each stage when immunohistochemistry was carried out, negative controls i.e. the
staining protocol with only the secondary antibodies were included to ensure that any
observed staining could not be attributable to non-specific binding of the
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Figure 5.14 Immunostaining of EBs grown out on Matrigel for 5 days with FLK-1 (green),
and either SCUTAL1 (a) or VE-Cadherin (b) (red) antibodies. Double positive cells fluoresce
yellow. DAPI nuclear stain is seen in blue. Scale bar represents 100pm.
Figures 5.12 and 5.13 show immunohistochemical staining of outgrowths of blast
colonies believed to be derived from BL-CFCs. In Figure 5.12 FLK-1 staining is
carried out with aSMA. The vessel-like structures stain positive for both antibodies.
This is most clear in Figures 5.12d and e. 5.12a shows an interesting pattern of
FLK-1 staining that was more rarely observed and could show the earliest stages of
cell elongation and vasculogenesis. 5.12f shows a striated pattern of FLK-1 and
aSMA expression that could represent muscle cell formations.
In Figure 5.13, both vessel-like structures (5.13a and c arrows) and muscle-like
fibres (5.13b asterisk) are seen. Both differentiated structures stain positively for
FLK-1 and VE-Cadherin. The vessels also showed SCL/TAL1 staining although the
veracity of this staining was questionable as the antibody staining was not very
strong and had not been optimised with a positive control as a suitable cell line was
not available. A negative control of undifferentiated cells had been used to eliminate
the possibility that the staining seen was non-specific antibody binding (data not
shown).
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These differentiation experiments were carried out 4 times where single staining for
FLK-1 and VE-cadherin were carried out and showed a high level of expression in
all cultures. Vessel-like localisation of the FLK-1 antibody was seen as shown in
Figure 5.12a and d and Figure 5.13a and c (approximately 1/20 frequency of
observation). However, the most typical pattern of FLK-1 staining was that shown in
5.12c. A pattern of muscle striations was commonly seen (approximately 7/10
frequency of observation) and always corresponded to patchy expression of both
FLK-1 and VE-cadherin.
Immunostaining of secondary EBs that had not differentiated at the time of blast
colony propagation (4-6 days of growth in methylcellulose) are shown in Figure
5.14 and in all differentiation experiments, the level of FLK-1 expression was both
less broadly seen and where visible, localised to foci. The brightness of antibody
binding to these foci was as intense as in the BL-CFC differentiation cultures. aSMA
antibody staining was never observed in secondary EB outgrowths however. This
may indicate the necessity for BL-CFC to be propagated to drive differentiation
through the mural cell fate.
The blast colonies (Figure 5.12, Figure 5.13) that were believed to be derived from
BL-CFCs displayed a high level of FLK-1 expression and formed vessel-like
structures. Although some low level FLK-1 expression was detected in outgrowths
from EBs (Figure 5.14), no vessel-like structures were seen to form and expression
of VE-Cadherin or SCL/TAL1 were weak. Expression of vascular markers from the
EB outgrowths was expected, due to the possibilities of random differentiation to the
vascular lineages. The lack of vessel-like structures and the comparatively low
levels of FLK-1 detection in relation to the blast colony outgrowths were
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Figure 5.16 Immunostaining for aSMA (green) in blast colony outgrowths after 10 days.
DAPI nuclear stain is seen in blue. Scale bar represents 100/um.
10-day-old outgrowths of the blast colonies were reassessed for FLK-1 expression
alongside endothelial, haematopoietic and mural markers. Although at this stage
many of the wells were very confluent and displayed muscle-like cellular
morphologies, staining revealed vessel-like structures amongst the dense cell mass
that co-stained for the endothelial VE-Cadherin marker and slightly for the
haematopoietic SCL/TAL1 cell marker as shown in Figure 5.15. There was a
considerable level of muscle formation too however, with two distinct morphologies
seen (Figure 5.16) depending on the confluence of the wells at the time of staining.
Staining for these vascular markers was carried out twice and in both instances these
vascular structures were observed amongst the aSMA staining cells that dominated
the cultures.
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5.2. Discussion and Conclusions
5.2.1. Optimisation of the BL-CFC Culture Assay
The BL-CFC assay was not straightforward and needed optimisation before it was
carried out successfully. The variables that were considered to be important in the
success of the assay included the age of EBs introduced into the assay, the
disaggregation method, the quality of the D4T conditioned medium and the
concentration of the growth factors added into the assay. Using CCE ES cells
(Robertson et al., 1986), it had been shown that BL-CFC existed in EBs from 2.5
days to 3.5 days of differentiation with maximal blast colony producing potential
observed at 2.75 days of differentiation (Kennedy et al., 1997). However, as a
different ES cell line was being used for these studies, this timescale could have
differed for the HM1 ES cell line and its flk-1 targeted derivative cell lines.
Although the earlier stages in the development of the BL-CFC culture regime were
carried out in the absence of D4T conditioned medium, indicating that its addition is
not the critical step in the success of the colony assay, if the D4T cells were secreting
factors that mitigated the potential for cells to grow in methylcellulose, they could
affect the rate of success of the colony assay. Also, as the assay was a very specific
one, the absence of the D4T CM, coupled with the HM1-derived ES cell line's
possible poorer plating efficiency in methylcellulose or a different timescale of
differentiation would have affected the plating efficiency required for the success of
the assay.
5.2.1.1. The Importance of the Method of EB
Disaggregation on Successful Methylcellulose
Differentiation
As elaborated on in the results section, basic haematopoietic differentiation assays
were carried out in order to assess the importance of disaggregation methods and to
subsequently introduce elements of the BL-CFC culture protocol to the
methylcellulose to assess their influence on the success of the assay.
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Figures 5.4 and 5.6 show the results of two experiments comparing trypsin and
dispase disaggregation methods. Both experiments showed that the dispase
disaggregation method had a strong impact on the viability on the cells and, as a
consequence, the number of colonies yielded in the haematopoietic assay. As
different time points (2.75, 3, 3.5 and 4 days of differentiation) were taken in the
setup of the experiment, it was evident that with HM1 ES cells, the 2.75-day
timepointwas the best for BL-CFC differentiation in accordance with observations
made by Kennedy et al., (1997).
Earlier timepoints should have been analysed if it was to be shown that 2.75 days of
differentiation was optimal. However, EBs at that stage of differentiation are very
small and it was seen to be sufficient to use the best timepoint out of those tested.
Kennedy et al. had observed a 24-hour window of BL-CFC presence in EBs. It
appeared that the HM1 ES cells at least had a higher proliferative potential at the
earliest stages of differentiation. It was therefore decided to use the 2.75 day
timepoint from that point forth, at least until all other parameters for BL-CFC had
been optimised. The other parameters had to be addressed first so that a yield of
blast colonies could be obtained (rather than colony-forming or haematopoietic
potential as was the case at this stage).
Another observation was that the number of secondary EBs dropped and more
mature haematopoietic colonies arose as the time in the differentiation cultures
increased. This indicated that the colonies forming were healthy and had the
potential to develop beyond secondary EBs, which only show the proliferative
potential of the cells plated in the methylcellulose, to form differentiated
haematopoietic colonies as seen in Figure 5.3. This trend was summarised in Figure
5.5 and 5.6. The latter showed the direct increase in haematopoietic colonies as time
of differentiation increased and the number of secondary EBs dropped.
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5.2.1.2. Conditioning Regime had Little Influence on
Plating Efficiency
By comparing the colony numbers after addition of conditioned medium to the
haematopoietic assays in Figure 5.7 with the colony numbers seen in the previous
experiments, it was evident that the conditioned medium enhanced the plating
efficiency of the cells in the assays resulting in a higher frequency of secondary EBs
being observed after 7 days of culture. The length of time allowed for conditioning
or the presence of ECGS of the conditioning regime did not appear to significantly
affect the efficiency of the culture method. A control that should have been
incorporated into this experiment was the culture of cells in the absence of any
conditioned medium. This would have been a useful measure of the importance of
the conditioned medium in the assay as well as the level of assay variability that
could be attributed to the conditioned medium.
Since these experiments were carried out, Gordon Keller and Marion Kennedy have
published a detailed description of how they carry out the BL-CFC culture, including
the production of the D4T conditioned medium (Kennedy and Keller, 2003). Their
method also involves the use of medium without ECGS and is carried out for 3 days.
They used the D4T cells at confluence and repeated the conditioning up to 5 times.
However, they did suggest that the conditioned medium should be tested each time it
is prepared, for its ability to support the growth of blast colonies in the presence of
VEGF and IL-6 in order to standardise the culture regime (Kennedy and Keller,
2003).
5.2.1.3. Progression to a Complete BL-CFC Assay
The only step that remained following the assurance that the D4T conditioned
medium was not negatively affecting the success of the BL-CFC cultures was to
remove the haematopoiesis-inducing growth supplements and replace them with the
KL and VEGF growth factors to complete the BL-CFC assay and see whether blast
colonies capable of the multipotentiality of the haemangioblast could be isolated.
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The transition to carrying out the full BL-CFC culture was successfully completed on
the first attempt and yielded many colonies. The blast colonies were distinguished
from the secondary EBs using descriptions and published photographs (Kennedy et
al., 1997; Choi et al., 1998; Faloon et al., 2000; Robertson et al., 2000; Kennedy and
Keller, 2003). However, although the difference between secondary EBs and blast
colonies was easy to distinguish, the appearance of such colonies was not limited to
the BL-CFC assay and were often seen in previous haematopoietic colony assays
before the colonies ruptured to form the various haematopoietic colonies seen. It
would have been interesting to see whether these blast colonies behaved similarly if
they were not picked into Matrigel but were maintained in KL and VEGF for a
longer culture duration. Would they have differentiated to a variety of
haematopoietic lineages or would they have required prompt stimulation down a
haemangioblastic lineage to prevent cell death?
5.2.2. Potentiality of BL-CFCs
Both blast colonies and secondary EBs were picked and cultured on Matrigel to
assess the colonies for their potential to differentiate down the haematopoietic and
endothelial lineages. The nonadherent cells were separated from these cultures and
when grown in methylcellulose-based haematopoietic assays, a range of erythroid
and myeloid haematopoietic colonies were observed (see Figure 5.3 for examples).
Ideally, all three haematopoietic lineages (myeloid, lymphoid and erythroid) should
have been identified to prove the haematopoietic potentiality of the blast colonies.
The remaining adherent cells were cultured for a further 5 days on Matrigel. Most of
the colonies displayed a similar course of differentiation. They adhered and spread
when plated out and after initially exhibiting endothelial-like morphologies, the
dense cells formed muscle-like fibres and swirls. Staining revealed dense vascular-
like networks that could not be identified by the naked eye (Figures 5.13 and 5.15).
These putative vessels showed strong FLK-1 and VE-Cadherin expression indicative
of endothelial cells. Although some staining for SCL/TAL1 was seen, confidence in
the efficacy of the SCL/TAL1 antibody was low and what staining was seen was
very patchy. If these observations are real, patchy and localised SCL/TAL1
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expression along the vessel walls could be understood to support the argument for
the haemogenic potential of vessel endothelium (Chapter 1,1.10.6).
5.2.3. Differentiation of the BL-CFC to aSMA+ Muscle
Cell Fate
The research carried out on the BL-CFC to date has shown its ability to differentiate
to form cells from the haematopoietic and endothelial lineages. The BL-CFC
cultures carried out in the present body of work confirm this and also demonstrate
that the blast colonies, supposedly derived from BL-CFCs, show a strong
differentiation capability to form aSMA expressing smooth muscle cells (Figure
5.16). This agrees with the findings of Yamashita et al. (2000) who found from their
analysis of haemogenic endothelial cells differentiated on collagen IV that the cells
also had the ability to differentiate to form smooth muscle cells.
5.2.4. Are BL-CFCs In Vitro-Derived
Haemangioblasts?
The secondary EBs taken from the BL-CFC cultures did proliferate after plating on
Matrigel. However, in general, their growth was slower and phenotypically, the
range of cell morphologies seen was far more restricted than that observed from
outgrowths of blast colonies (data not shown). Also, Matrigel cultures of EBs
yielded fewer confluent wells of cells (data not shown). Although staining for FLK-
1 was seen in the Matrigel cultures of the EBs (Figure 5.14), no aSMA staining was
seen and the SCL/TAL1 and VE-Cadherin staining was questionable. Certainly no
morphologically distinct vascular structures as seen in the blast colony cultures were
seen.
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It may have been the case that the EBs were able to show some response to
stimulation by KL1 and VEGF ligands but that they were not primed to coordinate an
organised response to these ligands as a result of the absence of VEGF and the c-Kit
receptors. This coordinated response together with growth on a permissive
adherence substrate, in this case Matrigel, probably provided sufficient stimulation to
drive the blast colonies, which, when picked from methylcellulose, lack a cohesive
structure or distinct cell morphologies, to form blood vessels and differentiate to all
the lineages seen in blood vessels. This does indicate a difference between the
picked blast colonies and EBs with respect to differentiation potential. However, to
confirm that these blast colonies were derived from haemangioblastic BL-CFCs,
molecular analysis of the expression patterns of the two types of colonies would need
to be carried out and tracked throughout differentiation under different stimuli.
Gordon Keller's group have convincingly shown that a cell type can be isolated from
EBs between 2.5 and 3.5 days of differentiation. This so-called BL-CFC can be
selected for using the blast colony culture regime and can be shown to have
potentiality to the endothelial and haematopoietic lineages. In the above experiments
it was also seen to differentiate into muscle-like fibres in accordance with studies
using the Collagen IV haemangioblast differentiation protocol (Yamashita et al.,
2000) that found that their bipotential cells were also able to differentiate to aSMA
expressing muscle.
What has not been shown of the BL-CFC is whether its potentiality is in fact limited
to the haemangioblastic lineages. When the EBs are disaggregated and cells plated
into the BL-CFC cultures in methylcellulose, the growth factors are believed to only
stimulate the growth of colonies from haemangioblastic BL-CFC from the otherwise
heterogeneous cell population. If this BL-CFC could be isolated (prior to its
differentiation and induction of blast colony formation) using its molecular profile, it
1 The exact role of c-kit and its ligand in haematopoiesis are unclear. They are expressed on YS-
derived precursors and stem cells found in the foetal liver (Ogawa et al., 1993; Ikuta and Weissman,
1992). What is known is that they are not directly required for the establishment of the
haematopoietic system (Kabrun et al., 1997).
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would be interesting to see whether it could respond to stimuli that could direct it to
other lineages or whether it truly is limited to the haemangioblastic cell fates.
Both the Keller and Nishikawa (discussed in the following chapter) differentiation
protocols were devised using a different ES cell line (CCE ES cells in both protocols
(Robertson et al., 1986; Nishikawa et al., 1998a)) and different growth conditions to
those used in the isolation and maintenance of the HM1 cell line. ES cells are known
to adapt to their isolation and growth conditions. Not only that, but the varying
characteristics and responses observed in different ES cell lines under pluripotential
as well as differentiating conditions mean that any differentiation protocol devised
for one ES cell line is possibly going to have a different effect on another cell line.
At the very least, it may be less effective in generating the desired cell type or
lineage. The difficulties encountered in the Keller differentiation protocol may be
attributable to the use of a different ES cell line for the differentiation experiments.
The fact that CCE ES cells appear to be the ES cell line of choice for many vascular
and haematopoietic differentiation investigations may indicate that a characteristic of
the line is easy induction of these lineages.
This highlights an inconsistency and a major disadvantage of in vitro modelling of in
vivo events. Each ES cell line is affected by its means of isolation and subsequent
culture. Although crucially, each line is ultimately pluripotent, subtle variation
between lines with respect to growth, ease of differentiation to particular pathways
and vigour can have more profound influences on complex manipulation of the ES
cell lines and the observations and conclusions drawn from such investigations.
Ideally, several ES cell lines should be tested in a differentiation protocol as a
measure of the robustness of the protocol and the results obtained from it.
5.2.5. Use of the BL-CFC Assay to Isolate Pure FLK-1 +
Cell Populations
Following successful repetition of the BL-CFC assay, attempts were made to
incorporate HAT selection with the differentiation culture in conjunction with the use
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of Jlk-l/KPRT targeted ES cells. Despite many attempts, HAT could not be
optimised with the BL-CFC culture technique irrespective of the time at which HAT
was added. In light of the technical difficulties that prevented the isolation of a pure
population of FLK-1+ cells with the BL-CFC assay, the Nishikawa protocol for the
isolation ofFLK-1+ cells differentiated on collagen IV was optimised for FLK-1+ cell
yield first, then for the isolation of the derived FLK-1+ cells following the addition of
HAT to the cultures (see Chapter 6).
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5.3. Summary
• The BL-CFC culture regime proved to be highly problematic and required
much practise and optimisation.
• Although finally carried out successfully, the putative haemangioblastic cells
were never assessed for their in vivo repopulation ability.
• The BL-CFC culture system was found not to be compatible with a FLK-1
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Directed Differentiation for Flk-1
Expression II: Nishikawa Protocol
6.1. Introduction
6.1.1. Two-Dimensional Differentiation on Collagen IV
The need to form the EB structure has been shown to be dispensable following the
differentiation of ES cells on feeder cells (Gutierrez-Ramos and Palacios, 1992;
Nakano et al., 1994) although it was not proved whether defined haematopoietic
differentiation was independent of three-dimensional cell morphologies that may
have formed during the differentiation procedure. Nishikawa and colleagues set out
to determine whether it was also possible to attain haematopoietic and vascular
differentiation in a two-dimensional culture system.
This alternative method of ES cell differentiation for the haematopoietic and vascular
lineages involves the growth of ES cells seeded at very low density on collagen IV,
which is the principal constituent of the basement membrane (Figure 6.1). The
basement membrane supports overlying epithelial or endothelial cells and functions
as a selective barrier for macromolecules. It consists of the basal lamina and an
underlying network of reticular collagen. When first investigating substrates that
would support mesodermal and haematopoietic differentiation without an EB
generation step, gelatin, fibronectin, type I and type IV collagens were tried with
collagen IV being found to be the most effective (Nishikawa et al., 1998a). Also, it
was discovered that differentiation of VE Cadherin+ endothelial cells was enhanced
by the addition of SCF and VEGF, and that it was not required for FLK-1 induction
or differentiation of cells of the vascular system.
Utilising this culture regime coupled with FACS sorting and analysis of the various
distinct populations of cells that arose from FLK-1+ cells, Nishikawa and colleagues
examined the segregation of the FLK-1 expressing cell population differentiating on
collagen IV, the kinetics of differentiation and the expression profile and subsequent
cell fate of the different cells that arose from the early FLK-1+ sorted population.
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They used this in vitro experimentation system to try and replicate the sequence of
events that take place in the developing embryo and the potentiality of cells bearing
specific marker profiles (Nishikawa et al., 1998a; Nishikawa et al., 1998b,
Hirashima et al., 1999; Hirashima et al., 2003). They isolated FLK-1+ cells from a
heterogeneous population; this in itself increased the appearance of blood
progenitors. Using FACS they followed the expression profile of these cells under










Figure 6.1 Diagram showing the steps involved in the two-dimensional differentiation of ES
cells on collagen IV to express FLK-1, as devised by Nishikawa et al. (1998). LG, L-
glutamine; BME, /3-mercaptoethanol; SCF and VEGF growth factors could also be added to
increase the yield of VE-Cadherin+ cells.
6.2. Aims
• To successfully replicate and optimise the Nishikawa collagen IV
differentiation regime with theflk-HHPRT targeted ES cell lines.
• To optimise differentiation protocols for the expression of FLK-1.
• To devise a selection regime to isolate a pure population of FLK-1 expressing
cells for in vivo transplantation.
From preliminary differentiation and HAT selection trials described in Chapter 4, it
was apparent that the HPRT transgene was functional and that the HAT selection
regime seemed to work. However, the protocol for differentiation and application of
the selection regime needed to be optimised for the highest level of enrichment for








FLK-1 expressing cells. Ideally, the FLK-1+ cells isolated should be progenitor cells
and not terminally differentiated endothelial cells so that after in vivo transplantation,
their potentiality is greater, in turn broadening the potential for their use
therapeutically.
6.3. Optimisation of a Selection Regime for Flk-
11HPRT Expressing Cells
6.3.1. Experimental Outline
Preliminary attempts using the collagen IV differentiation protocol to deduce the
functionality of the HPRT transgene in Chapter 4 were repeated with the HAT
selection applied at three initial timepoints of 0, 2 and 4 days after plating on
collagen IV. The plates were observed daily to see whether cells were surviving the
selection and proliferating as would be expected of /Ik-J/HPRT expressing
progenitor cells. Nishikawa et al., (1998a) reported the presence offlk-1 expressing
cells as soon as one day after plating at low density (104 cells/well of a 6 well plate)
on collagen IV coated plates. However, in the current experiments, the ES cells
plated out on collagen IV did not display any signs of growth until approximately 48
hours post-plating. Although there was variation between different experiments,
sometime after 48 hours post-plating there was a noticeable increase in cell number
on the collagen IV plates. The differentiating ES cells both proliferated and spread
across the surface area of the plates. The decision was taken to apply HAT selection
at 0, 2 and 4 days post-plating, based on this observation and under the assumption
that the population explosion and differentiation may have been correlated with the
expression of flk-1 and the differentiation of the ES cells to the vascular lineages.
The expectation was that 2-4 days post-plating would be the optimal time point for
maximal yield of flk-1 progenitors that had yet to terminally differentiate to the
endothelial lineage. The same procedure was repeated with the HM1 parental ES
cell line as a negative control. As these cells do not possess the hprt gene, they were
expected to die in HAT selection and give an indication of the speed of the selection




Figure 6.2 shows the results of one of three such trials, all of which were similar in
trend. Each growth condition or treatment within each experiment was carried out in
triplicate to guard against spurious observations. The cells placed directly into
selection on the day of plating on collagen IV did not plate down at all (Figure 6.2 b
shows the cells 2 days after differentiation and selection were applied). This is
unsurprising given that the cells would not have had time to respond to the inductive
influence of the collagen IV substrate before selection for FLK-1 expression took
effect. Cells that were allowed to differentiate for 2 days before selection was
applied showed poor and short-lived cell survival after selection for two subsequent
days. Although they had adhered and formed dense colonies on the collagen surface,
there had been little proliferation before selection was applied (Figure 6.2 c, d). The
cell survival from all the selection plates was poor although more viable and
endothelial-like cells were propagated from the wells that were placed under
selection after 4 days of culture on collagen IV (Figure 6.2 f, h). The control HM1
cells showed the fastest level of death, however (Figure 6.2 i, j), indicating that a
survival advantage was conferred by the HPRT transgene as hoped for. This
suggested that the HAT selection should be applied at a later stage and that flk-1
expression in these ES cells was induced at a later stage than observed by the
Nishikawa group. ES cells plated at 104 cells per well of a 6-well plate reached
confluence by the eighth day of differentiation. To try and capture the cells in a
highly proliferative state, selection was thought to be better if applied before cell
confluence was reached. The experiment was therefore repeated with HAT selection
applied after the sixth day of differentiation.
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F8 fffc-f/HPRT ES Cell Line HAT Selection Control
No Selection Selection Applied HM1 Cells In HAT Selection
Figure 6.2 Cell number and morphology of flk-1/hprt ES cells growing with (b, d, f, h) and
without (a, c, e, g) HAT selection. HAT selection was applied at various timepoints: at the
time of plating on collagen IV: day 0 (b), and at 2 (d) and 4 days (f, h) after plating.
Cultures were maintained until 8 days after plating when the control plates were fully
confluent (g). HM1 ES cells were used as a negative control to assess the level of cell
death expected from a completely HPRT deficient ES cell line (i,kj). Cells maintained under
identical growth conditions in the absence of any selection are shown in j and I. Scale bar
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When applied after 6 days of differentiation, selection for a proliferating population
of endothelial-like cells was far more effective than when applied at earlier stages
(Figure 6.3). Cell death was apparent after 24 hours, and by 48 hours a clear
morphological distinction could be made between cells in the presence (Figure 6.3
d) and absence (Figure 6.3 c) of selection. The selected cells were endothelial in
morphology: displaying typical "cobblestone" contours and uniform size. In the
absence of selection, cells formed a densely packed monolayer where cell
morphology could not be easily discerned and the cells on the surface were highly
reffactile. HM1 ES cells were placed under selection in parallel with the flk-lfHPRT
ES cell lines as a control for cell death. All HM1 cells should die in HAT selection
and were used as a guide to assess how long it took for all non-expressers of FLK-1
and the HPRT transgene to be killed. The HM1 wells were clearly sparser than the
others, however, even after 4 days of selection a few cells still remained attached to
the wells.
As the HM1 line is HPRT deficient, it was expected that all cells would be killed off
effectively on application of HAT selection. However, observing these cells
"surviving" despite several days of selection, led to the mode of action of HAT being
considered. HAT has a selective influence on actively cycling cells in which there
would be a need for purine synthesis and therefore a reliance on the activity of HPRT
in the presence of the aminopterin inhibitor. If the differentiating cells had senesced
and stopped cycling before the HAT selection had taken effect, they would not be
killed by its presence. This had implications for the purification of a pure flk-1
expressing progenitor population. Cells in the differentiating flk-1/VLVRT ES cell
populations could senesce and lose the ability to respond to HAT selection. If the
level of cell survival seen in the HM1 population was an accurate reflection of the
level of contamination from senescent cells, then this was not an issue, however, it
cannot be assumed that the level of contamination was as low each time. An added
consideration was the possibility of there being terminally differentiated and
quiescent endothelial cells that had exited the cell cycle and were therefore also
resistant to the effects of HAT selection. The collagen IV plates were found to be
variable between batches so it was never taken for granted that an observation would
be repeatable with a different batch of plates.
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6.3.2.1. Elimination of Non-Cycling Cells
In order to eliminate any non-cycling cells that were resistant to HAT selection, a
trypsinisation and replating regime was inserted into the selection protocol. Figure
6.3 shows the path of differentiation and selection after optimisation from the point
of plating 104 cells per well of a collagen IV 6-well plate. A noticeable level of cell
death was visible after 24 hours of HAT selection in comparison with cells not in
selection; the selection regime was consistently seen to take effect quickly. 24 hours
after selection was introduced, the cells were trypsinised and replated in a new well.
Replating the cells after a longer period of selection resulted in a lower plating
efficiency and a loss of proliferation in the cell population in comparison with cells
in selection for the same length of time but which had undergone the replating step at
an earlier stage of selection. The best selection regime established, (Figure 6.4 A)
involved a 24-hour selection period before replating and subsequent maintenance of
the cells in selection. The number of cells dying in selection was at its peak after 24
hours of selection. In control plates of wildtype cells, residual cells did survive the
selection procedure, presumably due to the fact that they were not metabolically
active and therefore insensitive to the HPRT selection method employed. After
replating, the flk-l/HPRT cells that attached all had a uniform endothelial-like
morphology. Cell death continued at a lower but steady level thereafter until after
about 2 weeks of differentiation, few cells remained. Those that did had a high
cytoplasm to nucleus ratio and no longer had a tight uniform morphology. Figure
6.4 B shows HM1 ES cells placed in selection in parallel with the F8 clone of the flk-
7/HPRT ES cells. HM1 cells were successfully eliminated following the replating
step.
Adding a disaggregation and replating step to the collagen IV differentiation protocol
and selection regime aided the isolation of a morphologically uniform endothelial-
like /7&-7/HPRT expressing cell population. These cells could be maintained in
selection for over a week, however, little proliferation was observed and the cells
could not be expanded. The possible reasons for the failure to grow the selected cells
























































6.3.3. Transcriptional Profile of Differentiating Cells
With and Without of Selection
In order to determine whether the FLK-1+ cells were progenitors or mature
endothelial cells, RT-PCR was carried out on isolated RNA from cells at different
stages of differentiation from differentiation on collagen IV and from spontaneous
differentiation as a comparison.
6.3.3.1. Experimental Outline
RNA samples were harvested from cells differentiating on collagen IV for RT-PCR.
RNA was taken immediately before selection was applied (6 days of differentiation),
24 hours after selection was applied (7 days of differentiation), 24 hours after the
replating step had been carried out (8 days of differentiation), and two timepoints
thereafter (10 and 12 days of differentiation) to see whether markers of
multipotentiality, haematopoietic-specific genes and endothelial-specific genes were
being transcribed.
RNA was isolated from cells differentiated as a monolayer on gelatin coated plates
and from EBs as a comparison for the induction of vascular transcription from
directed differentiation on collagen IV.
6.3.3.2. Results
Figure 6.5 shows the relative expression of key genes in vascular development in ES
cells differentiated using different differentiation techniques. Samples from cells
differentiated in the presence and absence of HAT selection were taken from cells
differentiated on collagen IV and used for transcriptional analysis. Robertson et al.
(2000) observed induction of brachyury in 2-day-old EBs, flk-1 in 2.5-day-old EBs
and scl/tall in 3.5-day-old EBs. It is evident from the very low levels of brachyury
expression that differentiation had passed the early, undefined mesodermal stage
when brachyury would typically be expected to be expressed. Brachyury was not
seen in EBs, or in cells differentiated as a monolayer and was only faintly seen in 6-
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day-old cultures on collagen IV. Expression of scl/tall, expressed in the earliest
stages of haematopoietic commitment was seen. Pecam-1, flk-1 and flt-1 were all
expressed, signifying commitment to the endothelial pathway. Flk-1 expression was
first observed at 2.5 days of differentiation in EBs and 4 days of differentiation for
monolayer cultures. By 6 days growth on collagen IV, flk-1 expression was very
strong and in all instances offlk-1 expression, a similar pattern offlt-1 induction was
also seen. Although expressed more clearly in monolayer cultures, both on gelatin
and on collagen IV, pecam-1 expression was noticeably low in differentiating EBs.
The amplification of transcripts was not successfully standardised using the (3-actin
housekeeping gene control despite attempts to equalise the cDNA concentration used
in each reaction, so direct comparisons of the levels of expression cannot be made.
However, there were clear trends for the expression patterns over the course of
differentiation. (In order to accurately compare cDNA quantities, real-time RT-PCR
could have been employed, had there been more time.) In the collagen IV
differentiation, the levels of transcript for all the vascular genes dropped over time.
This was not seen in the monolayer and EBs analysed however, these exhibited
lower levels of expression for all the genes analysed and only a short period of
differentiation was investigated for EB differentiation.
An anomaly was observed with respect to hprt expression and its expected
correlation with flk-1 expression (Figure 6.5). Although hprt expression was seen in
all instances where flk-l expression was seen for collagen IV differentiation and in
EBs, no hprt transcript could be amplified from monolayer differentiation, which
was peculiar. This result was repeatable and could not be attributed to PCR error or
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6.3.4. Patterns of Gene Expression during
Differentiation on Collagen IV as Detected By
Immunohistochemistry
Immunohistochemical staining for FLK-1 (haemangioblastic, endothelial),
SCL/TAL1 (haemangioblastic, haematopoietic), VE-Cadherin (endothelial) and
aSMA (smooth muscle) were carried out at different stages of differentiation on
collagen IV to assess the patterns of differentiation and protein expression over a
specific time period. This would add to the RT-PCR results by confirming the
expression of the genes of interest at the protein level, and show any patterns of
expression that could not be deduced from transcription data.
6.3.4.1. Experimental Outline
A differentiation experiment was set up with collagen IV coated 6-well plates where
selection was applied after 6 days of differentiation. 24 hours after the HAT
selection was introduced, the cells were trypsinised and replated to eliminate any
non-cycling cells that would otherwise be unresponsive to the selective influence of
HAT. Cells were fixed and stained 4, 6, 9 and 12 days after differentiation was
initiated. The cells taken after day 6 of differentiation were maintained in HAT
selection. At each stage when immunohistochemistry was carried out, negative
controls i.e. the staining protocol with only the secondary antibodies were included
to ensure that any observed staining could not be attributable to non-specific binding
of the fluorescently-labelled secondary antibody. See Appendix E for examples of
negative control samples.
6.3.4.2. Results
At 4 days of differentiation, the cells that had adhered to the collagen IV matrix had
just undergone the typical population explosion and spreading that was always seen
between 2-4 days of differentiation. The cells that plated down initially proliferated
in dense clumps to form three-dimensional small clumps before the typically
observed cell growth outwards of the colonies and across the culture surface leaving
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more densely packed colony centres. Low level FLK-1 expression was seen across
the entire cell population VE-Cadherin was also seen to be expressed. It was
expressed in cells that were growing two-dimensionally and had distinctly
endothelial morphologies. All VE-Cadherin+ cells were also FLK-1+, however,
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By 6 days of differentiation, the cells in 6-well plates were confluent. Colonies
differentiating outwards had merged although the foci of each colony remained
denser and morphologically uniform compared to the outgrowths. They were
generally higher expressers of FLK-1 as well. The FLK-1 staining of the denser foci
was not due to an increase in non-specific antibody binding to denser cell masses
because there were also dense colonies that did not stain for FLK-1 as well as ones
that did (See arrow in Figure 6.7c).
1. Double Positive 2. VE-Cadh - Cy3 3. FLK-1 - FITC
a lj§
FLK-1/FITC; VE-Cadh/Cy3 VE-Cadh/Cy3 FLK-1 /FITC
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Figure 6.7 Immunohistological staining for FLK-1 (green/FITC) and VE-Cadherin (red/Cy3)
in collagen IV differentiation cultures after 6 days. Rows a and b show co-staining of FLK-1
and VE-Cadherin. The FLK-1 staining is shown in the far right column (3), the VE-Cadherin
staining is shown in the centre column (2). The merged images for both epitope stains are
shown on the far left (1). The bottom row shows FLK-1 stained cells with varying colony
morphologies. The asterisk shows striated coexpression of FLK-1 with VE-Cadherin. The
arrow shows a dense colony not staining positive for FLK-1. DAPI nuclear stain is seen in
blue. Scale bar represents 100pm.
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Although not expressed across the whole FLK-1 expressing population, levels of
VE-Cadherin had also increased by 6 days of differentiation. Some colonies of
growing cells exhibited a distinct pattern of VE-Cadherin expression where the
central cells of a colony grew very three-dimensionally and stained strongly for
FLK-1. On the periphery of these foci, cells grew flatter, expressed FLK-1 and VE-
Cadherin and had tight endothelial morphologies. Adjacent to these cells, the cells
grew the flattest, more cytoplasmic and more trapezoid in shape. They expressed
FLK-1 but not VE-Cadherin. Figure 6.8 shows examples of the cell morphologies
seen in colonies of cells growing on collagen IV.
Figure 6.8 6-day-old colonies differentiating on collagen IV displaying colony structures and
the various striations of cell morphology typically seen. Scale bar represents 200pm,
At day 9 of differentiation, the differentiating cells had been in selection for 72 hours
and had been trypsinised and replated 48 hours prior to fixation and staining. Strong
FLK-1 expression was seen throughout these plates. The cell surface pattern of
staining was consistent with what is typically seen in endothelial cells i.e. discrete
but intense staining across the cell surface, giving cells a mottled staining pattern
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Figure 6.10 Immunostaining for FLK-1 (a, b) and aSMA (c, d) after 12 days of
differentiation. DAPI nuclear stain is seen in blue. Scale bar represents 10O/jm.
By 12 days of differentiation, most of the cells had lost their endothelial morphology.
Most were very flat and trapezoid in morphology. They stained strongly for aSMA
as well as FLK-1 (Figure 6.10). Little cell proliferation was seen. Despite this,
upon disaggregation and replating, many cells re-adhered to the collagen IV even
though HAT selection was still being maintained. This indicated that FLK-1 was
still being expressed to high enough levels to transcribe sufficient HPRT for cells to
survive in HAT although cell proliferation was low or undetectable.
6.3.4.3. Summary of Immunohistochemistry Results
From the earliest stages of differentiation, FLK-1 was detectable by
immunohistochemistry. At 4 and at 6 days of differentiation, no clear SCL/TAL1
staining could be detected (Figure s 6.6 and 6.7) although the antibody against
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SCL/TAL-1 was not optimised fully (due to the absence of a positive control
SCL/TAL-1 expressing cell line) and was therefore not thought to be reliable. The
FLK-1 expression increased by 6 days of differentiation when VE-Cadherin could
also be detected. Concentric patterns of staining were seen across the colonies. The
central cells were FLK-1+. These densely packed cells were surrounded by
morphologically endothelial cells that stained for both FLK-1 and VE-Cadherin. As
the cells lost their endothelial morphology and became more cytoplasmic, they lost
VE-Cadherin staining and showed lower FLK-1 staining. This lowered level of
staining may have been due to the cells being flatter and more spread out and not
related to levels of FLK-1 expressed on the cell surface.
At 9 days of differentiation the cells had been subjected to selection and replating so
the colonies had been lost. Most cells stained strongly for FLK-1 and displayed
typical mottled endothelial staining patterns (Choi et al., 1998). VE-Cadherin
staining was also common and only stained FLK-1+ cells. Not all FLK-1+ cells
expressed VE-Cadherin however. VE-Cadherin staining was still detectable at 12
days of differentiation, albeit at very low levels. Most cells exhibited muscle cell
morphology and stained positive for aSMA while still retaining FLK-1 expression.
6.4. In Vivo Transplantation of Purified FLK-1
Expressing Cells
Differentiated and selected FLK-1+ cells were grafted into a mouse blastocyst to see
whether the in vitro isolated cell population could contribute to haematopoietic and
vascular lineages. It was therefore necessary to track the injected cells. The F8 flk-
7/HPRT cell line was co-transfected with two plasmids: one contained a blasticidin
cassette; the other, pEGFP-Cl (BD Biosciences) contained the EGFP reporter driven
by the CMV promoter. The GFP plasmid was transfected at a ten fold higher ratio
than the blasticidin cassette to increase the likelihood that any blasticidin resistant
cells isolated would have also had the GFP construct transfected and integrated into




The transfected lines selected were maintained clonally. For in vivo grafting assays,
they were differentiated for 6 days before selection was applied. At 7 days of
differentiation, they were replated and maintained in HT (hypoxanthine and thymine)
selection. The aminopterin needed to be eliminated 4 days prior to the injection of
these cells back into embryos. The aminopterin would have had its inhibitory effect
on the purine biosynthesis pathway for approximately 4 days and would have
resulted in cell death in vivo in the absence of an immediate source of purines as
would be the case ifHAT selected cells were grafted directly back into embryos.
The need to wean cells off the aminopterin had the disadvantage of prolonging the
culture period required to complete the selection of FLK-1+ cells and prime the cells
for grafting. At least 48 hours of selection followed by replating was required.
Adding 4 days of HT maintenance meant that the cells used for injection had
undergone at least 10 days of differentiation. It was believed that in order to
maximise the enrichment for FLK-1 expressing cells but minimise the terminal
differentiation of the cells to endothelial or muscle cells, 9-day-old differentiated
cells would give the best and most specific engraftment. Together with the HT
weaning period, the minimum time required would be 10 days.
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6.4.2. Results
A variety of differentiation and selection regimes were tried during the course of
these experiments as summarised in Table 6.1.
DIFFERENTIATION











6 7 8 12 14 0
6 7 11 15 22 0
6 7 9 13 9 0
6 7 7 9 17 3(1*)
Table 6.1 Differentiation and selection regimes employed for in vivo transplantation of
differentiated FLK-1+ cells. * 1 live birth was harvested 2 days post-birth. 2 neonatal murine
pups died.
In 3 of the 4 grafting experiments carried out, the pregnant mice carrying the
blastocyst injected embryos were sacrificed at 10 dpc to harvest the embryos and
look at any contribution that the blastocyst-injected cells could have made to the
developing foetus. In these experiments, all foster mothers were found to show no
signs ofpregnancy or were carrying decidua that did not contain embryos, a sign that
the pregnancies had been resorbed.
In one experiment, the foster mother was allowed to carry the transferred embryos to
birth. Three mice were carried to term. Two mice were dead at birth. The live birth
was sacrificed after 2 days and it's internal organs removed and cryopreserved. GFP
immunohistochemistry was carried out on the organs.
Figure 6.11 shows the results of the antibody staining of the organs that were
successfully removed and stained for the GFP protein with a FITC-conjugated GFP
antibody. Some organs infiltrated by a complex and broad vascular network were
found to show a high level of staining, however others, such as the brain which is
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also highly vascularised were found to only have peripheral staining. Wild-type
tissues showed no staining with the GFP antibody (data not shown). The staining
pattern did not show localisation of the injected cells to the vascular lineages
indicating that the cells were either not restricted to the vascular lineages or that they
had been reprogrammed to take on other cell fates. The latter may be the less likely
possibility of these two, however, given that the cells injected would be likely to be
equivalent to cells from a later developmental timepoint than those in the blastocyst
in which they were injected. A lack of time prevented further differentiation and
grafting experiments being carried out or double staining for vascular markers to be
carried out to distinguish the location of the vasculature in the tissue sections and the
relative locations of the GFP-marked cells.
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6.5. Discussion
6.5.1. Optimisation of Collagen IV Differentiation and
Selection Regime
The Nishikawa protocol for the differentiation of FLK-1+ cells (Nishikawa et al.,
1998a) was modified to optimise the time at which selection was applied. It was
found that unlike the observation of Nishikawa and colleagues, where FLK-1 is
induced almost immediately after plating on collagen IV, HM1-derived ES cells
plated at the recommended low density, took several days before growth and
differentiation were observable. The selection regime needed to be introduced as
soon as possible if the FLK-1+ cells isolated were to be progenitor cells and not
terminally differentiated endothelial cells. It was found that the earliest time that
selection could be applied without the death of all cells was 6 days after plating on
collagen IV.
The observation was made in the HM1 parental ES cell line, that the selection
procedure, though highly effective, did not kill all of the differentiating HM1 cells.
HAT selection only has an effect on cycling cells. As endothelial cells are able to
enter quiescence (Witmer et al., 2002), and senescence is also a common problem
associated with differentiated cells in vitro, in order to obtain as pure a FLK-1+ cell
population as possible, a replating step was introduced into the differentiation
protocol to eliminate non-cycling cells. The replating step was found to be effective
after being introduced as little as 24 hours after selection was applied.
After replating, the cells grew with uniform endothelial-like morphologies.
Spherical refractile cells were seen to bud off them and a steady although slow rate
of proliferation was observed for up to a week after the replating step was performed.
These observations hinted that the cells being purified were haemogenic endothelial
cells.
Transcriptional analysis using RT-PCR over the course of collagen IV differentiation
(Figure 6.5), showed that by 6 days of differentiation, key vascular genes were being
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transcribed in the adherent cells including scl/tal-1 which, being an early
haematopoietic and haemangioblastic marker, would not necessarily be associated
with the adherent cells, were they already terminally differentiated to endothelium.
This indicated that at these earlier stages of differentiation, either haematopoietic
precursors were adhering to the adherent cells (possibly supporting the haemogenic
endothelium theory) or that the adherent cells were haemangioblastic themselves, co-
expressing flk-1 and scl/tal-l. As differentiation progressed, expression levels
dropped for all of the vascular markers until at 14 days of differentiation, none could
be detected. In the absence of exogenous growth factors to stimulate growth,
progenitor maintenance or further differentiation to vascular lineages, it is not
surprising that expression was lost. Pecam-1 expression showed the same
downregulation over time that was seen for the other genes.
Monolayer differentiation showed the lowest levels of vascular gene induction out of
the three modes of differentiation that were analysed except for Tpecam-1 induction
which was detected at very low levels in EBs. This hints that there may be cellular
interactions on cells growing as a monolayer that are not present or which are
inhibited in three-dimensional EBs or vice versa. Another notable outcome was the
inability to detect hprt transcription in monolayer differentiation on gelatin. As the
flk-1 transcripts were found to be less highly expressed in the monolayer
differentiation in comparison with the in EBs and collagen IV differentiation, it was
possible that the absence of hprt transcript was a sensitivity issue with the PCR.
There was a clear peak in vascular transcripts at 3 days of EB differentiation, which
corresponds with the Keller observations of the haemangioblastic window in
differentiating EBs (Kennedy et al., 1997; Choi et al., 1998).
6.5.1.1. Immunohistochemical Patterns of Expression
During Differentiation
The data obtained from immunohistochemical staining of differentiating ES cells
helped to visualise the patterns of differentiation. Early on in the differentiation
procedure, SCL/TAL1 and FLK-1 were seen to be expressed by clustered cells in the
middle of outwardly differentiating colonies of cells. By 6 days, a clear colony
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structure had developed with central, densely packed and refractile FLK-1+ cells
being surrounded by endothelial FLK-1+ VE-Cadherin+ cells followed by a muscle
cell-lie peripheral ring of FLK-1+ cells (Figures 6.7 and 6.8). There were clear
similarities to blood vessel morphology and structural order and may hint that a
similar order and pattern of differentiation is maintained during vasculogenesis or
angiogenesis whereby there exist cells displaying haemangioblastic characteristics
including expression of FLK-1 and SCL/TAL1. Haematopoietic cells may bud off
these cells and FLK-1+ VE-Cadherin+ cells grow out from them. Peripheral to these





Blood Vessel Differentiating Colony
Hierarchy Hierarchy
Figure 6.12 Schematic diagram showing the similar hierarchy of cell layers in blood vessels
and cells differentiated on collagen IV in vitro.
At 9 days, after the replating step to eliminate noncycling cells, the colony hierarchy
was lost and flat sheets of FLK-1+ cell remained. Most of these stained for VE-
Cadherin and were therefore confirmed to be endothelial. It was clear that by 9 days
of differentiation, most cells were no longer haemangioblastic in appearance and
displayed signs of lineage restriction to the endothelial lineage, both morphologically
and according to their expression profiles. By day 12, two distinct cell morphologies
were seen: the FLK-1+ endothelial-like cells were still present, although VE-
Cadherin was not detectable at very high levels, and aSMA+ muscle-like cells. This
may be attributable to the lack of direction given to the cells beyond the enrichment
for FLK-1. Perhaps in the absence of a follow on signal, these differentiating cells
may be unable to proliferate for an extended length of time in culture.
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A concern regarding the selection regime being applied to the cells was the removal
of a cellular hierarchy that could have been acting as an in vitro niche with certain
FLK-1" cells supporting FLK-1+ cells, possibly even promoting their proliferation
and maintenance in an undifferentiated state. The influence of growth factors may
have powerful stimulatory influences on the cell signalling mechanisms that drive
differentiation (reviewed in Czyz and Wobus, 2001; Burdon et al., 2002). However,
alternative forms of activation via mechanoreceptors and adherence to extracellular
matrices and adhesion molecules also exist (Chen et al., 1999; Jalali et al., 2001;
Wang et al., 2002). Although there is redundancy in the modes of activation of
various signalling cascades, it is likely that transcriptional activation via integrins
and other adherence molecules could significantly affect the fate and activity of a
pluripotent or differentiating cell. Of course, the reverse scenario was also possible
with non FLK-1 expressing cells promoting terminal differentiation of FLK-1+ cells
or redirection away from vascular cell fates, meaning that the removal of such cells
would be an advantage.
6.5.1.2. In Vivo Potentiality of In Vitro-Derived
Differentiated Progenitors
To address the concerns regarding the removal of a niche-like hierarchy with the
HAT selection and the effect this may have had on the in vitro derivation of a
haemangioblastic cell population, these differentiated cells were transplanted back to
the blastocyst stage embryo. Even if haemangioblastic cells had successfully been
isolated from ES cells, these cells being injected into the blastocyst were at a
developmentally more advanced stage than the embryo in which they were intended
to integrate. Several different experiments were carried out, however, most of the
blastocyst transfers did not survive to 10 dpc when they were to be harvested. In
one experiment, the pregnancies were allowed to go to term. The only live birth was
sacrificed after 2 days and its organs analysed for contribution from the GFP labelled
and differentiated cells. All highly vascularised organs that were looked at showed
some staining for GFP and had therefore been infiltrated by the differentiated ES
cell-derived cells. The brain only showed a small level of expression peripherally. It
was difficult to determine the lineage specificity of the cells from the staining
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patterns. The GFP+ cells did appear to be highly localised to the endothelial or
haematopoietic lineages, however all the organs examined were highly penetrated by
the vasculature and due to fenestration (permeability of the endothelial layer) of the
endothelial cells in these organs, blood lineages could freely enter the tissues. It was
unfortunate that there was no time to successfully repeat the grafting experiments
and stain for markers from the vascular lineages as well as for GFP to determine
whether the in vitro-derived cells were maintaining a vascular identity or if they were
contributing to other lineages.
Even if they were not vascular-specific in their lineage specifications in vivo, the
transplanted cells were differentiated beyond the time of expression of markers of
more plastic cell status e.g. brachyury and had been differentiated in the absence of
LIF for 9 days. They had been maintained in the blastocyst despite their more
advanced stage of differentiation and were able to contribute to many lineages. If
studies could have been extended, it would have been interesting to see whether
these cells were vascular and if they were not, whether they were restricted to
mesodermal tissues and organs. Many more questions regarding reprogramming, the
possibility of cell fusion, dedifferentiation and transdifferentiation arise from these in
vivo results and would have benefited from the execution of further in vivo studies.
6.6. Summary
• The haemangioblast differentiation protocol on collagen IV was optimised for
the highest and quickest yield of HAT resistant cells which were assumed to
be FLK-1+.
• These cells were seen to colonise highly vascularised organs although it was
not determined whether they were specific to cells of the vasculature or had
differentiated to other lineages.
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Concluding Remarks and Future
Directions
7.1. Introduction
There is a broad range of potential applications for stem cells especially the more
versatile ES cell. ES cells enable the study of development and differentiation at the
molecular level in vitro, they enable the generation of precisely designed transgenic
mice to model disease and could be used to determine the effect and efficacy of
chemical components or drugs before the requirement for in vivo studies in animal
models and clinical trials. The most desirable and powerful application of stem cells
focuses on their pluripotency and their possible use to facilitate the establishment of
cell-based therapies for disorders resulting in the degeneration of tissue or the loss of
cell function. In theory, any disorder could be treated, the limiting factor being the
ability to differentiate the appropriate cell type.
This project was designed to investigate the possibility of deriving a progenitor
population of cells from ES cells in vitro and seeing whether this in vitro derived
population could be grafted in vivo and recapitulate the function for which it was
intended.
Mimicking in vivo events through the differentiation of ES cells has been possible
(Doetschman et al., 1985) and has been a useful tool for investigating the signalling
events that govern differentiation in the developing embryo (reviewed in Czyz and
Wobus, 2001; Burdon et al., 2002). It is unlikely that the true complexity of cellular
interactions and signalling will be deciphered or applied to in vitro differentiation
methods; the aim of in vitro differentiation is therefore to generate a cell population
that is similar enough to its in vivo counterpart to be recognised and captured by the
appropriate machinery once grafted in vivo, and directed down the appropriate
lineage for further differentiation and specification.
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The haemangioblast seemed like the ideal candidate as the chosen progenitor. It has
been thought for many years to exist but has never been isolated in vivo. Promising
investigations in chick development hint at its existence (Martin et al., 1980;
Pardanaud et al., 1996; Tavian et al., 1996; Jaffredo et al., 1998; North et al., 1999;
Ogawa et al., 2001), however, difficulty in accessing the murine embryo at 6-7 dpc,
the time of the supposed emergence of the haemangioblast, means that it has never
been located in the mammalian model. A cell that is reminiscent of the
haemangioblast in its function has been isolated through the in vitro differentiation of
ES cells, namely the BL-CFC (Kennedy et al., 1997; Choi et al., 1998). Other
differentiation studies lend their support to the hypothesis that the haemangioblast
hypothesis should at least incorporate the possibility that the endothelium of the
forming vasculature has haemogenic capabilities (Nishikawa et al., 1998a;
Nishikawa et al., 1998b; Yamashita et al., 2000; Hirai et al., 2003).
By marking ES cells with a reporter gene allowing for the identification of the
haemangioblast in culture, isolation of a suitable population of haemangioblastic
cells and injection into a blastocyst were to be carried out to test the in vitro-derived
cells' abilities to reconstitute the haemangioblastic lineages. (When this project was
initiated, the plan had been to generate embryonic lethal flk-1'1' blastocysts for
progenitor injection to see whether the lethality could be overcome by the
transplanted cells) The success of such an experiment would verify the possibility of
deriving a progenitor population in vitro that was functionally active in vivo and
would also show that cells at a more advanced stage of development could be
supported in the blastocyst-stage embryo and be maintained until the appropriate
stage of development for their direction to an appropriate function as has previously
been shown with HSCs (Muller et al., 1994).
7.2. Gene Targeting at the Flk-1 Locus
The flk-1 gene is known to mark the earliest mesodermal cells that are specified to
the haemangioblastic cell fates. Though not the sole marker of the haemangioblast, it
was the best candidate as the marker to isolate a cell population for analysis and
transplantation. Two targeting strategies utilised, placed an EGFP reporter or an
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hprt minigene under the transcriptional control of the flk-1 promoter. The GFP
reporter would allow for the optimisation of in vitro differentiation protocols for
maximal flk-1 expression as well as FACS sorting of a FLK-1+ cell population whilst
the Aprt-targeted cells could be selected for in culture as the ES cell line targeted was
otherwise HPRT deficient (Selfridge et al., 1992).
After a series of problematic targeting experiments, the two targeting strategies were
successfully carried out. Further investigations aimed at trying to deduce the reasons
for the very low targeting frequencies observed were ultimately inconclusive
although the possibility that isogenicity of DNA in the arms of homology
incorporated in the targeting vectors remained a possible explanation.
7.3. Silencing of the GFP Transgene
Unfortunately, after a few preliminary differentiation experiments, it became
apparent that in the flk-1/GFP targeted cell lines, the EGFP transgene was being
silenced. RT-PCR and Western blotting confirmed that the silencing was occurring
at the post-transcriptional level. The cause of loss of transgene expression was never
resolved. However, it highlighted the necessity to carefully consider vector design
and the genetic locus being targeted. As both of the isolatedflk-1/GFP targeted lines
were silenced, the problem may have been due to the design of the targeting vector
and possibly a response to there being two polyadenylation signals in the targetedflk-
1 allele. This may have caused the mRNA sequence to be subject to nonsense-
mediated mRNA decay (Maquat and Carmichael, 2001). In hindsight, measures
should have also been taken to excise the PGRneo to protect against any silencing
induced by its presence (Ramirez-Solis et al., 1993; Rijli et al., 1994; Fiering et al.,
1995; Olson et al., 1996; Weissmann & Aguzzi, 1999).
Others have also reported a noticeable improvement in transgene expression when
introns were incorporated into the transgene (Fehling et al., 2003). This may explain
why the HPRT transgene was expressed in cell lines but the GFP transgene was not.
The former had incorporated introns whereas the GFP transgene was a cDNA.
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7.4. Differentiation of ES Cells for FLK-1
Expression
The flk-llGFP cell lines were abandoned in the differentiation experiments although
several chimaeric mice and heterozygous mutants (which also failed to show GFP
expression) were generated from the cells. Differentiation experiments were
continued using the flk-1/HPRT targeted cell lines. Two very different
differentiation protocols were tried out. The Keller protocol generated the suggested
in vitro equivalent of the haemangioblast: the BL-CFC (Kennedy et al., 1997; Choi
et al., 1998) and the Nishikawa protocol that derived a monolayer culture of
endothelial-like cells which also had haematopoietic and mural cell potential,
supporting the haemogenic endothelium hypothesis.
Optimising the Keller regime was found to be highly problematic. Varying cell
density, timing of the BL-CFC culture assay and the method of production of the
conditioned medium, which was incorporated into the assay, did not affect the
efficacy of the protocol. However, the method of disaggregation of EBs before the
setting up of the BL-CFC culture regime was found to be important, with dispase
disaggregation resulting in a better yield of BL-CFCs than trypsin, probably due to
dispase's more specific protein targets for lysis. Blast colonies derived from BL-
CFCs were successfully differentiated to endothelium, haematopoietic precursors and
muscle cells as seen after further differentiation on Matrigel and
immunohistochemistry and in haematopoietic assays in methylcellulose.
Unfortunately, due to the requirement for several lengthy optimisation steps to
successfully carry out this culture technique, there was not sufficient time to
successfully optimise a selection regime to isolate HPRT+ cells via HAT selection.
Considering the variability and the difficulties encountered with this differentiation
technique, the possibility to successfully select a pure FLK-1+/HPRT+ cell population
seems unlikely.
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Although it was shown that the blast colonies arising from BL-CFCs had the
potentiality expected of the haemangioblast, it cannot be concluded that the BL-CFC
is the in vitro-devived haemangioblast. It would be interesting to see whether BL-
CFCs can be directed to other cell fates if different cytokines are applied to the blast
colonies derived from BL-CFCs. This line of investigation relies on the ability to
isolate BL-CFCs from differentiating EBs, which is, at present, limited by the
inability to fully characterise the putative haemangioblast. Initial trials with cells
sorted for FLK-1 and SCL/TAL-1 could act as a starting point for these experiments
as well as further characterisation of the haemangioblast.
7.5. Isolation of FLK-1 Expressing Cells
The Nishikawa differentiation protocol was far more successful from the outset.
Cells were grown as a monolayer on collagen IV coated plates; there was no need for
the formation of three-dimensional EBs to stimulate differentiation suggesting that
the collagen IV matrix was a sufficient stimulus for differentiation. Also, there was
no need for added cytokines unless the yield of FLK-1+ cells from differentiation on
collagen IV was to be specifically directed for differentiation to a particular lineage
e.g. endothelium (Yamashita et al., 2000). As the earliest committed progenitors
were desirable in this project, such stimulation was omitted. The HAT selection for
FLK-1+ cells was successfully incorporated into this differentiation protocol. A
passaging step was also incorporated to eliminate the presence of non-cycling cells
that were rendered non-responsive to the effects of HAT. After selection of FLK-1+
cells was deemed effective, the cells were weaned off aminopterin in preparation for
blastocyst injection. Several attempts were made to inject selected FLK-1+ cells into
blastocysts; only one case resulted in a live birth. The neonatal mouse showed
colonisation of the HAT-selected and differentiated (and subsequently GFP-tagged)
FLK-1+ cells in some vascularised organs e.g. kidneys, liver and heart, but not in
others e.g. the brain - a highly vascularised organ. Unfortunately, there was not
enough time available to continue with the in vivo colonisation studies. Also, the
specificity of the colonised cells could not be determined as there was not enough
tissue material available to costain the GFP+ cells found in the mouse organs for
vascular markers to determine the fate of the transplanted cells.
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Migrating endothelial cells are usually accompanied by non-endothelial cells e.g.
pericytes, smooth muscle or fibroblasts (Nicosia and Ottinetti, 1990; Nehls et al.,
1992). Isolation of a pure population for in vivo transplantation may not matter if
selection is immediately followed by grafting e.g. after FACS for cells expressing a
specific set of desirable markers; however, removing such companion cells could
have detrimental effects in the middle to long term i.e. whilst cells are being cultured
under selection as these cells could have signalling or conditioning properties
essential to the survivals of progenitor, early vascular or non-quiescent cells. The
removal of FLK-1" cells via HAT selection, could therefore equate to the elimination
of a niche or a cellular hierarchy during differentiation that could impact on the
viability of the cell population that is being isolated. It strengthens the argument for
the use of flow cytometry for the isolation of cells.
7.6. Possibilities For Further Investigation
As well as continuing the transplantation experiments with the HAT-isolated cell
population, several avenues of investigation would be beneficial to pursue to develop
this body of work. The HAT-selected cells following differentiation did express
FLK-1 and did contribute to embryonic organs following injection into the
blastocyst. However, by the time they were harvested for injection, their
proliferative capacity had dropped and the majority of cells appeared endothelial in
morphology. Though still expressing FLK-1, it is possible that these cells were not
haemangioblastic, but endothelial. With the progress made in FACS, specific cell
types can be purified from heterogeneous populations with ease, as long as
antibodies can be used to bind to the cells. FLK-1 is a cell surface marker that can
bind fluorochrome labelled antibodies for FACS for a pure FLK-1+ cell population
without the need to adopt complicated transgenic methods. However, incorporation
of transgenic strategies with sorting for desirable cell surface markers could be
utilised to speedily isolate progenitor populations for therapeutic transplantation.
This has already been achieved by Chung et al. (2002). The haemangioblastic
SCL/TAL-1 transcription factor cannot be sorted for. By targeting the SCL/TAL-1
genetic locus with a non-functional CD4 cell surface marker, they enabled
233
SCL/TAL-1 expressing cells to be isolated via the expression of this epitope. In
combination with sorting for FLK-1 directly, a clever strategy to further study and
characterise a putative haemangioblast population was developed. This needs to be
further built upon to gain a better understanding of the haemangioblast and its role in
development. The adoption of a similar strategy to further characterise the putative
haemangioblast would be interesting, although dependent on the selection of a
reliable candidate gene for targeting that is expressed early in vascular specification
but not preferentially expressed in any one of the different vascular cell fates.
It has yet to be proved definitively that the haemangioblast exists in vivo, though
there is much in vitro and in vivo data to suggest that it is likely to exist and the
criteria for identification of progenitors and their subsequent descendants are always
contentious issues. An array of different cell surface markers are used to identify
pre-haematopoietic mesoderm and haematopoietic or endothelial precursors. It is
common to find conflicting data suggesting that the expression of a marker one
group has used to purify a supposedly pure haematopoietic progenitor population is
actually heterogeneously expressed in a pure haematopoietic progenitor population
isolated by another group based on expression of a different cell surface marker e.g.
the discovery that CD34" LTR-HSC exist (Osawa et al., 1996; Ando, 2001). It is
therefore likely that several candidate markers that are expressed around the time that
the vascular system is established will need to be evaluated with care to identify a
likely marker of a haemangioblastic cell.
7.6.1. Extrinsic Influences on Vascular
Differentiation
As mentioned, the process of selection was flawed due to the lag time taken for
selection to take effect and a pure population to be isolated. It may be possible to
speed up commitment to the haemangioblastic lineages, without terminal
differentiation to a specific cell fate by considering the application of extrinsic
influences on ES cells in vitro. Many in vitro differentiation experiments carried out
to try to understand the molecular mechanisms that underlie the cell specification in
ontogeny do not address the role of the specific microenvironment on the potentiality
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and maintenance of a progenitor. The in vitro culture and manipulation of cells,
particularly ES cells used to recapitulate the actual mechanisms of lineage
determination, are limited by the crudeness of the experimental systems that are used
to mimic in vivo signalling and cell fate determination. However, extrinsic
influences could be a crucial element in the mimicry of in vivo events and
potentially, a niche hierarchy. Such stimulation is also integral to the development of
cell-based therapies if they are to be robust and accepted at the graft site after
transplantation.
The extracellular matrix and shear stress stimulate the differentiation and
maintenance of progenitors. In vitro, endothelial cells have been shown to respond
to shear stress with increased cell division and motility at the sites of flow separation
(Tardy et al., 1997). Incorporation of shear stressors, the use of scaffolds, the
creation of a hypoxic environment along with the application of appropriate
cytokines with the HAT selection regime would all have been interesting to
investigate concurrent with the differentiation and selection of the FLK-1 selectable
cells to see if they enhanced the yield and maintenance of an early progenitor
population.
Levenberg et al. (2002) isolated endothelial cells from spontaneously differentiated
hES cell-derived EBs using FACS isolation with the PECAMI antibody. These cells
formed vessel-like structure in vitro and proliferated to form vessels when
transplanted into SCID mice supported by either a poly-L-lactic acid or a polylactic-
glycolic acid scaffold. These in vivo generated vessels were found to harbour murine
haematopoietic cells in their lumen. Not only is this a promising example of the
potential use of hES cells in therapy but also supports the theory that endothelial
cells have haemogenic capabilities.
Niklason et al. (1999) used biodegradable polymer scaffolds and bioreactors
simulating in vivo conditions to successfully grow blood vessels from cells taken
from bovine aorta. The use of the bioreactor induced inward migration of SMCs,
typical of native blood vessels. This was not observed in cultures maintained outside
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a bioreactor but with otherwise identical growth measures. This highlights the
importance of extrinsic influences in the development of therapeutically viable and
structurally correct tissues for transplantation.
7.7. In Vitro-Derived Cells as Therapies
BM-derived endothelial progenitors have been previously isolated (Takahashi et al.,
1999) and can be recruited for repair and generation of vessels in ischemic or
damaged tissues, tumours and even non-damaged tissues (Asahara et al., 1999).
Asahara et al. (1997) isolated CD34+, FLK-1+ cells from human peripheral blood.
They injected this population of cells into the tail vein of athymic nude mice that had
had their femoral artery removed and hence had ischaemia in the hindlinb. The
peripheral blood cells successfully differentiated to endothelial cells that
revascularised the ischaemic hindlimb showing that haemangioblastic or endothelial
progenitors existed in adult peripheral blood. More recently vascular structures have
been differentiated from hES cells with a protocol based on differentiation on
collagen IV (Gerecht-Nir et al., 2003). Levenberg et al. (2002) successfully injected
their isolated endothelial cells into mice where they formed seemingly functional
microvessels.
These are encouraging achievements in the development of vascular cells with
potential therapeutic applications. As the molecular mechanisms underlying ES cell
self-renewal and differentiation are disseminated, a greater understanding of the
signalling mechanisms required for specific lineage differentiation will hopefully
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Cloning Strategy: flk-1/HPRT Vector Construction
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3.) Excision of Lac Z reporter using Eco Ri and Pst I
enzymes.
Structure of the HPRT Mniaene






4.) Concurrently, the HPRT minigene was excised from the
DWM-1 plasmid using Pst I and Eco RI
Arnpr fik-1 S'Momoiooy
5.) The isolated HPRT fragment was used to replace the
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6.) The ftK-1!HPRT plasmid was linearised for





Cloning Strategy: flk-1/GFP Vector Construction
/Bam HI
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FIk-1 5'homology LacZ
2.) Insertion of excised fragment into pBluescript SK+ at




3.) Excision of Lac Z reporter using Eco Rl and Pst I
enzymes.
4.) The Eco Rl and Pst I overhangs were blunted, in







7.) The isolated EGFP cDNA was used to replace the excised






8.) The /Wt-l/GFP plasmid was linearised for electroporation
with the single cutting Not I enzyme.
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Appendix B:
Statistical Analysis of the significance of EB
disaggregation techniques and EBs age on cell
survival and differentiation in methvlcellulose culture.
1)3 day and 4 day Embryoid Bodies
The first data set consists of counts of 3 day and 4 day Embryoid Bodies (EBs) that
have been cultured for different lengths of time (7, 14, 21 days) under two treatment
regimes (trypsin, dispase) and are derived from 4 different cell lines (HM1, Rl, D12,
F8). All observations are in triplicate.
1.1) 3 day Embryoid Bodies
The raw mean counts and standard error bars for day 3 EBs are shown in Fig 1
below.
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■ HM1 □ D12 DF8 DR1
Statistical Analysis
On the original scale there is a dependency between the variance and the mean, ie.
the variation between triplicate counts increases as the mean value increases. Before
analysis the counts were transformed onto the log scale to remove this dependency.
Analysis of variance was used to look at the effects of treatment (trypsin, dispase),
cell line (HM1, Rl, D12, F8) and day (7, 14, 21) on the numbers of EBs observed.
The final ANOVA table is shown below (data on log scale). No interactions were









d.f. s.s. m.s. v.r. Fpr.
1 20.7907 20.7907 36.55 <.001
3 77.7428 25.9143 45.56 <.001









celljine d12 f8 hm1 r1
2.76 3.34 1.34 4.19
day 7. 14. 21.
3.60 3.00 2.12
Standard errors of means
Table treat cell line day
rep. 36 18 24
d.f. 65 65 65
e.s.e. 0.126 0.178 0.154
Conclusions
The number of day 3 EBs is affected by all factors in the experiment. The F statistics
in the ANOVA table are highly significant (p<0.001) in all cases. When individual
levels of a factor are compared with each other (eg. one cell line compared to
another) the significance is generally lower.
1. Cell line: The differences between cell lines are consistent across the other factors.
R1 has the highest counts followed by F8, D12 and HM1. Overall the difference
between cell lines is significant at the 0.1% level. Individually all cell lines differ
from each other (p<0.05).
2. Day: The numbers of EBs decrease as day increases from 7 to 14 to 21. Overall
the difference is significant at 0.1%. Individually all days differ from each other
(p<0.05).
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3. Treatment: Trypsin produces consistently higher counts than dispase. The
difference is significant at the 0.1% level. In this case the F statistic is used because
the factor has only two levels.
1.2) 4 day Embryoid Bodies
The counts for Day 4 EBs are uniformly lower than those for Day 3 EBs across all
treatment/cell line/day combinations (see Fig 2 below). There are 26 zero counts out
of 72 counts for individual replicates. Only R1 consistently produced reasonably
high mean numbers of EBs across all treatment combinations (8.7-31.7). F8 and
HM1 produced means in the range 0.0-2.3 and D12 in the range 0.0-8.7. Only cell
line R1 has an average count greater than zero for all days and both treatments. The
very low counts make analysis more difficult.



































































The data were transformed onto the log scale to stabilise the variance. Some
treatment groups heave zero variance because three all replicates produced no EBs.
The treatment combinations that were more successful, eg. R1 x trypsin, tend to have
high variances. Analysis of Variance was performed on the transformed data, as for
Day 3 EBs. In this case all the interactions were significant and no general
conclusions could be drawn. The effect of treatment (trypsin or dispase) varies
significantly across days (7/14/21) and between cell lines (Rl, D12, HM1, F8).
Analysis of variance
Variate: Ieb4
Source of variation d.f. s.s. m.s. v.r. F pr.
celljine 3 171.2762 57.0921 75.54 <.001
treat 1 0.1616 0.1616 0.21 0.646
day 2 27.4326 13.7163 18.15 <.001
celljine.treat 3 15.2261 5.0754 6.72 <.001
celMine.day 6 18.7489 3.1248 4.13 0.002
treat.day 2 5.3400 2.6700 3.53 0.037
cell_line.treat.day 6 11.4794 1.9132 2.53 0.033






celMine d12 f8 hm1 r1
0.20 -1.23 -1.20 2.56
treat disp tryp
0.13 0.03
day 7. 14. 21.
0.95 -0.29 -0.41





cell line day 7. 14. 21.
d12 1.68 -1.10 0.02
f8 -0.27 -1.90 -1.50
hm1 -0.72 -0.60 -2.30
r1 3.11 2.44 2.13
treat day 7. 14. 21.
disp 1.38 -0.50 -0.49
tryp 0.53 -0.08 -0.34
treat disp tryp
cell line day 7. 14. 21. 7. 14. 21.
d12 2.14 -2.30 -0.27 1.23 0.10 0.31
f8 -0.27 -2.30 -1.50 -0.27 -1.50 -1.50
hm1 0.87 0.31 -2.30 -2.30 -1.50 -2.30
r1 2.77 2.30 2.12 3.46 2.57 2.14
Standard errors of differences of means
Table eelMine treat day celMine
treat
rep. 18 36 24 9
d.f. 48 48 48 48
s.e.d. 0.290 0.205 0.251 0.410
Table celMine treat celMine
day day treat
day
rep. 6 12 3
d.f. 48 48 48
s.e.d. 0.502 0.355 0.710
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Conclusions
For day 3 EBs dispase produces significantly more EBs than trypsin (p<0.001) and
the number falls significantly from 7 to 14 and then to 21 days (p<0.05). The R1 cell
line produces the most EBs followed by F8, D12 and FIM1. The differences between
individual lines are significant (P<0.05).
For day 4 EBs the interactions between treatment, day and cell line are all significant
and no general statements can be made about the significance of these effects. The
trend is for numbers of EBs to decrease as day increases from 7 to 21 and for R1 to
produce the highest numbers of EBs, as was the case for day 3 EBs. There is no clear
difference between trypsin and dispase, unlike day 3 EBs.
Comments
These data can also be analysed assuming that the cell lines are "random" - i.e. that
the individual cell lines are not of interest but merely represent a sample from a range
of cell lines. If an analysis on this basis is performed the results are similar. For day 3
EBs the effects of treatment and day are significant as they were for the ANOVA.
For day 4 EBs only the effect of day is significant. The overall conclusions remain
the same.
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2) 2.75 and 3.5 day EBs
The data set is of the same form as in (1) except for the age of the EBs (see Figures 3
& 4 and ANOVA tables below). The pattern of the responses of the cell lines to the
treatments over time is similar and the same type of statistical analysis was
performed.
2.1) 2.75 day Embryo Bodies
















■ HM1 38.3 11.7
■ D12 80.3 38.7
□ F8 52.3 17.3



















IHM1 □ D12 □ F8 □ R1
Results
For 2.75 day EBs there is a significant interaction between treat and cell line. This is
due to the fact that HM1 has almost the same number of EBs under Trypsin and
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Dispase compared with Rl, D12 and F8, which have more EBs on the dispase
treatment than on the trypsin treatment. Figure 3 shows this effect clearly. The
differences between numbers of EBS for Rl, D12 and F8 are significant at the 5%
level when tested individually. The effect of day is also significant (p<0.001). The
numbers of EBs decreases approximately linearly with time.
ANOVA: Ieb2.75
Source of variation d.f. s.s. m.s. v.r. F pr.
treat 1 10.86905 10.86905 152.36 <.001
day 2 13.00004 6.50002 91.11 <.001
celljine 3 31.04519 10.34840 145.06 <.001
treat.celMine 3 2.79274 0.93091 13.05 <.001






































Standard errors of differences of means
Table treat day celljine treat
cell line
rep. 36 24 18 9
d.f. 62 62 62 62
s.e.d. 0.0630 0.0771 0.0890 0.1259
If an analysis assuming random cell lines is performed then the effects of treatment
and day are both significant (p<0.01). Dispase is superior to trypsin and the numbers
of EBs decreases approximately linear as the number of days increases from 7 to 21.
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Conclusions
As for day 3 and day 4 EBS there is a clear effect of time. Numbers of EBS decrease
as days increase from 7 to 21. The effect of treatment is not so simple. The treatment
effect (trypsin versus dispase) is very small for one cell line (HM1) but dispase is
consistently (and statistically significantly) superior for the other 3 (Rl, D12, F8). If
the analysis with random cell lines is used then this is not an issue (it is taken into
account as random variation) and the effect of treatment is significant overall.
2.2) 3.5 day Embryo Bodies
Results
For 3.5 day EBs there is a significant interaction between treatment and cell line.
There is no consistency between the treatments. Trypsin is superior for F8 and HM1.
Dispase is superior for Rl and D12, which have higher numbers of EBs on both
treatments than the other 2 cell lines. Again the effect of day is significant and
consistent - an approximately linear decrease over time.
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■ HM1 BR1 □ D12 □ F8
An analysis assuming random cell lines produces a significant difference only
between days. There is no significant treatment effect.
Conclusion
The only consistently significant effect is that of day. Dispase is still superior to
Trypsin for some cell lines but the effect is less consistent than it was for 3 and 4 day
EBs.
3) 2.75 and 3.5 day haematopoietic colonies
Some EBs turn into haematopoietic colonies. Figures 5 and 6 below show the
numbers of haematopoietic colonies at 2.75 and 3.5 days for the same set of
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treatments and cell lines described above. The same analysis was used as for EBs
and, as before, the data were transformed onto the log scale to stabilise the variance.
3.1) 2.75-day haematopoetic colonies
There is a significant interaction between treatment and cell line. Three cell lines
produce more haematopoietic colonies (HCs) on dispase, namely Rl, D12 and F8.
One cell line, HM1, produces more HCs on trypsin. The effect of day is also
significant (p<0.05). There are more HCs on day 21 than on day 14.
Figure 5: 2.75 day haematopoeitic colonies
■ HM1 ■ R1 □ D12 □ F8
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ANOVA: Ih2.75
Source of variation d.f. s.s. m.s. v.r. F pr.
treatment 1 6.83949 6.83949 70.57 <.001
day 1 0.43667 0.43667 4.51 0.040
celMine 3 14.95083 4.98361 51.42 <.001
treatment.celMine 3 4.84846 1.61615 16.67 <.001















celMine d12 f8 hm1 r1
3.158 2.391 2.347 3.684
treatment cell line d12 f8 hm1 r1
disp 3.631 3.051 2.187 4.221
tryp 2.684 1.730 2.508 3.148
Standard errors of differences of means
Table treatment day celMine treatment
cell line
rep. 24 24 12 6
d.f. 39 39 39 39
s.e.d. 0.0899 0.0899 0.1271 0.1797






















If cell line is treated as random then the effect of day is no longer significant but the
effect of treatment is significant (p<0.01). Dispase produces significantly more HCs
than Trypsin when the variation between cell lines is seen as another source of
random experimental error rather than a systematic effect.
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3.2) 3.5 day haematopoetic colonies
The results of the ANOVA are very similar to those for 2.75 day HCs (see table
below). There is a significant interaction between treatment and cell line. Dispase is
superior only for D12, it is marginally better for R!, F8 produces more HCs on
trypsin and HM1 produces almost identical results on each treatment (see Figure 6
below). Again there is a significant effect of day (p<0.01). There are more HCs on
day 21 than on day 14.
If cell line is treated as a random effect then there is a significant effect of day
(p<0.01) but no other significant effects. This is in contrast to the results for 2.75 day
HCs.
Conclusion
In this case the conclusions are dependent upon the assumptions about the cell line
effect. If cell lines are assumed fixed then for both 2.75 and 3.5 day HCs there is a
significant effect of day (more HCs on day 21 than on day 14) but no consistent
treatment effect because this varies across cell lines. If we assume cell lines to be a
random effect then the results for 2.75 and 3.5 day HCs are not consistent. There is a
significant effect of treatment on day 2.75 (dispase is superior to trypsin) but no
treatment effect on day 3.5. Conversely there is no effect of day on 2.75 day HCs but
there is a significant day effect (day 21 has more HCs than day 14) on 3.5 day HCs.
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Figure 6: 3.5 day haematopoeitic colonies
IHM1 □ R1 □ D12 □ F8
ANOVA: Ih3.5
Source of variation d.f. s.s. m.s. v.r. F pr.
treatment 1 0.0919 0.0919 0.89 0.352
day 1 1.0052 1.0052 9.70 0.003
celHine 3 13.0225 4.3408 41.91 <.001
treatment.celljine 3 1.2177 0.4059 3.92 0.015

























treatment cell line d12 f8 hm1 r1
disp 3.208 1.719 2.799 3.484
b 2.786 2.123 2.775 3.176
Standard errors of differences of means
Table treatment day celljine treatment
cell line
rep. 24 24 12 6
d.f. 39 39 39 39
s.e.d. 0.0929 0.0929 0.1314 0.1858
Least significant differences of means (5% level)
Table treatment day celljine treatment
cell line
rep. 24 24 12 6
d.f. 39 39 39 39
I.s.d. 0.1879 0.1879 0.2658 0.3758
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Appendix C:
Supplementary photographs of repeats of the
differentiation trial shown in Figure 6.2
D12 fffc-T/HPRTES Cell HAT Selection Control
Line
No Selection Selection Applied HM1 Cells in HAT Selection
Cell number and morphology offlk-1/hprt ES cells growing with (b, d, f, h) and without (a, c,
e, g) HAT selection. HAT selection was applied at various timepoints: at the time of plating
on collagen IV: day 0 (b), and at 2 (d) and 4 days (f, h) after plating. Cultures were
maintained until 8 days after plating when the control plates were fully confluent (g). HM1
ES cells were used as a negative control to assess the level of cell death expected from a
completely HPRT deficient ES cell line (i, j). Cells maintained under identical growth








Figure6.3Coursf selectionandc lld a h afterHATselectioni appliedt6d yso differentiationofflk- 1/HPRTEScellson collagenIV.Cellsinand outfselectionarehow at6( ,b)8cd)nd10 (e,f)daysof differentiation.HAT sensitiveHM1EScells thathavebeenpl c din selectionfor4daysre shown(g)alongside thoseathavnobeen placedund rHAT selection(h).Scaleb r represents200pm.
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